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DOI:10.14753/SE.2019.2295
6 
 
LOQ  limit of quantitation 
LPS  lipopolysaccharide 
MAO  monoamine oxidase 
MEKC micellar electrokinetic capillary chromatography 
MIC   minimal inhibitory concentration 
MS  mass spectrometry 
MS/MS tandem mass spectrometry 
NADPH nicotinamide adenine dinucleotide phosphate 
NF-κB  nuclear factor κB 
NMR  nuclear magnetic resonance 
NOESY  nuclear Overhauser effect spectroscopy 
Ovx  ovariectomized 
P2CP, P4CP pterocarpan C-2/4 prenyltransferase 
P6aH  pterocarpan 6a-hydroxylase 
PPARα, , δ peroxisome proliferator-activated receptor α, , δ  
pRi T-DNA root infecting plasmid transfer DNA 
rDA  retro Diels-Alder  
ROESY rotating frame Overhauser effect spectroscopy 
SAM  S-adenosyl-L-methionine  
SC50   50% radical scavenging concentration 
SFE  supercritical fluid extraction 
SIM  selective ion monitoring 
SPE  solid-phase extraction 
TIC  total ion-current chromatogram 
TOCSY total correlation spectroscopy 
TRAIL tumor necrosis factor α-related apoptosis inducing ligand 
UHPLC ultrahigh pressure liquid chromatography 
VEGF  vascular endothelial growth factor  
VR  vestitone reductase 
 
  
DOI:10.14753/SE.2019.2295
7 
 
 Introduction 
Natural products and plant derived remedies accompanied us since prehistoric times and 
they are still a popular choice of self-healing. Although, many herbal extracts are proved 
to have beneficial health effects, the responsible components are undefined in the majority 
of cases. With the help of phytochemical and phytoanalytical techniques, the aim of 
pinpointing the most potent molecules in the herbal drugs can be executed. The results of 
these studies are not only feeding the intrinsic curiosity – How and why does it work? – 
but can be the base of the quality control of herbal drugs and preparations. Taking 
advantage of the capacities of biotechnology, the metabolite profile of the plant can be 
fine-tuned, resulting in easier accessibility to the beneficial molecules. Furthermore, with 
the structural knowledge of the effective compounds, new semisynthetic, structurally 
optimized molecules can be created.   
The aim of this work is to reveal the phytochemical and phytomedicinal values of O. 
spinosa and O. arvensis, as these plants have been used in ethnomedicine since hundreds 
of years.  The roots of this plants are a typical example of herbal drugs, where the 
ethnomedicinal use is confirmed by in vitro and in vivo tests, however, the exact 
compounds responsible for the effects are unknown.  
In the literature overview, the as complete as possible description of the plants, their 
chemical constituents and their biological effects was carried out. As related species can 
possess similar phytochemical profile, their most interesting constituents and 
pharmacological effects are summarized, too. As isoflavonoids seemed to be the most 
promising compounds, their analytical possibilities are presented, as a base of the 
experimental work. During our research, we aimed to explore the isoflavonoid profile in 
details using various analytical techniques, to understand the operation of the plant as a 
miniature chemical factory. The chemical profile of O. spinosa and arvensis roots and 
their in vitro hairy root cultures were compared regarding qualitative and quantitative 
points of view.  
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1.I. Characterization of Ononis species 
1.I.1. Botanical characterization of Ononis spinosa L. and Ononis arvensis L. 
The members of the Ononis genus, which belongs to the family Leguminosae, are natively 
distributed in Europe, Central Asia and North-Africa. Ononis genus includes 86 species 
(see Figure 1) [1]. 
 
Figure 1: The phylogenic tree of Ononis species (and some other Leguminosae species) 
based on ITS DNA sequences [1]. 
Ononis spinosa L. (spiny restharrow) is a tall subshrub which grows to a height of 60 cm. 
It has a short rhizome and a ligneous taproot which can be up to 50 cm long. The upright 
stems which grow out of this are lignified at the base and slightly hairy. Numerous short 
shoots have developed into prickly thorns, but thornless varieties also exist. The lower 
leaflets are trifoliate and pinnate, while the upper ones are small and unifoliate with a 
DOI:10.14753/SE.2019.2295
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long oval shape and dentate edges. The leaves are covered with very fine glandulous hairs. 
The striking butterfly-shaped flowers are pink or purplish in color and grow in the upper 
angles between leaf and stem. The flowers are generally solitary but sometimes also grow 
in loose clusters (Figure 2). They produce soft-haired pods bearing rounded, lumpy seeds. 
Spiny restharrow is to be found in dry meadows and pastures, by fields and waysides, but 
also in peat areas and sand dunes. It favors sunny locations with weak loamy or chalky 
soils. Fertilizing causes it to disappear [2]. 
Ononis arvensis L. (field restharrow) is a perennial shrub preferring humid fields and 
meadows overall in Europe. The 30–80 cm high erect stem is covered by long and thick 
trichomes, but thornless. The plant has an unpleasant smell due to the excrete of the 
glandular trichomes. It has alternating stalked leaves; the blade has three elliptic-quite 
round leaflets with serrated margins. The terminal leaflet is stalked. The large stipules are 
united with the stalks. The butterfly-like corolla is pinkish and fused at base. The flowers 
are axillary in pairs. Inflorescence is a leafy terminal raceme or flowers axillary in pairs 
(Figure 3). The 1-3 seeded opening pod is 6-9 mm. The synonym names are Ononis 
hircina Jacq. and Ononis spinosa subsp. hircina (Jacq.) Gams. It usually grows in dry 
places in different kinds of fields like inland meadows, grazing land and banks [3].  
 Figure 2: Ononis spinosa L. Figure 3: Ononis arvensis L. 
DOI:10.14753/SE.2019.2295
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1.I.2. Chemical characterization of Ononis species 
Ononis spinosa L. 
The following chemical constituents were identified in Restharrow root:  
Isoflavonoids [4]–[11]:  
• formononetin, ononin (formononetin 7-O-glucoside), formononetin 7-O-
glucoside 6”-malonate, rothinidin (pseudobaptigenin 7-O-glucoside), genistein, 
genistin (genistein 7-O-glucoside), biochanin A, sissotrin (biochanin A 7-O-
glucoside), biochanin A 7-O-glucoside 6”-malonate, daidzein, daidzin (daidzein 
7-O-glucoside), calycosin D (3’-methoxy daidzein), tectoridin,  
• trifolirhizin (maackiain 3-O-glucoside), medicarpin 3-O-glucoside 
• 2,3-dihydro-ononin, onogenin, onogenin-7-O-glucoside, sativanone, and 
sativanone-7-O-glucoside. 
Phenolic lactones: 
• spinonin [12], and clitorienolactone B [11] were also characterized. 
Triterpenes: 
• α-onocerin (onocol) [13] 
• β-sitosterol, stigmasterol, campesterol, cholesterol, α-spinasterol [7], [14] 
• saponin (3-O-[α-L-rhamnopyranosyl-(1→2)-β-D-xylopyranosyl-(1→2)-β-D-
glucuronopyranosyl]-3β,22α-dihydroxyolean-13-en-11) [15] 
Phenolic acids: 
• p-hydroxybenzoic, vanillic acid, caffeic acid, syringic acid, p-coumaric acid, 
cinnamic acid, sinapin acid, salicylic acid, gentisic acid [7, 14] 
Lectins: 
• Lectins Index Nomenclature LECp.Ono.Spi.ro.Hga1 [16] 
Essential oil (small amount): 
• trans-anethole (major constituent), carvone, menthol, menthone, isomenthone, 
linalool, estragole, borneol and cis-anethole [17] 
Ononis arvensis L. 
Isoflavonoids (from roots) [18]–[21]: 
• ononin  
• onogenin  
• maackiain, trifolirhizin  
DOI:10.14753/SE.2019.2295
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Phenolic acids (from aerial parts): 
• hydroxycinnamic acids [22] 
• hydroxybenzoic acid, ellagic acid [23] 
Flavonoids (from aerial parts) [23]: 
• dihydro-quercetin, rutin, quercetin, kaempferol, isorhamnetin 
• catechin, epicatechin 
• luteolin, apigenin, chrysin, eriodyctiol, naringenin 
• phloridzin, phloretin  
Stilbenes (from aerial parts): 
• piceol, trans-resveratrol [23] 
Coumarins (from aerial parts): 
• scopoletin, scopolin [24] 
Triterpenes (from whole plant) [13]: 
• α-onocerin (onocol) 
• β-sitosterol, stigmasterol, campesterol, cholesterol, α-spinasterol  
Lectins [25] 
The representative structures of isoflavonoid derivatives, special phenolics and terpenoids 
can be seen in Figure 4. 
 
 
Figure 4: Representative structures of O. spinosa and O. arvensis 
DOI:10.14753/SE.2019.2295
12 
 
Other Ononis species 
Isoflavonoids were also described for O. angustissima [26], O. speciosa [27], O. natrix 
[28], [29], O. viscosa [30], O. vaginalis [31], [32], O. serrata [33], O. pusilla [34], while 
flavonoids were found to be in O. angustissima [35], [36], O. speciosa [27], O. natrix 
[37], and O. pusilla [34]. Special phenolic lactones were isolated from O. angustissima 
[26] and O. speciosa [38]. The essential oil of O. angustissima [39], [40], O. reclinata 
[34], O. natrix [41], O. viscosa [42] were studied. Probably the most unique compounds 
in Ononis species are the alkyl derivatives of resorcinol, benzoic acid, isocoumarin and 
anthranilic acid (see Figure 5), which are present in O. speciosa [27], [43], O. natrix [28], 
[37], [44]–[49], O. viscosa [50], [51], O. pubescens [52] and O. pusilla [34].  
 
 
Figure 5: Alkyl derivatives of resorcinol, benzoic acid, isocoumarin and anthranilic acid 
found in various Ononis species 
 
1.I.3. Biological activities of Ononis spinosa extracts 
Ethnomedicinal use 
O. spinosa root has been widely used since ancient times and it is mentioned in many old 
documents such as Dioskurides (increases diuresis and breaks stones), Plinius (the root 
expels bladder-stones), Matthiolus (stimulates diuresis, powerfully breaks the stones), 
Lonicerus (expels the stone and urine) or Schroder (stimulates diuresis and against 
kidney- and bladder-stones). It has been traditionally used for the treatment of the lower 
urinary tract disorders in the irrigation therapy as a diuretic medicine for inflammatory 
conditions of the lower urinary tract and for preventing and treating kidney and bladder 
disorders, gravel and small stones [53]. Ononis species have been used for centuries as 
DOI:10.14753/SE.2019.2295
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folk remedies in Turkey as diuretic, antiseptic and antimicrobial aids. In their folk 
medicine, restharrow root is also used for gout and rheumatic complaints and skin 
disorders [40], [54]. 
Diuretic effect 
In vivo experimental studies on the diuretic effect of Ononidis radix were performed and 
described in a dissertation thesis of Wilhelm Bulow already in 1891 [55]. Fifty years later, 
Vollmer et al. investigated again the diuretic effects of Ononis extracts on various species. 
The per os administration of aqueous extract of the roots to rats induced the most 
pronounced effect, although in a very high dose of 1 g/animal. Infusion of O. spinosa root 
was administrated orally to rabbits and resulted in an elevation of urinary output by 26% 
[56], [57].  
Hilp et al. confirmed a diuretic activity with in vivo studies. Oral administration of 
infusions of the O. spinosa root caused slight diuresis (average of 12% increase compared 
to the control) and decoctions an antidiuretic effect of 7-20% in rats. The essential oil 
extracted with steam distillation showed a diuretic effect as well, however, the aqueous 
residue of steam distillation exhibited a weak anti-diuretic effect [17]. 
Rebuelta et al. aimed to investigate the diuretic mechanism of O. spinosa extracts and 
investigated the urinary output as well as the alkali ion excretion. In order to specify the 
compounds responsible for the flushing effect, they tested the dried aqueous and methanol 
extracts and the ash of the roots on rats in a dose of 0.3 g. Theophylline (5 mg/kg) served 
as positive control, whereas the control group received distilled water. The urinary 
volume was registered in every hour (see Figure 6) and the cumulative amount of Na+ 
and K+ ions was measured by atom absorption spectrometry (see Figure 7). The results 
showed that the various extracts and ash of the root were slightly more effective than 
theophylline. The highest increase in volume was experienced with the aqueous extract 
and the ash. The Na+ and K+ excretion was elevated mostly by the administration of ash 
and dried methanol extract. Rebuelta et al. have drawn the conclusion that the diuretic 
effect is caused mainly by the flavonoid glycosides and the high potassium content of the 
root [58]. 
DOI:10.14753/SE.2019.2295
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Figure 6:  Effects of intragastrical administration of distilled water, teophyllin, dried 
aqueous and methanol extract and the mix of ash and methanol of O. spinosa root [58] 
 
 
Figure 7: Cumulative sodium- and potassium ion content of urine collected from rats 
treated with distilled water, theophyllin, dried aqueous and methanol extract of O. 
spinosa root, ash, and mix of dried methanolic extract and ash [58] 
Bolle et al. administered 2 g/kg O. spinosa root extract to rats per os and intraperitoneally. 
As a control, isotonic saline solution was used. After 2 hours the urinary volume increased 
in the per os group with 103%, which means a significant difference. However, according 
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to their results, the excretion of Na+ and K+ did not change. Interestingly, in the 
intraperitoneal group difference in diuresis was not observable [59].  
 
Anti-inflammatory and analgesic effect 
Investigating the analgesic activity, nor the per os neither the intraperitoneally 
administered ethanol extract showed effectiveness during the murine hot plate test. The 
phenylquinone-induced writhing reaction was decreased by 80% if the rats had been pre-
treated with 100 or 500 mg/kg dry ethanol extract. Administering 500 mg/kg ethanol 
extract  intraperitoneally to rats decreased the carrageen induced paw edema by 46% after 
3 hours and 34% after 5 hours [59].  
Yölmaz et al. evaluated the analgesic effect of aqueous O. spinosa root extract using the 
murine tail flick test. For positive controls, aspirin (100 mg/kg) and morphine (10 mg/kg) 
were used. The herbal extract was administered in 25 mg/kg, 50 mg/kg and 100 mg/kg 
intraperitoneally. Their results showed, that the O. spinosa extract significantly alleviated 
pain after 30, 90 and 150 minutes to administration in 50 mg/kg and 100 mg/kg doses. 
The most outstanding results emerged in the 50 mg/kg group (see Figure 8) [60]. 
Öz et al. investigated the anti-inflammatory effect of fractions of O. spinosa root ethyl 
acetate extract obtained by column chromatography. In the carrageenan-induced paw 
edema in mice, the dried extract administered in 100 mg/kg dose showed significant 
inhibition of swelling thickness, which was similar to the effect of 10 mg/kg 
indomethacin. However, nor in the 12-O-tetradecanoylphorbol-13-acetate-induced ear 
edema test, neither in the adjuvant-induced chronic arthritis exhibited any extract 
significant inhibitory effect [61].  
The cytosolic phospholipase A2α is one of the potential targets for anti-inflammatory 
drugs, since this enzyme plays a key role in the inflammation processes seen in health 
disorders, like asthma, allergic reactions, arthritis and neuronal diseases. In the study of 
Wink et al., inhibition of the enzyme by methanol extracts from medicinal plants rich in 
polyphenols was determined. O. spinosa exhibited an IC50 value of 39.4 µg/mL, resulting 
one of the most potent tested medicinal plant [62].  
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Figure 8: The standardized results of tail flick test using aspirin, morphine and 25, 50 
and 100 mg of aqueaous extract of O. spinosa root [60] 
 
Antibiotic effect 
Petroleum ether, ethanol, butanol and aqueous crude extracts of the whole aerial parts of 
O. spinosa were tested against four bacterial and three fungal species by Mahasneh et al. 
Using the disc diffusion method, methanol and hexane extracts did not show any activity 
and compared with standard antibiotics, the other extracts had low to moderate activity. 
The butanol extracts at 4 mg/disc had high-moderate antifungal activity against 
Aspergillus flavus, Fusarium moniliforme and Candida albicans relative to miconazole 
nitrate at 40 μg/disc [63].  
Çitoǧlu and Altanlar aimed to evaluate the antibiotic effect of the aerial parts of O. 
spinosa using the same method. The discs were impregnated with O. spinosa extract made 
with 75% aqueous ethanol, ampicillin or fluconazole. The tested microorganisms and the 
results can be seen in Table 1, which suggest that the extract had a moderate antibiotic 
and antifungal effect [64] 
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Table 1: Inhibition zones after the application of O. spinosa extract, ethanol, ampicillin 
or fluconazole 
 Inhibition zones (mm) 
 E. 
Coli 
P. 
Aeruginosa 
B. 
Subtilis 
S. 
Aureus 
C. 
Albicans 
C. 
Glabrata 
C. 
Krusei 
O. spinosa 11 11 1 11 16 7 16 
Ethanol - - - - - - - 
Ampicillin 12 n.d. 13 15 n.d. n.d. n.d. 
Fluconazole n.d. n.d. n.d. n.d. 18 20 20 
 
Antioxidant effect 
Çoban et al. evaluated ethanol extracts from six species representing six different 
families, used in traditional medicine in Turkey for their antioxidant activities. In vitro 
tests included superoxide anion radical scavenging activity (determined 
spectrophotometrically on the basis of inhibition of cytochrome c reduction) and lipid 
peroxidation (investigated on rat liver homogenate induced with FeCl2-ascorbic acid). 
The extract of O. spinosa aerial part showed concentration-dependent superoxide anion 
radical scavenging activity. The results of the superoxide anion formation assay showed 
that the ethanol extract of O. spinosa had moderate scavenging activity (IC50 1.35 mg/ml) 
and it had no significant effect on lipid peroxidation [65].  
Wound healing effect  
In order to establish the ethnopharmacological wound healing use of Ononis species, Öz 
et al. investigated the n-hexane, ethyl acetate and methanol extracts of O. spinosa roots 
and aerial parts. As the results showed that the most potent was the ethyl acetate extract 
of the roots [66], they continued the experiments with the silica gel fractions of this 
extract. The fractions were tested in linear incision and circular excision wound models 
and hydroxypyroline estimation assay on rats. The fifth fraction (Fr5) exhibited 
remarkable wound healing activity with the 33.4% tensile strength value on the linear 
incision wound model (madecassol as internal standard 53.8%) and 51.4% reduction of 
the wound area at the day 12 on the circular excision wound model (madecassol 100%). 
Hydroxyproline content of the tissue treated by Fr5 was found to be 30.9 ± 0.72 μg/mg 
(madecassol 47.7 ± 0.57 μg/mg). Trifolirhizin, ononin, medicarpin 3-O-glucoside, 
onogenin 7-O-glucoside and sativanone 7-O-glucoside were isolated from Fr5 and tested 
for their wound healing activities by measuring their inhibition of hyaluronidase, 
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collagenase and elastase enzymes. Ononin and sativanone 7-O-glucoside inhibited 
hyaluronidase and elastase enzymes by 31.66% and 41.75%; 45.58% and 46.88%, 
respectively, at the dose of 100 μg/mL [61].  
Addotey et al. executed bioactivity guided isolation from O. spinosa root extracts, based 
on hyaluronidase inhibition activity, too. Hot water and hydroalcoholic extracts showed 
moderate inhibiting effects (IC50 1.36 and 0.73 mg/ml) while dichloromethane extract 
exerted an IC50 of 190 μg/mL. Bioassay guided fractionation of the dichloromethane 
extract yielded four isoflavonoids with anti-Hyal-1 activity: onogenin, sativanone, 
medicarpin and calycosin-D with inhibition rates of 25.4, 61.2, 22.4 and 23.0%, 
respectively, at test concentration level of 250 μM. The IC50 value of sativanone, the most 
active compound was determined of 151 μM, which was better than that of the positive 
control glycyrrhizinic acid (177 μM) [11].  
 
1.I.4. Biological activities of Ononis arvensis 
In ethnomedicine, the aerial part has been applied for typhus and hernia, as aphrodisiac, 
and for stomach disorders as decoction. It is believed, that the plant maintains the optimal 
level of living water in the body therefore it can be used against diarrhea. The herb is 
traditionally applied for liver and stomach disorders as a decoction in the human and 
veterinary medicine [23]. 
Dénes et al. investigated the antimicrobial activity of different extract of O. arvensis aerial 
parts. Firstly, the methanolic extracts of separated leaves and stems were partitioned with 
n-hexane, chloroform, ethyl acetate and butanol, then these fractions were dried and re-
dissolved in DMSO. The activity of the extracts was tested again Staphylococcus aureus 
(ATCC 25923), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 
27853), Salmonella typhimurium (ATCC 14028) and Candida albicans (ATCC 90028) 
using tube diluting and microdiluting method. The chloroform extract of the leaves 
exhibited strong antimicrobiotic activity against E. coli and C. albicans (MIC = 51 μg/ml 
and 12.75 μg/ml), interestingly, the n-hexane extract showed only antifungal activity 
against C. albicans (MIC = 8 μg/ml). The ethyl acetate extract of the leaves inhibited the 
growths of S. aureus and C. albicans, however, the same extracts of the stems proved to 
be more effective (MIC = 16 and 8 μg/ml). The chloroform extract of the stems could 
inhibit only the growth of P. aeruginosa (MIC = 43.5 μg/ml) and the butanol extract could 
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inhibit only S. typhimurium (MIC = 46.5 μg/ml). The methanol and aqueous extracts 
showed no significant antimicrobial effects and no extract could inhibit the growth of E. 
coli.  
 
1.I.5. Biological activities of other Ononis species 
The results of the most important in vitro and in vivo tests of various other Ononis species 
are summarized in the Table 2.  
 
1.I.6. Possibilities to produce isoflavonoids by in vitro cultures of Ononis species 
Plant cells are miniature reactors which produce a vast array of natural products. Most of 
these products are small molecules and are of keen interest, because they have shown 
potential as food additives, nutraceuticals, pharmaceuticals and cosmetic ingredients. 
Some metabolites can be accumulated with a higher yield in in vitro cultures than those 
in parent plants, suggesting that the production of plant-specific secondary metabolites 
by plant in vitro cultures instead of whole plant cultivation possesses great potential. 
Plants can also be genetically engineered to produce commercially interesting proteins 
including vaccines, antibodies, and other mainly therapeutic proteins [67], [68]. 
Secondary metabolites, including isoflavonoids, can be produced by using different 
biotechnological approaches, such as callus cultures, cell suspension cultures and/or 
organ cultures. Since it was observed that production of secondary metabolites is 
generally higher in differentiated plant tissues, there were attempts to cultivate whole 
plant organs, i.e. shoots or roots in in vitro conditions. As it was expected, such organ 
cultures produced similar patterns of secondary metabolites as intact plants. 
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Table 2: Summary of the biological activities, the type of experiments and used extracts of various Ononis species 
Species Investigated effect Type of 
substance 
Experiment Result Source 
O
. 
a
n
g
u
st
is
si
m
a
 
α-amylase and α-
glucosidase 
inhibition 
MeOH-H2O 
extract  
n-BuOH extract  
in vitro enzymatic test IC50 = 0.94 mg/ml 
IC50 = 0.99 mg/ml     
[69] 
antioxidant isolated 
trifolirhizin 
DPPH,  
ABTS,  
reducing power assays 
IC50 = 19.53 µg/ml 
IC50 = 28.29 µg/ml 
IC50 = 38.53 µg/ml 
[26] 
 
neuroprotective isolated 
maackiain and 
medicarpin  
(30 / 75 µM) 
protective effect on Aβ25–35 
peptide induced cytotoxicity in 
PC12 cells 
significant increase in cell 
viability 
O
. 
m
a
cr
o
sp
er
m
a
 
wound healing 
effect 
aqueous and 
EtOH extracts 
of aerial parts 
(5 mg extract 
topically) 
in vivo linear incision model  significant increase in tension 
strength (40.7% and 45.3%) 
[54] 
wound healing 
effect 
aqueous extract 
of aerial parts 
(5 mg extract 
topically) 
in vivo circular excision model  significant wound contraction 
after 8, 10 and 12 days 
 
anti-inflammatory 
activity 
aqueous (200 
mg/kg) and 
EtOH extracts 
of aerial parts 
(100 and 200 
mg/kg) 
 
in vivo acetic acid-induced 
increase in capillary permeability  
inhibition of 35.7% 
and inhibition of 30.3% and 
37.6% 
 
2
0
 
 
DOI:10.14753/SE.2019.2295
21 
 
 
O
. 
va
g
in
a
li
s 
anti-inflammatory 
activity 
isolated 
maackiain (2.8 
mg/kg) 
in vivo carregeenan induced rat 
paw edema 
65.7%  [32] 
hepatoprotective 
activity 
isolated 
trifolirhizin 
(7.5 mg/kg) 
in vivo CCl4 induced liver 
damage 
SGOT 28.79% decrease, 
SGPT 34.57% decrease, ALP 
31.20% decrease, bilirubin 
27.48% decrease 
 
estrogenic activity isolated 
trifolirhizin 
in vivo increase in uterine weight 93%  
O
. 
n
a
tr
ix
 
cholinesterase 
inhibition 
EtAc extract of 
aerial parts 
in vitro enzyme inhibitory assay 
(Elmann’s method) 
1.46 mg galanthamine 
equivalent/g AChE 
0.93 mg galanthamine 
equivalent/g BChE 
[29] 
tyrosinase inhibition aqueous extract 
of aerial parts 
in vitro enzyme inhibitory assay 
(dopachrome method) 
52.81 mg kojic acid 
equivalent/g 
α-glucosidase 
inhibition 
 
 
MeOH extract 
of aerial parts 
in vitro enzyme inhibitory assay 
(chromogenic PNPG method) 
 
17.52 mg acarbose 
equivalent/g 
DNA protective 
effect 
 
 
 
aqueous extract 
of aerial parts 
(5 and 10 
mg/ml) 
in vitro plasmid stability 70 and 78% inhibition 
cytotoxicity EtAc extract of 
aerial parts 
in vitro test on MDA MB-231 
cell line 
IC50 = 28.75 µg/ml [70] 
 
anti-inflammatory 
activity  
EtAc extract of 
aerial parts 
in vitro test on LPS induced HeLa 
cell line 
10 µg/ml 80-100% inhibition 
of production of TNFα 
[71] 
2
1
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The advantage of using organ cultures is that they are relatively more stable in production 
of secondary metabolites than cultures of undifferentiated cells, such callus or suspension 
cultures. For the objective of production of plant secondary products, generally two types 
of organ cultures are considered, i.e. root cultures and shoot cultures. Root systems of 
higher plants, however, generally exhibit slower growth than cultures of undifferentiated 
plant cells and are difficult to harvest. Compared to the cell suspension cultures, organ 
cultures generally display a lower sensitivity to shear stress, but they show a high degree 
of spatial heterogeneity in biomass production [72].  
Callus culture is the culture of dedifferentiated plant cells induced on media usually 
containing relatively high auxin concentrations or a combination of auxin and cytokinin 
in in vitro conditions. Fedoreyev et al. established callus cultures from Maackia 
amurensis and analyzed them for isoflavonoids. The isoflavones daidzein, retuzin, 
genistein and formononetin and the pterocarpans maackiain and medicarpin were found 
to be produced by these cultures in approximately four times higher concentration than 
the content of the heartwood of M. amurensis plants [73]. Moreover, Li et al. established 
six callus cultures of Genista species with the objective to produce isoflavones with 
phytoestrogenic activity. Callus cultures of all species produced more isoflavones than 
the parent herbs. In vitro cultures had lower contents of genistein esters than the herbs 
[74]. Stable and optimized callus cultures are the first step of preparing the inoculum for 
liquid suspension cultures. Production of secondary metabolites in cell suspension 
cultures have been widely published and it was proposed as a technology to overcome 
problems of variable product quantity and quality from whole plants due to the effects of 
different environmental factors, such as climate, diseases and pests. The approach of 
using plant cell suspension cultures for secondary metabolite production is based on the 
concept of biosynthetic totipotency of plant cells, which means that each cell in the 
cultures retains the complete genetic information for production of the range of 
compounds found in the whole plant. The effect of the potential elicitors (killed cells of 
P. aeruginosa and E. coli, linoleic acid, arachidonic acid, chitosan, CrCl3, AgNO3, CoCl2, 
NiCl2, CdCl2, CuSO4, jasmonic acid, salicylic acid, iodoacetic acid and substituted 
anilides as pyrazine-2-carboxylic acid) on the production of flavonoids in callus culture 
and cell suspension of Ononis arvensis L. was examined by Tůmová and coworkers. All 
the tested elicitors markedly increased the production of flavonoids in comparison to the 
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control, however, only spectrophotometric methods were used to characterize the 
flavonoid content [77–86].  
Genetic transformation of plants mediated by root inducing (Ri) plasmid of 
Agrobacterium rhizogenes bacterium occupies a special place in plant cell engineering, 
since this technique is based on a natural phenomenon that allows cultivation of isolated 
growing plant roots on hormone-free media. Application of wild-type unmodified 
agrobacterial strains allows to obtain root cultures capable of long-term growth in vitro 
due to an increased sensitivity of the cells to auxins while other biochemical properties 
remain unaltered. The in vitro cultivated roots could synthesize root-specific metabolites, 
which makes their application possible for large-scale biotechnological production of 
ecologically pure crude drugs. A collection of pRi T-DNA transformed roots of certain 
dicotyledons was made by Kuzovkina et al; including O. arvensis transformed by R 1601, 
A4 plasmids and O. spinosa transformed by R 1601 plasmid [89]. Although, the 
qualitative and quantitative relations of isoflavonoid content of these root cultures are 
unknown.  
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1.II. Isoflavonoids 
1.II.1. Structural features and occurrence of isoflavonoids 
The Leguminosae, with 19500 estimated species, is the main source of naturally occurring 
isoflavonoids. With only a few exceptions, Leguminosae isoflavonoids are restricted to 
the Papilionoideae, the largest of the three subfamilies currently recognized by legume 
taxonomists (Figure 9). For example, no reports of isoflavonoids from either the 
Caesalpinioideae or the Mimosoideae appeared [90].  
 
Figure 9: Distribution of isoflavonoids in legumes. Clades that produce isoflavonoids 
are highlighted with pink [91] 
 
Isoflavones are the most frequently reported of all the isoflavonoid subclasses, whereas 
isoflavanones are considerably rarer and can be found usually in racemic form (Figure 
10). Reduction of isoflavanones leads to isoflavans, many of which act as phytoalexins 
in legumes. Laevorotatory, dextrorotatory, and racemic isoflavans are known in nature. 
Pterocarpans contain a tetracyclic ring system derived from the basic isoflavonoid 
skeleton by an ether linkage between the C-4 and C-2´positions. Pterocarpans act as 
phytoalexins in leguminous plants and are produced following either fungal infection or 
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abiotic elicitor treatment. Dextrorotatory, levorotatory and racemic pterocarpans are 
known in nature with either a 6aR,11aR or 6aS,11aS configuration at the two chiral 
centers. Coumestans represent the fully oxidized version of pterocarpans. Rotenoids are 
a class of isoflavonoids characterized by the inclusion of an extra carbon atom into a 
heterocyclic ring. Almost all the known rotenoids contain an isoprenoid substituent and 
are noted for their insecticidal, piscicidal and antiviral activities. They can be 
conveniently subdivided into three major types, rotenoids, 12a-hydroxyrotenoids and 
dehydro-rotenoids depending on the oxidation level. Some rarities amongst isoflavonoids 
are coumaronochromones, isoflav-3-enes, isoflav-3-en-2-ones (3-arylcoumarins) and 2-
arylbenzofurans (see Figure 10). In contrast to flavonoid oligomers which are a major 
group of flavonoid derivatives, similar oligomers of isoflavonoids are sporadic in nature 
[92]. 
Figure 10: Structure and numbering of isoflavonoid skeletons 
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The structural diversity of isoflavonoids is a result of the metabolic engineering of the 
aglycone skeleton and glycosylation. The number and complexity of possible substituents 
on the basic structural skeleton (hydroxyl, methoxy, methylenedioxy, prenyl or isoprenyl, 
etc.), the different oxidation levels and the frequent presence of extra heterocyclic rings 
(formed by cyclization between vicinal hydroxy and methoxy or monoprenyl groups) 
account for the multiplicity of subgroups among isoflavonoids (see Figure 11). Some 
isoflavonoids are amino-substituted; these are called “isoflavonoid alkaloids”, whereas 
others may be chlorinated [93] 
 
 
Figure 11: Examples for the structural modification of isoflavonoid skeletons 
 
 
Figure 12: Examples for O- and C-glycosides 
 
In plants, isoflavonoids may be encountered as aglycones or as glycosides with generally 
glucose, rhamnose or apiose as the sugar component [93]. The number of known 
isoflavonoid glycosides is extremely small compared with the vast range of flavonoid 
glycosides [92]. Although the majority of glycosides are O-linked glycosides, several C-
linked glycosides are also known together with a few compounds characterized by both 
C- and O-glycosylation (see Figure 12). One of the most important sources of C-linked 
isoflavones is the genus Pueraria. Through an enzymatic step, the 7-O-glucosides of 
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isoflavones and isoflavanones, and the 3-O-glucosides of pterocarpans could be 
malonylated to their 6”-O-malonyl derivatives [90].  
Although isoflavonoids could be observed with vast majority in Leguminosae species, 
there are some examples in other families, as well. In monocots, few families (only 6 have 
been reported) seem able to produce isoflavonoids. The Iridaceae are the major source of 
isoflavonoids in this group, with more than 50 different compounds described, mainly in 
the genus Iris where they are present in the rhizomes of approximately 20 species. Among 
the dicots, five non-leguminous families are particularly outstanding because of their 
relative abundance in isoflavonoids: the Asteraceae (21 molecules), the Chenopodiaceae 
and the Nyctaginaceae (19 molecules each), the Moraceae (18 molecules), the 
Ochnaceae (17 molecules). However, the presence of isoflavonoids has been reported in 
only few species among these five families. Isoflavonoids have also been mentioned in 
various commercial beers, bourbons, teas and coffees but no study has documented their 
occurrence in the plants themselves [93].  
 
1.II.2. Biosynthesis of isoflavonoids 
Both flavonoids and isoflavonoids are synthesized through the central phenyl-propanoid 
pathway [94]. The factor differentiating isoflavonoids from other flavonoids is the linking 
of the B-ring to the C-3 rather than the C-2 position of the C-ring. The initial steps of 
isoflavonoid biosynthesis are now well characterized at the molecular level, but there is 
limited progress on the later enzymatic steps that produce the wide range of complex 
derivatives found in different legume species [95].  
2-Hydroxyisoflavon synthase 
2-HIS is a key cytochrome P450 enzyme that catalyzes the entry-point reaction into 
isoflavonoid biosynthesis, converting flavanones to isoflavones by an unusual aryl 
migration reaction (Figure 13). 2-HIS only present in legumes for the synthesis of 
isoflavonoids. Arabidopsis possesses 273 putative P450 genes, but none of them has 2-
HIS activity for synthesizing isoflavone. Introducing soybean 2-HIS into Arabidopsis 
thaliana resulted in production of genistein at a high level, indicating its central role in 
the biosynthesis of isoflavonoids and extremely high substrate specificity [94].  
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Figure 13: The biosynthesis of isoflavonoids from flavonoids catalyzed by 2-HIS [95] 
Methylation 
Methylation is one of the key modifications of natural products including (iso)flavonoids 
to modulate their in vivo activity by limiting the number of reactive hydroxyl groups, thus 
altering their solubility and functions. Isoflavone-O-methyltransferase (IOMT) has been 
identified in various leguminous plants. It is an S-adenosyl-L-methionine (SAM)-
dependent methyltransferase transferring a methyl group from SAM to isoflavones 
yielding the methyl ether derivatives (see Figure 14). 4′-O-methyltransferase (HI4′OMT) 
is a dual function enzyme with both 4′-O- and 3-O-methylation activity [94].  
Isoflavone 2’- and 3’-hydroxylase 
Two P450s of the CYP81E subfamily, isoflavone 2’-hydroxylase (I2’H) and isoflavone 
3’-hydroxylase (I3’H), catalyze key steps in the formation of the more complex 
isoflavonoids. Hydroxylation of formononetin at the C-3’ position produces calycosin, a 
precursor for subsequent methylenedioxy bridge formation (yielding pseudobaptigenin) 
as part of the branches leading to maackiain- and pisatin-type phytoalexin end products, 
as well as to the rotenoids and other complex derivatives. Hydroxylation at the C-2’ 
position of daidzein, formononetin, or pseudobaptigenin provides the hydroxyl required 
for C–O–C bridge formation that defines the pterocarpans (e.g., glycinol) (Figure 14) 
[96]. 
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Isoflavone reductase 
The 2’-hydroxyisoflavones are reduced to the corresponding isoflavanones by a NADPH-
dependent isoflavone reductase (IFR). IFR catalyzes enantiospecific conversions with 
high specificity for isoflavones [94]. The isoflavanones are the final isoflavonoid 
intermediates of pterocarpan biosynthesis (see Figure 14). Variant IFR activities between 
species are thought to contribute to the stereochemistry of the pterocarpans produced, in 
particular, (+)-maackiain in Pisum sativum, (-)-maackiain in Cicer arietinum, (-)-3,9-
dihydroxypterocarpan in G. max, and (-)-medicarpin in M. sativa [95].  
 
Figure 14: Steps of isoflavonoid biosynthesis resulting pterocarpans [95] 
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Vestitone reductase and 7,2’-dihydroxy-4’-methoxyisoflavonol dehydratase 
Based on analysis of enzyme preparations, the conversion of isoflavanones to 
pterocarpans was thought initially to be catalyzed by a single NADPH-dependent 
enzyme, termed the pterocarpan synthase. However, it was subsequently shown that in 
M. sativa the conversion of vestitone to medicarpin involves two enzymes, vestitone 
reductase (VR) and 7,2’-dihydroxy-4’-methoxyisoflavanol dehydratase (DMID) (Figure 
14). The reaction series from vestitone to the pterocarpan is thought to proceed by the 
VR-catalyzed reduction of vestitone to DMI, followed by the loss of water and formation 
of the C–O–C bridge between the heterocycle and the B-ring, catalyzed by DMID. In 
some species, the products of VR and DMID (maackiain and medicarpin) are the main 
pterocarpan phytoalexins. They are typically glucosylated and malonylated and stored in 
the vacuole. In species such as G. max, P. sativum and P. vulgaris, the pterocarpans are 
further converted by a series of reactions to species-specific compounds. For G. max and 
P. sativum, the initial reaction is a hydroxylation catalyzed by pterocarpan 6a-
hydroxylase (P6aH) (Figure 15) [95].  
SAM:6a-hydroxymaackiain 3-O-methyltransferase 
Methylation of the 3-hydroxyl of (+)-6a-hydroxymaackiain by hydroxymaackiain 3-O-
methyltransferase (HM3OMT) produces the major phytoalexin of P. sativum, (+)-pisatin 
(Figure 15) [95]. 
Prenyltransferases 
The formation of phytoalexins such as glyceollins and phaseollins requires C-prenylation 
by a range of pterocarpan prenyltransferase activities, with dimethylallyl pyrophosphate 
as the prenyl donor. For glyceollins and phaseollins, prenylation occurs at position C-2 
(pterocarpan C-2 prenyltransferase, P2CP) or C-4 (pterocarpan C-4 prenyltransferase, 
P4CP) of glycinol or C-10 of 3,9-dihydroxypterocarpan (Figure 15) [95]. 
Prenylpterocarpan cyclases 
The final step of glyceollin and phaseollin formation is the cyclization of the prenyl 
residues of glyceollidins and phaseollidins, carried out by P450 prenylcyclases. These 
activities have been studied in detail for the formation of three glyceollins (I, II, and III) 
from glyceollidin I and II, and it is thought that specific activities are involved in each 
reaction (Figure 15) [95].  
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Figure 15: Biosynthesis of pterocarpane based phytoalexins [95] 
Isoflavonoid glucosyltransferase and malonyltransferase 
Glycosylation is a key modification to decorate plant natural products with various 
sugars, enhancing their solubility and stability and facilitating their storage and 
accumulation in plant cells. It is also a major factor in determining the bioactivity and 
bioavailability of natural products. Uridine diphosphate glycosyltransferases are the 
central players in glycosylation of plant natural products. Isoflavonoids are often 
modified by glycosylation, for example, the predominant soy isoflavones are genistein 7-
O-glucoside and daidzein 7-O-glucoside and some malonyl conjugates [94]. In various 
isoflavonoid O-glucoside containing plants the main isoflavone constituents are actually 
isoflavone 7-O-glucoside 6”-O-malonates, however, these labile esters could be 
overlooked due to inadequate sample preparation methods [97]. 
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Flavonoid 6-hydroxylase 
The hydroxyl groups at C-5 and C-7 of the A-ring are introduced during the formation of 
chalcones by chalcone synthase. However, isoflavonoids also occur with C-6 and C-8 
hydroxylation. The cDNA of the possible enzyme represented an elicitor induced P450 
(CYP71D9) with flavonoid 6-hydroxylase activity, which may be involved in the 
biosynthesis of isoflavonoids with 6,7-dihydroxylation of the A-ring. The recombinant 
protein did not act on the isoflavonoids or pterocarpans directly, but rather accepted 
flavanone and dihydroflavonol substrates, including liquiritigenin, suggesting 
hydroxylation occurs prior to aryl migration of the B-ring (see Figure 13) [95]. 
 
1.II.3. Biological activities of selected isoflavonoids 
In the following section, the biological activities of the eight isoflavonoids characterized 
in this thesis are highlighted in order to emphasize their importance. 
Biological activities of formononetin 
As formononetin is one of the most basic isoflavonoids regarding their biosynthesis (see 
page 27), it can be identified in many Leguminosae plants (175 hits for “Isolated as 
Natural Product” in Reaxys database) which possesses beneficial biological activities. As 
a consequence, there is magnitude orders higher amount of publications investigating the 
biological effects of formononetin. 
• Neuroprotective effect 
Amyloid beta (Aβ) is the main component of the amyloid plaques that accumulate in the 
brains of Alzheimer patients. Chen et al. reported the protective role of formononetin 
against Aβ25-35-induced neurotoxicity as formononetin (1-5 μM) significantly increased 
the viability of the cells and decreased the cell apoptosis. Formononetin also accelerated 
the non-amyloidogenic process of amyloid β precursor protein by enhancing α-secretase 
activity and soluble amyloid β precursor protein α release [98]. The study of Sun et al. 
also shows that formononetin increases soluble amyloid β precursor protein α secretion 
and thus protects cells from hypoxia-induced apoptosis [99]. In the study of Fei et al., it 
is established that formononetin in a 15 mg/kg/day dose significantly improved learning 
and memory ability by suppressing Aβ production from amyloid β precursor protein 
processing. Moreover, these results did not differed significantly from that of achieved 
with 1 mg/kg/day donepezil [100].  
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The work of Li et al. concluded that formononetin mediates promising anti-traumatic 
brain injury effects against neurocytes [101], [102]. In addition, the work of El-Bakoush 
et al. established that formononetin inhibits neuroinflammation by targeting nuclear 
factor κB (NF-κB) [103]. In the study of Jia et al., formononetin reduced H2O2-induced 
apoptosis of retinal ganglion cells in a dose of 0.5-10 μM [104].  
• Angiogenic effect 
The study of Huh et al. investigated the influence of formononetin on the expression of 
growth factors contributing to wound healing in human umbilical vein endothelial cells 
(HUVECs). Formononetin (10 and 50 μM) in in vitro and ex vivo tests resulted to be more 
potent than recombinant vascular endothelial growth factor (VEGF125), but in the in vivo 
test of wound closure it did not differed from VEGF125 significantly [105]. Based on in 
vivo tests, formononetin promotes early fracture healing through angiogenesis activation 
in the early stage of fracture repair, and osteogenesis acceleration in the later stages used 
in a 200 μg/kg dose [106]. On the contrary to the previous results, Auyeung et al. aimed 
to examine the potential of formononetin in controlling angiogenesis and tumor cell 
invasiveness in human colon cancer cells and tumor xenografts in mice. The results 
showed that 200 μM formononetin downregulated the expression of the key pro-
angiogenic factors. The tumor size and the number of proliferating cells were reduced in 
the tumor tissues obtained from the formononetin-treated group [107]. In the study of Wu 
et al., formononetin could inhibit the VEGF secretion of human retinal pigment 
endothelial cells under hypoxia in 0.2-5.0 μM concentration. Furthermore, formononetin 
could prevent hypoxia-induced retinal neovascularization in vivo (5-10 mg/kg), however, 
it did not reach the effectiveness of conbercept (1 mg/kg) [108].  
• Vasorelaxive activity 
Wu et al. and Sun et al. evaluated the vasorelaxation effects of formononetin, on rat 
isolated aorta and in vivo, the underlying mechanisms involved. Their results suggest that 
formononetin caused vascular relaxation via endothelium/NO-dependent mechanism and 
endothelium-independent mechanism which involves the activation of BKCa and KATP 
channels. The antihypertensive mechanism in vivo may be associated with the down-
regulation of α1-adrenoceptors and 5-HT2A/1B receptors, and the up-regulation of 
endothelial NO synthase expression in arteries [109]–[111]. The NO-dependent 
mechanism was also supported by the study of Bai et al. [112]. 
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• Osteogenic activity 
In the study of Ha et al., therapeutic potencies of phytoestrogens were investigated. In 
ovariectomized (Ovx) rats, formononetin-treated groups given 1 and 10 mg/kg/day 
displayed increased trabecular bone areas within the tibia [113]. Tyagi et al. achieved 
similar results. Formononetin treatment (10 mg/kg/day for 12 weeks) significantly 
restored the lost trabecular microarchitecture in the femurs and tibia of osteopenic Ovx 
rats and promoted new bone formation [114], [115]. Microcomputed tomography analysis 
showed that formononetin promoted bone healing and this effect observed was equal to 
parathyroid hormone treatment in many aspects [116]. In the study of Huh et al., 
formononetin led to a dramatic increase in normal osteoblast progenitor proliferation and 
differentiation, while decrease in osteoarthritic osteoblasts [117]. According to the results 
of Gautam et al. formononetin maximally stimulated osteoblast differentiation at 100 nM 
but had no effect on osteoblast proliferation. It neither activated estrogen receptor in 
osteoblasts nor had any effect on osteoclast differentiation and did not exhibit estrogen 
agonistic effect in uteri. Daily oral administration at 10.0 mg/kg/day dose to recently 
weaned female Sprague-Dawley rats for 30 consecutive days increased bone mineral 
density [118].  
• Phytoestrogenic activity 
To investigate a possible mechanism by which phytoestrogens might influence mammary 
carcinogenesis, Wang et al. examined the capacity of formononetin to stimulate 
mammary gland proliferation. Among animals treated with formononetin at 40 
mg/kg/day for five days, mammary gland proliferation was enhanced 3.3-fold over saline-
treated controls and was comparable to that of animals treated with 17β-estradiol at 1 
μg/kg/day for five days. In subsequent in vitro binding studies, formononetin 
competitively bound murine mammary estrogen receptors, but with a relative binding 
affinity 15,000 times less potent than that of 17β-estradiol [119]. Ji et al. established a 
highly sensitive bioassay system by placing estrogen-responsive elements upstream of 
the luciferase reporter gene and used this assay to determine the estrogenic activity of 
formononetin. Formononetin activated expression of the estrogen-responsive reporter 
gene in human breast cell line MCF-7 in a concentration-dependent manner (0.5-500 
μM), and this activation was inhibited by estrogen antagonist (ICI 182780 at 100 nM) 
[120]. Umehara et al. investigated the concentrations, in which isoflavones can show 
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similar results to 10 and 100 pM 17β-estradiol. On on T47D cell line 30 nm formononetin 
had equivalent effect to 10 pm 17β-estradiol. Formononetin activated expression of the 
estrogen-responsive reporter gene in cell line MCF-7 and T47D equivalent to 10 pM 17β-
estradiol at 10 nM concentration [121]. Chen et al. aimed to further investigate the 
potential effect of formononetin in promoting cell proliferation in ER-positive cells and 
used in vivo and in vitro studies to elucidate the possible mechanism. Compared with the 
control, low formononetin concentrations (2-6 μM) stimulated ERα-positive cell 
proliferation. Additionally, in the in vivo studies, uterine weight in Ovx mice treated with 
formononetin increased significantly (in contrast to page 36) [122]. The growth of uterine 
tissues was confirmed by other researchers, as well [123], [124].  
• Antigiardial activity 
Khan et al. isolated several isoflavones from Dalbergia frutescens and determined their 
antiprotozoal activities against Giardia intestinalis. Among the isolated compounds, 
formononetin was the most potent antigiardial agent, with an IC50 value of 0.03 μg/ml, as 
compared to the value for metronidazole, the current drug of choice, of 0.1 μg/ml. The in 
vivo results indicated that, although formononetin is active, relatively large doses are 
required [125]. According to Lauwaet et al. the antigiardial activity of formononetin is at 
least partially due to its capacity to rapidly detach trophozoite [126].  
• α-glucosidase activity 
The heartwoods extract of Dalbergia odorifera demonstrated a potent inhibition on yeast 
α-glucosidase in vitro. Thus, bioassay-guided purification of EtAc soluble fraction was 
conducted to purify the active principles responsible for the inhibition. All active 
components isolated demonstrated a significant inhibition on yeast α-glucosidase in a 
dose-dependent manner, but formononetin showed an outstanding activity (IC50 = 0.51 
mM) [127]. As the methanol extracts of all the parts of Dalbergia tonkinensis were found 
to be potential sources of α-glucosidase inhibitors, as well (showing more efficient 
inhibitory activity than that of acarbose), Van Bon et al. executed a bioassay-guided 
fractionation and isolated the most active compounds, sativanone and formononetin. 
Formononetin showed weak inhibition against rice α-glucosidase, good inhibition against 
rat α-glucosidase, and a very efficient effect on α-glucosidases from yeast and bacterium 
(on yeast, its potency was approximately the twice as in the report of Choi et al.) (see  
Figure 16) [128].  
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Figure 16: α-glucosidase inhibitory effect of formononetin and acarbose in different 
enzyme systems [128] 
 
• Pro-apoptotic effect 
Many researchers aimed to define the pro-apoptotic characteristics of formononetin, 
however, no outstanding results have been published yet. On the other hand, these studies 
are a great help for the understanding of the underlying molecular biological pathways 
which contribute to the beneficial health effects of formononetin  [129]–[144]. 
Biological activities of pseudobaptigenin 
• Peroxysome proliferator-activated receptor agonism 
Salam et al. executed a structure-based virtual screening of the peroxisome proliferator-
activated receptor γ (PPARγ) ligand binding domain against a natural product library 
which revealed 29 potential agonists. In vitro testing of this list identified six flavonoids 
to have stimulated PPARγ transcriptional activity in a transcriptional factor assay. Of 
these, isoflavonoid pseudobaptigenin was classed as the most potent PPARγ agonist, 
possessing low micromolar affinity (EC50 = 2.9 μM) [145]. Matin et al. aimed to develop 
novel, efficacious, and yet safer pan agonists of PPAR receptors. Based on the 
aformentioned results of Salam et al., pseudobaptigenin and its derivatives were screened 
beside numerous other natural product-based derivatives. 3’,5’-dimethoxy-7-
hydroxyisoflavone, pseudobaptigenin, 4’-fluoro-7-hydroxyisoflavone and 3’-methoxy-7-
hydroxyisoflavone exhibited a substantially higher PPARγ fold activation compared to 
rosiglitazone at 5 μM and 25 μM. In the PPARα activity tests they all demonstrated higher 
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fold activity than the positive control fenofibrate (1.3-fold activation). Pseudobaptigenin 
exhibited more potent PPARα activation than PPARγ activation. These four molecules 
were therefore identified as the most potent dual PPARα and γ agonists evaluated. The 
highest PPARδ agonist activity in the isoflavone series was observed for the same 
compounds as mentioned previously. Moreover, these isoflavones proved to be almost 
twice as potent activators of PPARδ than bezafibrate. To ensure that these active 
compounds were nontoxic to HEK 293 cell line, cytotoxicity profiles were investigated. 
Pseudobaptigenin and the other three compounds exhibited excellent tolerability [149, 
150]. 
 
Biological activities of calycosin 
• Antioxidant activity 
Promden et al. evaluated the antioxidant activities of 24 isoflavonoids that were 
previously isolated as pure compounds from D. parviflora using three different in vitro 
antioxidant-based assay systems: xanthine/xanthine oxidase, oxygen radical absorbing 
capacity, and 2,2-diphenyl-1-picrylhydrazyl (DPPH). The subgroup of isoflavones, and 
particularly calycosin showed the highest activities with 50% radical scavenging 
concentration (SC50) value of 0.25 μM. A further SAR analysis revealed that these active 
isoflavonoids from all three subgroups have the following common substituent pattern: 
the presence of R7-OH in ring A and the R4′-OMe in ring B with either R3′-OH or R5′-
OH. However, the presence of R7-OH and R4′-OMe in the molecule with no other key 
substituents (i.e., formononetin, SC50 = 117 µM), showed considerably lower activity, 
suggesting that these two substituents are not as important. In the other two assays, 
calycosin displayed only intermediate activity [148]. 
• NO production inhibition 
Morikawa et al. isolated constituents from Erycibe expansa (Convulvaceae) originating 
from Thailand and examined their inhibitory activities on lipopolysaccharide-activated 
nitric oxide production in mouse peritoneal macrophages. The most active component 
was calycosin showing an IC50 value of 13 μM. This result is nearly equivalent to that of 
caffeic acid phenetyl ester, an inhibitor of NF-κB activation (IC50 15 μM) [149]. 
• Alleviating the cellular effects of hypoxia 
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Fan et al. intended to investigate the effect of calycosin on impairment of barrier function 
induced by hypoxia in HUVECS. The in vitro results indicated that calycosin could 
inhibit hypoxia induced hyperpermeability [150]. 
• Antiprotozoal activity 
Araujo et al. isolated calycosin from Centrolobium sclerophyllum (Leguminosae) and 
tested its activity against Leishmania amazonensis promastigotes. Calycosin showed 
good antileishmanial activity, with calculated IC50 = 140 nM [151]. ElSohly et al. isolated 
calycosin, based on bioassay-guided fractionation, as the most active antigiardial 
compound of Machaenum aristulatum. Calycosin was tested against G. intestinalis and 
the antigiardial IC50 was determined as 1.9 μg/ml, which is twice as high as the IC50 of 
metronidazole (1.1 μg/ml) and ten times higher that of formononetin (0.28 μg/ml) [152]. 
The extracts of Psorothamnus arborescens, a desert shrub common in Mojave Desert, 
exhibited significant activity against Leishmania donovani axenic amastigotes and 
bloodstream form Trypanosoma brucei brucei. Bioassay-guided fractionation led to the 
isolation of calycosin, which showed very weak activity against L. donovani axenic 
amastigotes, but it displayed selective toxicity (about 15-fold) toward T. b. brucei 
bloodstream forms (IC50 = 12.7 µM) over Vero cells [153].  
 
Biological activities of calycosin D (3’-methoxydaidzein) 
• Antiprotozoal activity 
Beldjoudi et al. isolated 4 new flavonoids along with 13 known compounds from the 
heartwood of Dalbergia louvelii by following their potential to inhibit the growth of 
Plasmodium falciparum in vitro. One of the most active compounds 3’-methoxydaidzein 
showed antiplasmodial activity with IC50 value at 6.8 µM, however, this result is not 
comparable with the activity of chloroquine (IC50 = 0.13 µM). Since the antiplasmodial 
effect of the extracts of the plant and their fractions showed higher activity, than the 
isolated compounds itself, a synergistic play of the constituents is supposed [154].  
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Biological activities of onogenin 
• Antioxidant activity 
Promden et al. evaluated the antioxidant activities of 24 isoflavonoids that were 
previously isolated as pure compounds from D. parviflora using three different in vitro 
antioxidant-based assay systems: xanthine/xanthine oxidase, oxygen radical absorbing 
capacity and DPPH. Onogenin showed a very weak activity in the xanthine/xanthine 
oxidase test, and no activity at all in the other two assays [148].  
• Estrogenic effect 
In the same study (see page 32), Umehara et al. investigated the estrogenic effect of 
isoflavanone onogenin, too. Onogenin stimulated the proliferation of both cells, but its 
activity was only about the one millionth of the positive control, estradiol, and one 
thousands of genistein and T47D cells. Interestingly, luciferase induction at low 
concentrations was only observable on T47D/luc cells, but it still could not approach the 
activity of genistein [121].  
 
Biological activities of sativanone 
• Dermocosmetic use 
The study of Ham et al. examined the antiwrinkle effects of ethanol extracts of D. 
odorifera in UVB-irradiated human skin cells. Ethanol extracts of D. odorifera and their 
constituents, dalbergin and sativanone, induced expression of collagen type I and 
transforming growth factor-β1 in human dermal fibroblasts in a dose-dependent manner 
[155].  
• α-glucosidase inhibitory activity 
The other active compound which was responsible for the α-glucosidase inhibitor activity 
of Dalbergia tonkinensis extracts beside formononetin (see page 32), is sativanone. 
Regarding its enzyme inhibitory activity, it was similarly prominent as the isoflavone 
formononetin (see Figure 17). Moreover, their maximum inhibition rates were in the same 
range, and showed no significant difference from acarbose. As both isoflavanone 
sativanone and isoflavone formononetin differ markedly from the sugar analogue 
acarbose, the mechanism of enzyme inhibition still needs to be explored [128]. 
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Figure 17: α-glucosidase inhibitory effect of sativanone and acarbose in different 
enzyme sytems [128] 
 
Biological activities of medicarpin 
• Anti-allergenic effect 
To define the anti-allergenic components from Saiboku-To, a herbal medicine for 
bronchial asthma, Taniguchi et al. examined the effect of 11 compounds found in post-
administrative urine of Saiboku-To in in vitro and in vivo tests. In the in vitro test of 
blastogenesis, medicarpin displayed an IC50 value of 3.3 μg/ml (prednisolone 0.08 μg/ml). 
In a 100 mg/kg dose, medicarpin could inhibit ear swelling by 40.1% (prednisolone 5 
mg/kg 52.9%) [156]. However, its activity could not be linked to the metabolism of 
prednisolone, as it does not have a pronounced 11β-hydroxysteroid dehydrogenase 
activity [157].   
• Pro-apoptotic activity 
Shosaiko-to is a Kampo medicine used for the treatment of chronic hepatitis in Japan. 
Lately, over 200 cases of interstitial pneumonia have been reported resulting from 
Shosaiko-to therapy, and the number of cases increased when patients were administrated 
interferon-α at the same time. In the study of Liu et al., the in vitro effects of 7 phenolic 
compounds which had been detected from human urine after administration of Shosaiko-
to were examined by flow cytometry analysis, on inducing apoptosis. In human lung 
fibroblasts, medicarpin significantly inhibited the growth and reduced the viability of lung 
fibroblasts. Interferon-α had no apoptosis-inducing effect, and it did not show synergistic 
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interaction with any of the compounds derived from Shosaiko-to on inducing apoptosis 
[158]. Tumor necrosis factor α-related apoptosis-inducing ligand (TRAIL) is a promising 
anticancer agent with cancer cell-selective cell death inducing effect. However, the major 
limitation in the usage of TRAIL as a chemotherapeutic agent is the development of 
TRAIL resistance in many cancer types including myeloid leukemia. In the study of 
Trivedi et al., medicarpin is reported to sensitize myeloid leukemia cells to TRAIL-
induced apoptosis for the first time [159]. Gatouillat et al. aimed to determine if 
medicarpin may have pro-apoptotic effects against drug-sensitive (P388) and multidrug 
resistant P388 leukemia cells (P388/DOX). While 3 µM doxorubicin alone could not 
induce cell death in P388/DOX cells, concomitant treatment with doxorubicin and 
subtoxic concentration of medicarpin restored the pro-apoptotic cascade. Vinblastine 
cytotoxicity was also enhanced in P388/DOX cells (IC50 = 210 nM to 23 nM with 
medicarpin) [160].  
• Osteogenic activity 
During the phytochemical investigation of the stem bark of Butea monosperma, Maurya 
et al. isolated medicarpin and investigated it using neonatal (1–3 day old) rat calvaria 
derived primary osteoblast cultures. Medicarpin showed promising osteogenic activity, 
attributed to increased osteoblast proliferation, differentiation and mineralization. [161]. 
Bhargavan et al. evaluated osteogenic effect of medicarpin, too. According to their 
results, medicarpin stimulated osteoblast differentiation and mineralization at as low as 
0.1 nM. Co-activator interaction studies demonstrated the osteogenic action of 
medicarpin is ERβ-dependent. Medicarpin increased cortical thickness and bone 
biomechanical strength in rats, too [162]. Moreover, medicarpin at 0.1 nM suppressed 
osteoclast genesis in bone marrow cells and induced apoptosis of mature osteoclasts 
isolated from long bones. [163]. Goel et al. developed a convenient synthesis of natural 
and synthetic pterocarpans and investigated their osteogenic activity. A comparative 
mechanism study for osteogenic activity of medicarpin (racemic versus enantiomerically 
pure material) revealed that (+)-(6aS,11aS)-medicarpin significantly increased the bone 
morphogenetic protein-2 expression and the level of the bone specific transcription factor 
Runx-2 mRNA, while the effect was opposite for the other enantiomer, (−)-(6aR,11aR)-
medicarpin. For the racemate, (±)-medicarpin, the combined effect of both the 
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enantiomers on transcription levels was observed [164]. In conclusion, given its excellent 
oral bioavailability [162], medicarpin can be potential osteogenic agent.  
 
Biological activities of maackiain 
• Phytoalexin activity 
Enantiomers of the isoflavonoid phytoalexins maackiain and pisatin were tested for 
toxicity to 36 fungal isolates by Delserone et al. Nine of these species were pathogens of 
red clover, which synthesizes (-)-maackiain; seven species were reported to be pathogenic 
on garden pea, which synthesizes predominantly (+)-pisatin and minor amounts of (-)-
maackiain. In general, non-host phytoalexins were more potent inhibitors than host 
phytoalexins to growth of these pathogens. In addition, the opposite enantiomer of the 
host phytoalexin was often more inhibitory to a pathogenic fungus than the normally-
occurring enantiomer [165].  
• Anti-allergenic effect 
Mizuguchi et al. identified (-)-maackiain as the responsible component of the antiallergic 
effect of S. flavescens. Pretreatment with (-)-maackiain alleviated nasal symptoms [166]. 
In a further study, Nariai et al. identified the target protein of (-)-maackiain as Hsp90 
[167].  
• Neuraminidase inhibiting activity 
Ryu et al. isolated pterocarpans and flavanones from S. flavescens and screened for their 
ability to inhibit neuraminidase. Maackiain was shown to have an IC50 value of 3.2 μM, 
whereas its glycoside had an IC50 value of 237.5 μM.  The best inhibitor was the 3-O-
methylated derivative of maackiain with an IC50 value of 1.4 μM. Kinetic analysis 
disclosed that pterocarpan inhibitors are noncompetitive [168]. 
• Monoamine oxidase (MAO) inhibition activity 
Of the compounds isolated from the roots of S. flavescens, Lee et al. found (-)-maackiain 
to inhibit potently and selectively human MAO-B, with an IC50 of 0.68 μM, and to have 
a selectivity index of 126.2 for MAO-B. As compared with other herbal natural products, 
the IC50 value of maackiain for MAO-B is one of the lowest reported to date. In addition, 
maackiain reversibly and competitively inhibited MAO-B. Molecular docking simulation 
revealed that the binding affinity of maackiain for MAO-B (-26.6kcal/mol) was greater 
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than its affinity for MAO-A (-8.3kcal/mol), which was in-line with the inhibitory activity 
findings [169]. 
 
1.II.4. Analytical methods aiming the qualitative and quantitative determination of 
isoflavonoids 
Extraction and purification methods  
Although solvent extraction is the simplest an oldest method, it is still the most widely 
used technique for the analyte isolation in the case of solid samples, mainly because of 
its ease of use and wide-ranging applicability. Liquid samples can be directly injected 
into the separation system after filtration or the analytes can be firstly isolated using 
liquid-liquid extraction or solid-phase extraction. Soxhlet extraction (which has been 
known since 1879) is used less frequently to isolate isoflavonoids. Concerning solvent- 
and Soxhlet extraction, aqueous methanol or acetonitrile is used as a solvent, usually 
favoring more than 50% organic solvent content. Liquid-liquid extraction is usually 
aiming the extraction of aglycones as they can be extracted from aqueous environments 
using more apolar solvents e.g. ethyl acetate. If the determination of total isoflavonoid 
content in the form of aglycones is the purpose, chemical hydrolysis is usually performed 
with hydrochloric acid or formic acid at elevated temperatures (80-100 °C) [170]. Csupor 
et al. executed investigations to establish an acid hydrolysis method for the quantitative 
HPLC determination of total isoflavones including daidzein, genistein and glycitein. To 
optimize the extraction and hydrolysis of isoflavones, the effect of HCl concentration 
(1.5–6 N), hydrolysis time (25–210 min) and temperature (30–100°C) on total isoflavone 
aglycone content was studied. By mathematical fitting and optimization methods 
optimum hydrolysis conditions for maximizing the quantification of isoflavones were 
determined (t = 94 min, cHCl = 5.09 N, T = 80°C) [171]. Enzymatic hydrolysis with β-
glucuronidase or β-glucosidase is also used [170]. If the interest is in the intact 
isoflavonoid-glycosides, harsh extraction conditions and heating should be avoided as 
glucoside malonates are extremely sensitive to heat [172]. Ultrasound-assisted methods 
substantially shorten the time needed for liquid extraction. High intensity ultrasound-
assisted extraction (sonication) has been used for routine analyses. Longer extraction 
times, however, lower the recovery [173]. Microwave assisted extraction appears to be a 
fast and reliable method for soy isoflavones, as recovery of 97–103% was achieved. A 
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comparative study proved that microwave-assisted and Soxhlet methods were better for 
isoflavone content quantification, while sonication or stirring was the method of choice 
for determination of isoflavone composition (aglycones and glucoside conjugates) [173]. 
Supercritical fluid extraction (SFE) is used both for analytical purposes and in industrial 
scale for the preparation of functional foods. SFE with continuous on-line modifier 
addition to the extraction phase was applied to the extraction of isoflavones from red 
clover yielded extraordinarily high recoveries. According to a comparative study of 
daidzin and genistein recovery, SFE was slightly more efficient than pressurized solvent 
extraction and much better than Soxhlet or sonication [174]. Non-selective solid-phase 
extraction (SPE), typically alkyl-bonded silica or copolymer sorbents, is widely used for 
analyte extraction and enrichment from aqueous samples and sample extracts - primarily 
in environmental, pharmaceutical and biomedical analysis. In most cases the sorbent is 
C18-bonded silica and the sample solution and solvents are usually slightly acidified to 
prevent ionization of the isoflavonoids, which would reduce their retention. A prominent 
application could be the determination of isoflavonoids in plasma and other biological 
samples [170].  
 
Separation techniques 
Classical liquid chromatography techniques and several modifications using modern 
instrumentation are currently the most frequently applied techniques. Separation on 
reversed phase sorbents C18 (possibly C8) is one of the most preferred. The retention 
order of individual isoflavones increases in the order β-glucosides, malonyl-, and acetyl-
β-glucosides, and free aglycones are the most hydrophobic. Several factors influence the 
retention times of separated isoflavones, i. e. their affinity to the stationary phase, which 
can be modified with different functional groups, composition of the mobile phase, 
application of gradient elution, column temperature, etc. In most cases aglycones and 
glucosides are separated together with their derivatives in a single run on a reversed phase 
column. Isocratic elution is usually insufficient; therefore a suitable gradient therefore has 
to be optimized for gradient elution. It usually starts at ca. 10% v/v of organic modifier 
(acetonitrile or methanol are the most suitable modifiers), but separation of glucosides 
improves with gradually increasing modifier content [175]. A mixture of daidzin, glycitin, 
genistin, ononin, daidzein, glycitein, sissotrin, genistein, formononetin, and biochanin A 
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was completely separated in 40 min using optimized linear gradient elution with 0.2% 
formic acid and acetonitrile on a 150 mm x 2.1 mm, 3.0 µm C18 column. Later, complete 
separation was accomplished in 7 minutes on a 20 mm x 2.1 mm, 3.0 µm C18 column 
after re-optimization of the gradient-profile [176]. Application of columns of smaller 
inner diameter and mainly with a smaller stationary phase particle size (size below 2 µm) 
and application of new technologies in chromatographic instrumentation are preferred in 
chromatographic separation of isoflavones at present. These techniques allowed reduction 
of retention times to less than 60 s for complete separation of 10 isoflavones [8]. A 
mixture of phenolic acids and selected isoflavones was separated with retention times not 
exceeding 2.0 min on  C18, cyanopropyl and phenyl stationary phases using ultrahigh-
pressure liquid chromatography (UHPLC) [10]. Also, columns with a monolithic 
stationary phase have found wide applicability in separation of isoflavones. Using a 
monolithic silica-based reversed-phase column, isoflavones in soy extracts were 
separated and quantified with a mobile phase consisting of acetonitrile and acetic acid 
and separation of 12 isoflavones was complete in ca. 10 min with very good resolution 
[175].  
In the previous decade an enormous increase was observed in the number of papers 
dealing with the application of electromigration methods to the separation of natural 
substances, including isoflavonoids. Their ease of coupling to sensitive electrochemical 
detectors (EDs) is the main advantage of electromigration techniques. Capillary zone 
electrophoresis (CZE) is the most commonly used electromigration technique. Results 
obtained with CZE were compared with those obtained by HPLC separation. CZE 
separation was much faster than HPLC, however, the HPLC separation is more selective 
for identified isoflavones. This applies mainly to various real samples. Using ED sub-µM 
concentrations of isoflavones could be detected. The same electrochemical detector was 
used for micellar electrokinetic capillary chromatography (MEKC) analyzing puerarin 
and daidzein in plant materials and pharmacological preparation from Puerariae radix. A 
UV detector was used for the analysis of red clover and both methods applied sodium 
dodecyl sulfate as a surfactant for the pseudo-stationary phase. In contrast to CZE, MEKC 
also allows effective separation of hydrophobic aglycones that are sparingly soluble in 
the buffers used in CZE. Capillary electrochromatography is based on separation of 
analytes in a capillary filled with a sorbent. In contrast to HPLC, the separation is driven 
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by an electric field. A lauryl acrylate stationary phase polymerized directly inside the 
capillary was used for separation of a mixture of daidzein, genistein and glycitein and 
their conjugates in soy-based infant formulas. In addition to UV and ED detectors, 
electromigration column separations can also be directly coupled to mass-selective 
detectors and/or fluorescence detectors [175].  
Spectrometric methods 
UV-Vis detectors, and mainly diode array detectors (DAD) that can operate in a wide 
range of wavelengths, are the detectors most often applied in chromatographic and/or 
electromigration separations [175]. Isoflavonoids possess two characteristic UV-Vis 
bands, band I in the 300 to 550 nm range, arising from the B ring, and band II in the 240 
to 285 nm range, arising from the A ring. While the band I of isoflavones lies in the 240 
– 285 nm range, that of isoflavanone (no C-ring unsaturation) lies in the 270 – 295 nm 
range; conversely, the band II of isoflavones and isoflavanones lies around 303 – 304 nm 
[177]. As the UV-Vis spectra of many isoflavones are very similar, the applicability of 
UV-Vis detectors in identification of isoflavones is very limited, since approximately 700 
isoflavones are present in different plant materials [175].  
Mass spectrometry (MS) detectors that can detect individual aglycones of isoflavones, 
their derivatives or glucosides, and their other conjugates are the most effective tools for 
detailed studies of separated substances and for their identification. In addition to 
selective analyses, it is possible to apply mass spectrometry for structural analysis. Gas 
chromatography coupled to MS and electron impact ionization is not widely used in 
flavonoid analysis owing to the limited volatility of target molecules. Derivatization is 
needed, making the analysis more time consuming, and the fragmentation patterns of the 
derivatives are often difficult to interpret. Since the development of atmospheric pressure 
ionization sources (electrospray ionization (ESI), atmospheric pressure chemical 
ionization and atmospheric pressure photoionization), liquid chromatography-mass 
spectrometry (LC-MS) coupling became more efficient and easier to use, making it by 
far the most popular technique for on-line flavonoid analysis nowadays [178].  
ESI, which can be connected to LC or capillary electophoresis, is the most common 
technique for ionization of a sample. Very good results were obtained using ESI-
quadrupole MS in combination with liquid chromatography after SFE with limit of 
detections (LODs) for aglycones of 0.2–1.0 fmol and for glucosides of 1.3–3.6 fmol per 
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injection in negative ionization mode. It was also used for identification of their 
glucosides or in detection of isoflavones in soybean food samples (LOD for 
daidzin/genistin were 1.2/1.6 fmol and 1–3 fmol for daidzein, genistein, formononetin, 
biochanin A, and ononin). Each individual isoflavone can be characterized not only by its 
molecular ion, but mainly by specific fragmentation products [175]. Fragmentation is 
controlled by the so-called retro-Diels-Alder (rDA) reaction (by analogy with the Diels-
Alder cycloaddition), that involve breaking the C-ring bonds. These fragment ions are the 
most diagnostic for flavonoid and isoflavonoid identification since they provide 
information on the number and type of substituents in the A- and B-rings [178]. The 
aglycone fragment ions can be designated according to the nomenclature proposed by Ma 
et al. [179] (Figure 18/A).  
 
 
Figure 18: The nomenclature of isoflavonoid fragmentation based on Ma et al. and 
Domon and Castello with the product ions of retro-Diels-Alder fragmenation (A), the 
specific fragmentation of isoflavanones (B) and pterocarpans (C) 
 
For free aglycones, the i,jA+ and i,jB+ labels refer to the fragments containing intact A- and 
B-rings, respectively, in which the superscripts i and j indicate the C-ring bonds that have 
been broken. For conjugated aglycones, an additional subscript 0 to the right of the letter 
is used to avoid confusion with the Ai
+ and Bi
+ labels that have been used to designate 
carbohydrate fragments containing a terminal (non-reducing) sugar unit [178]. The basic 
rDA fragmentation leads to the cleavage of the C-ring of the isoflavonoid and results in 
a dien fragment of the A-ring and an alkyne fragment of the B-ring (Figure 18/A). The 
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characteristic rDA fragment in ESI(+) is the protonated A-ring; the B-ring fragment 
predominantly remains uncharged and therefore leads to a weaker signal in ESI(+)-MS. 
The structural information after rDA cleavage results from the distribution of substituents 
between rings A and B that can easily be estimated from the relationship between the 
former molecular mass and the mass of the A- ring fragment. However, only the 
distribution of the number of substituents on both rings is deductible, but no information 
on the exact position of the substituents in either ring has been obtained yet. A special 
type of rDA fragmentation occurs for isoflavonoids which are methoxylated in the B-
ring. Basically, the same rDA fragments are detected but a specific fragment with 1 amu 
less than the expected rDA fragment is additionally observed. This second signal results 
from a charged but not protonated rDA A-ring and based on observations, it is only 
detectable in the case of O-methylation on the B-ring [180]. Regarding isoflavanones the 
same rDA fragmentation as for isoflavonoids can occur in ESI(+)-MS/MS analysis. 
However, these molecules can be found in keto and enol form, and stabilizing the 
equilibrium using derivatizing agents, the enol form proved to be more abundant which 
can modify the fragmentation behavior of the isoflavanones. Beside the rDA 
fragmentation reactions, a further cleavage of the C-ring is characteristic for these 
molecules. In a competitive pathway, the bond between positions 2 and 3 is cleaved, 
leading to a charged 4-hydroxybenzyl cation fragment of the B-ring (Figure 18/B). This 
fragment hardly appears in the MS/MS spectra of isoflavones, bearing a double bond 
between positions 2 and 3. In contrast to the rDA reaction, this fragmentation pathway 
leads to a dominating charged B-ring product detectable in MS [180]. Pterocarpans, show 
much more complex fragmentation pathways; MS studies of different deuterated 
pterocarpan derivatives, as well as of pterocarpan glycosides, points out that these are 
dominated by various and successive ring openings and/or contractions [185, 186] (Figure 
18/C). In addition to the i,jA+ and i,jB+ ions, discussed above, losses of small molecules 
and/or radicals from the [M+H]+ ion are noted. Losses of 18 u (H2O), 28 u (CO), 42 u 
(C2H2O) and/or the successive loss of these small groups are commonly observed. These 
losses are useful for identifying the presence of specific functional groups, i. e. a methoxy 
group is easily detected by the loss of 15 u (CH3•) from the [M+H]
+ precursor ion. The 
loss of a CH3• radical appears to be prevalent so that the [M+H-CH3]
+• ion dominates the 
whole spectrum. This rather uncommon transition from an even-electron to an odd-
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electron ion is found to be characteristic for a phenolic methyl ether group. Losses of 56 
u (C4H8) point to the presence of a prenyl substituent [178]. In the structure analysis of 
flavonoids, positive ion collision induced dissociation (CID) spectra are most frequently 
used, whereas negative ion CID spectra are often considered to be more difficult to 
interpret. The negative ion mode is, however, more sensitive in flavonoid analysis and 
the fragmentation behavior is different, giving additional and complementary information 
[178]. In the negative mode, the 1/3 and 0/3 rDA fragmentations are predominant, and 
the 0/4 fragmentation is also observed sometimes, accompanied by extensive losses of 
CO, CO2 and C3O2 moieties [187, 188]. In some cases, a direct cleavage of the bond 
between the B- and C-rings, resulting in an [M-B-ring]- fragment, can be observed. Losses 
of small neutral molecules, such as CO (-28 u), CO2 (-44 u), C2H2O (-42 u) and the 
successive loss of these molecules, may also be prominent. Methylated compounds are 
characterized by the loss of 15 u resulting in an [M-H-CH3]
-• radical ion which generally 
constitutes the base peak [178]. 
Comparing the fragmentation of isoflavonoids with isomeric flavonoid compounds, 
isoflavones uniquely can lose two CO units, whereas a similar loss from flavones requires 
a barely possible aryl shift [184]. The exact mechanism of the double CO loss was 
investigated using isotope labeled molecules [185]. Abrankó and Szilvássy [186] and 
Keyume [187] investigated further the ion ratios of the fragmentated isomeric or isobaric 
flavonoids and isoflavonoids helping the differentiation between these phenolic 
compounds.  
Product ions from glycoconjugates are denoted according to the nomenclature introduced 
by Domon and Costello [188]. Ions containing the aglycone are labeled k,lXj, Yj and Zj, 
where j is the number of the interglycosidic bond broken, counting from the aglycone, 
and the superscripts k and l indicate the cleavages within the carbohydrate rings (Figure 
18/A). The glycosidic bond linking the glycan part to the aglycone is numbered 0. O- and 
C-glycosides can be differentiated by soft ionization techniques with low fragmentation 
energy, in which glycoside loss from O-glycosides undergo heterolysis of their hemi-
acetal O-C bonds and give rise to Yi+ ions at low energy. Whereas C-glycosides only 
produce [M+H]+ ions, and intraglycosidic cleavages will happen only on higher energies 
yielding i,jX fragments and characteristic ions of water loss in the case of 6-C-glycosides. 
The sugar type can be easily determined by the characteristic m/z values of the Ai, Bi and 
DOI:10.14753/SE.2019.2295
50 
 
Ci fragments arising from hexoses, deoxyhexoses and pentoses, which are not directly 
observable in the mass spectra but can be computed from the m/z differences of the parent 
ions and corresponding Xi, Yi and Zi [177]. 
Spectroscopic techniques  
One of the most immediate applications of circular dichroism (CD) spectroscopy is the 
determination of the absolute configuration of chiral isoflavonoid molecules, such as 
isoflavan-4-ols [189], isoflavones [190] and pterocarpans [168, 196]. CD is also routinely 
used to study the interaction of many flavonoids with biomolecules, providing valuable 
information on biomolecule-drug interaction, such as DNA binding, binding to serum 
albumin and hemoglobin, inhibition of β-amyloid toxicity and fibrillogenesis [177].  
One of the main applications of nuclear magnetic resonance (NMR) spectroscopy in 
flavonoid research is the structural elucidation of novel compounds, although NMR 
traditionally requires milligram amounts of samples, which is usually challenging to 
obtain when analyzing novel compounds. 1H NMR experiments provide valuable 
information about the number of hydrogens and also their type, by comparison of the 
recorded chemical shifts with compiled data. This is particularly useful in establishing 
the aglycone type and the acyl groups attached to it, as well as in identifying the number 
and the anomeric configuration of the glycoside moieties. 13C NMR data is used to 
complement 1H NMR data. Definite structural elucidation with the accurate location of 
the substituents, requires various 2D experiments. 1H homonuclear 2D experiments such 
as Correlation spectroscopy (COSY) and total Correlation Spectroscopy (TOCSY) are 
extremely useful to identify and isolate the 1H resonances of the individual spin systems 
and protons of the sugar rings. Heteronuclear Single Quantum Coherence (HSQC) 
establishes one bond correlations between the protons of a molecule and the carbons to 
which they are attached. Heteronuclear Multiple Bond Correlation (HMBC) application 
to flavonoids usually addresses assignment on non-protonated C atoms, from both the 
aglycones and acyl groups. HMBC can also be used to determine the linkage points of 
heteroatom- containing groups such as sugar residues and acyl groups. While the above 
mentioned 2D techniques are useful to establish the connectivities between atoms through 
bonds, the Nuclear Overhauser Effect (NOE), is effective at connectivities through space. 
The crosspeaks of 2D NOESY (NOE spectroscopy) spectrum may arise from both 
intramolecular and intermolecular proton interactions and has been successfully used to 
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establish rotational conformers and restrictions, establish intermolecular associations and 
even solve protein-ligand and DNA-ligand structures. Rotating frame Overhauser effect 
spectroscopy (ROESY) has been used in flavonoid research mainly to establish the 
stereochemistry of various flavonoids [177].  
Analytical methods for the investigation of the isoflavonoid content of O. spinosa 
While Ononidis radix has been official in Hungarian Pharmacopoeias since the 5th edition, 
the described analytical methods are very general even in the newest editions of 
Hungarian and European Pharmacopoeias. For phytochemical identification thin layer 
chromatography is prescribed. As only general reference compounds (resorcinol and 
vanillin) are used for retention factor standardization, the aim of the thin layer 
chromatography is rather the comparison of fingerprints of the methanolic extract and not 
the identification of compounds responsible for the pharmacological effect. For tests 
aiming the determination the quality of the drug, only general methods (loss on drying, 
total ash content and extractable content) are prescribed.  
 
Table 3: Various isoflavone glucoside derivatives in the extract made of O. spinosa 
roots [6] 
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umol/100g - 102.1 16.5 12.3 23.0 7.4 294.7 
mg/100g - 29.1 7.4 3.3 6.2 3.2 152.4 
 
Köster et al. investigated the isoflavonoid content of C. arietinum regarding not only 
aglycones, but 7-O-glucosides and 7-O-glucoside 6”-O-malonates, as well. They 
expanded the developed reversed phase HPLC method for the analysis of other plants in 
the Leguminosae family, including O. spinosa. Care was taken in these studies to extract 
the plant material carefully at low temperature with acetone and to avoid long time storage 
of the extracts at higher temperatures. Quantitative measurements were executed too, in 
order to define the amounts of biochanin A, biochanin A 7-O-glucoside (sissotrin), 
biochanin A 7-O-glucoside 6"-O-malonate (biochanin A GM), genistein, formononetin, 
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formononetin 7-O-glucoside (ononin) and formononetin 7-O-glucoside 6”-O-malonate 
(formononetin GM). The results show, that formononetin 7-O-glucoside 6"-O-malonate 
is the most characteristic molecule of O. spinosa roots (Table 3) [6]. 
Pietta et al. published the results of HPLC investigation of O. spinosa using reversed-
phase C18 column in 1983. They reported the presence of rutin, kaempferol, genistein, 
formononetin and biochanin A in the 50% ethanolic extract of O. spinosa root based only 
on the consistency of retention time with standard substances (Figure 19).  In addition, 
the quantity of formononetin, genistein and biochanin A were determined using external 
calibration method (Table 4). The amount of the characterized aglycones definitely not 
reflected the quantities characteristic to the root because during sample preparation high 
temperature was used (70°C), which may cause the decomposition of glycosides and 
glycoside malonates. Moreover, as the completeness of the hydrolyzation was not proved, 
the results could not interpret the total isoflavonoid content neither [5].  
 
 
 
 
 
 
 
 
 
Seven years later the same research group repeated their experiments, with the application 
of a diode-array detector. After the same sample preparation method, they used an 
isocratic method to separate the compounds of O. spinosa root based on an eluent system 
consisting of 2-propanol-tetrahydrofuran-water (28:2:70, v/v/v). For peak identification, 
formononetin, biochanin A and genistein were used. When the acquired UV spectra were 
computer normalized, plotted and superimposed, exact coincidence curves were obtained 
(match factor >990) and consequently, the peaks were assumed to be pure. Quantitative 
Figure 19: HPLC chromatogram of standards and of O. spinosa extract with the 
identified peaks. 1 = rutin; 2 = genistein; 3 = kaempferol; 4 = formononetin; 5 = benzyl-
4-hydroxybenzoate (internal standard); 6 = biochanin A [5] 
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measurements were implemented for the same compounds and the results showed the 
same order of magnitude (Table 4) [192].  
Benedec et al. investigated the isoflavonoid content of Glycyrrhiza glabra L., Glycyrrhiza 
echinata L. and Ononis spinosa L. using HPLC-MS technique. During sample 
preparation 80% methanolic extracts were made, then acidic hydrolysis was applied using 
2 M HCl.  
 
Table 4: The quantitative results of the isoflavonoid content of O. spinosa root extract 
[5], [192] 
O. spinosa 
samples 
genistein 
(mg/100g) 
formononetin 
(mg/100g) 
biochanin A 
(mg/100g) 
Indena [5] 0.8 4.3 0.15 
Brisighello [5] 6.6 5.1 0.20 
Ulrich [5] 5.3 6.3 0.22 
Galke [5] 0.3 3.1 0.06 
I [192] 1.7 3.2 0.08 
II [192] 2.1 4.7 0.21 
III [192] 3.8 5.9 0.30 
 
Table 5: The method of determination and the quantity of various isoflavones before 
and after hydrolysis [9] 
 Rt 
 
min 
Detection mode Parent ion  
[M-H]-  
m/z 
Quantifier ion 
[M-H]-  
m/z 
isoflavonoid content  
mg/100 g drug 
non-hydr. hydr. 
Daidzin 3.7 SRM 415 253 0.944 - 
Genistin  5.5 SRM 431 268, 269 1.173 - 
Ononin  8.9 SRM 429 267 175.72 18.939 
Daidzein  9.2 SIM 253 283 - 0.819 
Glycitein  11.0 SIM 283 283 - - 
Genistein  11.0 SIM 269 269 - - 
Formononetin  14.4 SIM 267 267 9.499 113.622 
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For the separation of compounds gradient method was used with eluents of 0.1% acetic 
acid and methanol. Aglycones were detected using Single Ion Monitoring (SIM) in ESI-
MS(-) mode, while glucosides were detected with Single Reaction Monitoring. The peaks 
of the sample were identified by comparison of their retention times with ones of 
authentic standards and by the m/z value of their pseudo-molecular ion. The quantity of 
chosen isoflavones were measured using external calibration before and after hydrolysis. 
The results can be seen in the Table 5. The most characteristic compound of the non-
hydrolyzed sample was ononin, while in the hydrolyzed sample, its aglycone, 
formononetin was the most significant [9]. The deficiency of the method is that no 
information was obtained about more complex glucosides, like glucoside malonates and 
that the completeness of the hydrolysis was not checked so that significant amount of 
glucosides (e. g. ononin) could have left in the sample.  It is worth to note, that while the 
glucoside of genistein could be detected and quantified in the non-hydrolyzed sample, the 
aglycone, genistein, could not be detected after hydrolysis.  
A rapid-resolution HPLC-DAD separation method (separation in less than 1 min) for the 
determination and identification of genistin, genistein, daidzein, daidzin, glycitin, 
glycitein, ononin, formononetin, sissotrin and biochanin A in fmol quantities in 
submicroliter sample volumes was optimized by Klejdus et al. on a Zorbax SB C18 
column (1.8 μm particle size) at 80 °C. The method was verified using samples of bits of 
soy and methanolic extracts from Trifolium pratense, Iresine herbstii and Ononis spinosa 
plants. Formononetin, ononin and pseudobaptigenin glucoside were identified by UV-
DAD and ESI-MS in negative ionization mode in the 90% methanolic extract of O. 
spinosa obtained with a Soxhlet apparatus. While the method itself was validated for 
quantitative aims, too, the isoflavone content of the plant extracts were not quantified and 
no information was given about the other peaks (Figure 20) [8].  
 
Figure 20: The rapid-resolution HPLC chromatogram of O. spinosa root extract [8] 
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Complete separation of aglycones and glucosides of selected isoflavones (genistin, 
genistein, daidzin, daidzein, glycitin, glycitein, ononin, sissotrin, formononetin, and 
biochanin A) was achieved by the same research group in 1.5 min using an UHPLC on 
different chemically modified stationary phases (C18, cyanopropyl and phenyl). In 
addition, simultaneous determination of isoflavones together with a group of phenolic 
acids (gallic, protocatechuic, p-hydroxybenzoic, vanillic, caffeic, syringic, p-coumaric, 
ferulic, and sinapic acid) was performed in 1.9 min. Separations were conducted using a 
gradient elution with a mobile phase consisting of 0.3% aqueous acetic acid and methanol. 
The developed UHPLC technique on the cyanopropyl column was used for separation of 
isoflavones and phenolic acids in samples of plant materials (T. pratense, G. max, P. 
sativum and O. spinosa) after acid hydrolysis of the samples and modified Soxhlet 
extraction. Individual substances were identified by their retention time. In the 
hydrolyzed extract of O. spinosa genistein (G), formononetin (F) and biochanin A (B) 
were found beside phenolic compounds [175]. However, in the chromatogram it can be 
clearly observed that the isoflavonoid aglycones are very poorly separated which makes 
the peak identification cumbersome (Figure 21).  
 
Figure 21: The chromatogram of hydrolyzed O. spinosa root extract on cyanopropyl 
stationary phase [10] 
 
Concluding the results of the analytical methods regarding the isoflavonoid content of O. 
spinosa the following deficiencies can be noticed: 
1. The sample preparation was executed at high temperature (with one exception), 
resulting in the hydrolysis of glucoside malonates, which are the most 
characteristic compounds of the native plant [6]. On the other hand, the complete 
hydrolysis was not reached using only heat or 2 M hydrochloric acid [9] (Table 
6). 
DOI:10.14753/SE.2019.2295
56 
 
2. The identification of the peaks was based on the similarity of retention times with 
standard components, which is insufficient in the lack of other evidences. In some 
cases, the UV spectra were compared with original standards and the molecular 
masses were checked, but these methods still cannot differentiate isomeric or 
isobaric compounds with reliability (Table 6).  
3. Information about other isoflavonoid compounds, for example isoflavanones and 
pterocarpans was not available, as only the compounds were identified which are 
available as standard substances commercially (Table 6).  
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Table 6: The summary of analytical methods regarding the isoflavonoid content of O. spinosa 
 
Köster et al. 1983 [6] Pietta et al. 1983 [5] Pietta et al. 1990 [192] Klejdus et al. 2007 [8] Klejdus  et al. 2008 
[10] 
Benedec et al. 2012 [9] 
Sample 
cold acetone (no other 
information) 
50% ethanol 
70°C 1h 
50% ethanol 
70°C 
90% methanol, Soxhlet 90% methanol, Soxhlet 80% methanol, 60°C 
Hydrolysis  - - -   - 2 M HCl 2 M HCl - 
Purification  - - C18 cartridge  0.45µm PTFE membrane filtration -  
Column 
LiChrosorb RP 18  
(250 x 4 mm, 5 µm) 
Waters µBondapak Cl8 
(300 x 3.9 mm) 
C8 Aquapore 
(250 x 4.6 mm, 7 µm) 
Zorbax SB-C18  
(30 x 2.1 mm, 1.8 μm) 
Zorbax SB-CN 
(50 x 2.1 mm, 1.7 µm) 
Zorbax SB-C18  
(100 x 3.0 mm, 5 µm) 
Eluents 0.8 ml/min 
gradient 
3% acetic acid  
acetonitril 
1.5 ml/min 
gradient 
water (pH=2.6 with 
10% phosphoric acid) 
acetonitrile 
1 ml/min 
isocratic 
2-propanol - THF - 
water 
(28:2:70) 
1.4 ml/min 
gradient 
0.2% acetic acid  
MeOH 
80°C 
0.7 ml/min 
gradient 
0.3% acetic acid  
MeOH 
60°C 
1 ml/min 
gradient 
0.1% acetic aid 
MeOH 
Detection UV-Vis 
261 nm 
UV-Vis 
263 nm 
UV-DAD UV-DAD 
ESI-MS(-) 
UV-Vis 
270 nm 
ESI-MS 
Identified 
compounds 
genistein,  
formononetin, 
ononin,  
formononetin GM, 
biochanin A, sissotrin, 
biochanin A GM 
rutin, kaempferol, 
genistein, formononetin 
and biochanin A 
genistein,  
formononetin,  
biochanin A 
rothinidin,  
ononin, 
 formononetin 
genistein,  
formononetin,  
biochanin A 
ononin, formononetin, 
daidzein, daidzin, 
genistin 
hydr. non-hydr. 
Quantified 
compounds 
(mg/100 g 
drug) 
genistein 3.3 
formononetin 6.2 
ononin 3.2 
sissotrin 29.1 
formononetin GM 
152.4 
biochanin A GM 7.4 
genistein 0.3-6.6 
formononetin 3.1-6.3 
biochanin A 0.06-0.22 
genistein 1.7-3.8 
formononetin 3.2-5.9 
biochanin A 0.08-0.30 
  
ononin 
18.9 
 
daidzein 
0.8 
 
formono-
netin  
113.6 
  
ononin 
175.7 
daidzin 
0.9 
formono-
netin  
9.5 
genistin 
1.2  
5
7
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 Objectives 
The main aim of this work was to characterize the isoflavonoid profile of the Ononis 
species native to Hungary: Ononis spinosa L. and Ononis arvensis L., since isoflavonoid 
derivatives possess numerous promising pharmacological effects. Qualitative and 
quantitative literature data on the isoflavonoid composition of the two Ononis species is 
limited to the compounds available as standard substances and the other isoflavonoid 
derivatives have not been studied. Although in vitro cultures were made from both 
species, there is no available information about the isoflavonoid content of these samples. 
Considering the above mentioned, our aims were the following: 
 
1. Explore the isoflavonoid profile of the roots of O. spinosa and O. arvensis in details 
and acquire structural information by the means of HPLC-DAD-ESI-MS/MS and 
UHPLC-DAD-ESI-Orbitrap-MS/MS.  
2. For compounds, which could not be identified by solely by mass spectrometry, our 
objective was to elaborate isolation methods and to characterize them using orthogonal 
spectroscopic techniques. 
3. For the quantitative determination of isoflavonoid aglycones in the herbal drugs and 
for the determination of the total isoflavonoid content in O. spinosa, O. arvensis and 
their in vitro hairy root cultures, our aim was to develop and validate a HPLC-DAD 
method. 
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 Materials and methods 
3.I. Plant material 
O. spinosa root was obtained from Rózsahegyi Ltd. (Erdőkertes, Hungary), 
Biohorticulture Bio-Berta (Kiskőrös, Hungary) and from Antica Erboristeria Romana 
Ltd. (Rome, Italy) and was received in a dried and chopped form according to the 9th 
European Pharmacopoeia. Other root samples were collected from Dunaegyháza 
(Hungary, 46°50′56.88″ N, 18°56′35.57″ E) and Hűvösvölgy (Hungary, 47°33′22.88″ N, 
18°58′33.89″ E). O. arvensis was collected near Beregújfalu (location: N 48°17'21.1", E 
22°48'08.7" – Beregszászi járás, Ukraine) and in the Homoród-valley (Romania, location: 
N 46°10'29.1", E 25°25'22.5"). The roots and the aerial parts of the plants were separated. 
The roots were washed to remove soil and the dried roots were ground. The aerial parts 
were ground without further separation of leaves and stems. In vitro hairy root samples 
of O. spinosa and arvensis were started in 1989 by Kuzovkina et al. [89] using R 1601 
plasmid. The integration of the plasmid to the plant DNA was checked by gel 
electrophoresis after PCR multiplication. The samples were cultivated on B5 liquid 
medium (with 2% saccharose content for O. spinosa and 3% for O. arvensis).  The 
samples were harvested 4 weeks after the transplantation and were freeze dried 
immediately. As the freeze-dried biomasses did not reach the minimal weight of the three 
parallel samples on their own, five samples were powdered and pooled.  
3.II. Solvents and chemicals 
HPLC-grade methanol and acetonitrile were obtained from Fisher Scientific 
(Loughborough, UK). Methnol-d4 and DMSO-d6 for NMR measurements were 
purchased from Sigma-Aldrich (Steinheim, Germany). Purified water prepared by 
Millipore Milli-Q equipment (Billerica, MA, USA) was used throughout the study. 
Formononetin, calycosin, naringenin, homoproline and homopipecolic acid were 
purchased from Sigma-Aldrich (Steinheim, Germany). Ononin was kindly provided by 
Professor S. Antus (University of Debrecen, Hungary) and medicarpin and maackiain by 
Professor J. Hohmann (University of Szeged, Hungary). All other chemicals were of 
analytical grade. 
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3.III. Extraction and sample preparation 
3.III.1. Analytical samples 
General 
From the dried and powdered sample 0.5 g was extracted with 2 x 30 ml of aqueous 
methanol (3:7, v/v) by sonication for 2 x 6 minutes (Braun Labsonic U, Melsungen, 
Germany). After filtration the solvent was evaporated to dryness under reduced pressure. 
The residue was redissolved in 2.5 ml of 70% v/v methanol and passed through 
Supelclean SPE LC-18 column (500 mg, 3 ml; Supelco, Bellefonte, PA, USA). SPE micro 
columns were activated with 2.5 ml methanol and water before 2.5 ml stock solution was 
loaded. After air drying the cartridge 1.5 ml methanol was applied to achieve complete 
elution of isoflavonoids. Prior to HPLC analysis the eluted extract was evaporated to 
dryness again and redissolved in 2.0 mL 70% v/v methanol and filtered through Minisart 
RC 15 0.2 μm membrane (Sartorius AG, Goettingen, Germany). 
Hydrolyzed sample for the investigation of beta amino acids 
For the hydrolyzed sample, 1 ml of the analytical sample was mixed with 1 ml of 
concentrated ammonia and evaporated to dryness with rotary evaporator set to 60°C. The 
residue was mixed with 2 ml of purified water and the liquid was passed through the same 
Minisart filter.   
Hydrolyzed sample for the quantitative analysis 
• Hydrolysis by hydrochloric acid 
0.5 g powdered drug was extracted with 25 ml 70% aqueous methanol three times. The 
unified extracts were filtered and dried under reduced pressure. Methanol, distilled water 
and concentrated HCl were added to the dried sample in ratios to obtain 80% methanol 
and 0.35, 0.4, 0.5, 1.22, 4 and 5 M hydrochloric acid concentration and 25 ml end volume. 
The samples were boiled under reflux and 1 ml sample was taken out after 10, 30, 50 and 
80 minutes. After cooling, the sample was mixed with 5 ml distilled water and applied to 
SPE LC-18 micro columns activated by 2.5 ml methanol and equilibrated with 2.5 ml 
water prior. The cartridges were washed with 2.5 ml water to remove the acid content, 
then isoflavonoid derivatives were eluted using 2.5 ml methanol twice. After filtration on 
Minisart filter the samples were investigated by HPLC-DAD-ESI-MS/MS. 
• Hydrolysis by glucosidase enzyme 
DOI:10.14753/SE.2019.2295
61 
 
0.1000 g was measured from each powdered plant material three times and mixed with 
50 µl of methanolic naringenin solution (4.000 mg/ml) then 1.5 ml water was added to 
the samples and mixed thoroughly. These samples were set aside for 24 hours to activate 
the indigenous glycosidase enzymes and hydrolyze the glycosides. In the next step, 3.5 
ml methanol was added, and the samples were extracted in ultrasonic bath for 25 minutes. 
After sedimentation the supernatant was collected, and the extraction was repeated twice 
with 70% methanol. The collected liquid phases were completed to 25.0 ml in volumetric 
flasks, 2.0 ml was filtered through Minisart RC 15 0.2 μm membrane, before HPLC-DAD 
and HPLC-DAD-ESI-MS/MS investigation. 
 
3.III.2. Isolation of aglycones 
To isolate isoflavonoid aglycones, 50.0 g dried and powdered plant material from 
Rózsahegyi Ltd. was mixed with 500 ml of water to activate the indigenous glycosidase 
enzymes of the plant for 24 h. After filtration, the extract was evaporated to dryness. 150 
ml acetone was added to the dark brown gum to redissolve the isoflavonoid aglycones 
and to leave behind the saccharides. The extract was filtered and dried to gain 2 g residual. 
This was redissolved in HPLC methanol to obtain a solution of 100 mg/ml concentration. 
For the separation of isoflavonoid aglycones a Hanbon Newstyle NP7000 HPLC system 
with a Hanbon Newstyle NP3000 UV detector (Hanbon Sci. & Tech. CO. Jiangsu, China) 
equipped with a Gemini C18 reversed phase column (150 x2 1.2 mm i.d; 5 μm, 
Phenomenex Inc.; Torrance, CA, USA) was used. Eluents consisted of 0.3% v/v acetic 
acid (A) and acetonitrile (B). Gradient elution was used with 10 ml/min flow rate and 
solvent system with 40% B at 0 min to 43% B in 18 min. Six fractions were obtained with 
this method, which contained pseudobaptigenin (44, 1.22 mg), formononetin (46, 3.15 
mg), onogenin (41, 2.87 mg), sativanone (45, 2.45 mg), maackiain (42, 5.19 mg) and 
medicarpin (47, 5.26 mg), respectively.  
 
3.III.3. Isolation of licoagroside B 
20.0 g ground root of O. arvensis was extracted with 200 ml of 70% methanol twice using 
ultrasonic bath at room temperature. After filtration, the extract was dried under reduced 
pressure. The residue was redissolved in water and 10 ml of acetone was added to remove 
saccharides. The precipitate was filtered, and the liquid phase was dried. The residue was 
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redissolved in 10 ml of water and passed through Supelclean SPE LC-18 columns (500 
mg, 3 mL; Supelco, Bellefonte, PA, USA). After air drying the cartridges, 3 ml of 50% 
methanol was used to elute glycosides, then 6 ml pure methanol was applied to achieve 
complete elution of isoflavonoids. The weights of the first and second eluates were 274 
mg and 171 mg, respectively. The 50% methanol fraction was redissolved in 2 ml of 
water and filtered through 0.22 m Minisart RC filter before subjected to preparative 
HPLC. For fractionation, the same preparative HPLC system was used. Eluents consisted 
of 0.3% v/v acetic acid (A) and methanol (B). Gradient elution was used with a 10 ml/min 
flow rate and a solvent system using 10% B at 0 min, 40% B in 10 min, 100% B in 15 
min and 10% B in 25 min. This method has not been optimized in terms of performance 
parameters as it only served for isolation purposes. Licoagroside B (1) eluted at 11.41 
min, the obtained fraction was reinjected for further purification. Finally, 8.9 mg 
licoagroside B was yielded in high purity  
 
3.III.4. Isolation of but-2-enolide aglycones and calycosin D aglycone 
From the powdered roots of O. arvensis 30.0 g was mixed with 200 of mL water for 48 h 
to activate the plant’s indigenous glucosidase enzymes. After filtration, the drug was 
extracted twice with 200 mL of 70% methanol using ultrasonic bath at room temperature. 
The extract was dried under reduced pressure and redissolved in water. The saccharides 
were precipitated with the same method as mentioned above. The total weight of the 
extract was 835 mg and was redissolved in 10 mL of water and filtered through 0.22 m 
Minisart RC filter before subjected to the same preparative HPLC system. The chosen 
chromatographic conditions fulfilled the criteria of isolation but were not optimized in 
terms of performance parameters. Eluents consisted of 0.3% v/v acetic acid (A) and 
methanol (B). Gradient elution was used with a 10 ml/min flow rate and solvent system 
with 50% B at 0 min, 50% B in 10 min, 100% B in 15 min and 50% B in 20 min. Puerol 
A (18) eluted at 8.40 min, while clitorienolactone B (31) and calycosine D (30) eluted at 
12.25 and 13.45 min, respectively. Clitorienolactone B was reinjected for further 
purification with isocratic 25% acetonitrile as solvent B, and calycosin D with isocratic 
35% acetonitrile. The yields were 4.8 mg for puerol A, 3.1 mg for clitorienolactone B and 
1.5 mg for calycosin D. 
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3.III.5. Isolation of but-2-enolide glycosides and calycosin D glycosides 
100 g powdered drug was extracted by 400 mL of 70% aqueous methanol twice. After 
filtration, the liquid phase was dried under reduced pressure at 60°C. The residue was 
dissolved in water to gain a viscous solution of 500 mg/mL concentration. This sample 
was purified using a CombiFlash NextGen 300+ (Teledyne ISCO, Lincoln, USA) 
equipped with a RediSep Rf Gold C18 column (150 g). As eluents methanol (solvent B) 
and 0.3% acetic acid (solvent A) were used with the following gradient program: 0 min 
30% B, 20 min 50% B, 25 min 100% B, 30 min 100% B. The flow was set to 60 ml/min 
and 16 ml fractions were collected. Fractions 23-27, 38-41 and 49-53 were unified and 
further purified by the same preparative HPLC system using isocratic 25% acetonitrile as 
eluent with 10 ml/min flow. Fr 23-27 yielded 15.4 mg calycosin-D 7-O-glucoside 
(compound 2). From Fr 38-41 puerol A 2’-O-glucoside (6) was isolated (eluted at 7.2 
min, 63.2 mg) along with clitorienolactone B 4’-O-glucoside (7, eluted at 8.6 min). 
Clitorienolactone B 4’-O-glucoside was further purified on a Luna C18(2) 100 A (5 μm) 
reversed phase column (150 x 10.00 mm i.d; Phenomenex, Inc; USA) using isocratic 25% 
acetonitrile and 2 ml/min flow, yielding 2.3 mg. Calycosin-D 6”-O-glucoside malonate 
was isolated from Fr 49-53 eluting at 11.3 min (1.1 mg).  
 
3.III.6. Isolation of homopipecolic acid isoflavonoid glucoside esters 
300.0 g dried and powdered plant material from Rózsahegyi Ltd. was extracted with 2 x 
3000 ml of 70% methanol in ultrasonic bath for 2 x 25 min. The extract was filtered and 
evaporated to dryness to obtain a dark brown gum. The residue was redissolved in 200 
ml water and divided into 5 ml fractions. Each fraction was mixed with 5 ml of methanol 
and acetone to precipitate the majority of the saccharides. The supernatant was filtered, 
and the organic solvents were evaporated at 45 °C. 10 ml portions of the residual dark 
solution were passed through a weak cation exchanger cartridge (Strata WCX Giga Tube, 
Phenomenex Inc.; Torrance, CA, USA) in order to enrich the nitrogen-containing 
compounds. The SPE cartridges were first conditioned by washing with 20 ml methanol 
and equilibrated with 20 ml water. The loaded cartridges were washed with 40 ml water 
and 40 ml methanol then eluted with 5% formic acid in methanol. After evaporation to 
dryness the sample was fractionated by the same preparative HPLC system that was 
mentioned before. Eluents consisted of 0.3% v/v acetic acid (A) and acetonitrile (B). 
DOI:10.14753/SE.2019.2295
64 
 
Gradient elution was used with 10 ml/min flow rate and solvent system with 20% B at 0 
min to 30% B in 20 min. Eight fractions were obtained with this method, out of which Fr 
1–2 contained degradation products and minor contaminants. From Fr 3 
pseudobaptigenin 7-O-glucoside 6”-O-piperidine 2-acetate (12, 0.6 mg) was obtained as 
a mixture with another isoflavonoid glucoside derivative. From Fr 4 formononetin 7-O-
glucoside 6”-O-piperidine 2-acetate (13, 1.3 mg) was isolated. Onogenin 7-O-glucoside 
6”-O-piperidine 2-acetate (14, 1.6 mg) was purified from Fr 5. Fr 6 provided sativanone 
7-O-glucoside 6”-O-piperidine 2-acetate (17, 1.5 mg) in high purity. Fr 7 and Fr 8 
contained solely the diastereomers of maackiain 3-O-glucoside 6”-O-piperidine 2-acetate 
(20, 4.5 mg) and medicarpin 3-O-glucoside 6”-O-piperidine 2-acetate (23, 3.7 mg), 
respectively. For investigation of diastereomers, the two isomers of maackiain 3-O-
glucoside 6”-O-piperidine 2-acetate and medicarpin 3-O-glucoside 6”-O-piperidine 2-
acetate were further purified with the same HPLC equipment. Gradient elution was used 
with 10 ml/min flow rate and solvent system with 15% B at 0 min to 20% B at 15 min 
and 20% B at 25 min.  
3.IV. Chromatographic conditions 
3.IV.1. HPLC-DAD conditions 
The isolated isomers of medicarpin 3-O-glucoside 6”-O-piperidine 2-acetate and their 
mixture were examined on a Waters 2690 HPLC system with a Waters 996 diode array 
detector (Waters Corporation, Milford, MA, USA) equipped with a Xselect reversed 
phase C18 column (150×4.60 mm i.d; 5 μm, Waters Corporation, Milford, MA, USA). 
Eluents consisted of 0.3% v/v acetic acid (A) and acetonitrile (B). The following gradient 
program was applied: 0.0 min, 15% B; 20.0 min, 20% B; 30 min, 20% B. Solvent flow 
rate was 1.0 ml/min and the column temperature was set to 25 °C. 20 μl sample was 
subjected on the column. 
For the quantification of isoflavonoid aglycones, the same HPLC system was used. 
Eluents consisted of 0.3% v/v acetic acid (A) and acetonitrile (B). The following gradient 
program was applied: 0.0 min, 35% B; 15 min, 50% B; 18, 20% B, 20 min, 80% B. 
Solvent flow rate was 1.0 ml/min and the column temperature was set to 25 °C, 20 μl 
extract was subjected on the column.  
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3.IV.2. HPLC-DAD-ESI-MS/MS conditions 
For chromatographic separation and mass spectrometric analysis of the analytical samples 
(hydrolyzed by ammonia, hydrochloric acid and glucosidase enzyme) an Agilent 1100 
HPLC system (degasser, binary gradient pump, auto- sampler, column thermostat and 
diode array detector) was used hyphenated with an Agilent 6410 Triple Quad LC/MS 
system equipped with ESI ion source (Agilent Technologies, Santa Clara, CA, USA). For 
the screening of Ononis extracts HPLC separation was attained on a Zorbax SB-C18 
Solvent Saver Plus (3.5 μm) reversed phase column (150 x 3.0mm i.d; Agilent 
Technologies, Santa Clara, CA, USA). Mobile phase consisted of 0.3% v/v formic acid 
(A) and methanol (B). The following gradient program was applied: 0.0 min, 29% B; 32.0 
min, 80% B; 34 min, 100% B; 37 min, 100% B; 42.0 min, 29% B. Solvent flow rate was 
0.4 ml/min and the column temperature was set to 25 °C. The injection volume was 2 μL. 
Nitrogen was applied as drying gas at the temperature of 350 °C at 9 l/min, the nebulizer 
pressure was 45 psi. The fragmentor voltage was set between 100 and 135 V and the 
capillary voltage was 3500 V. Full scan mass spectra were recorded in positive ion mode 
in the range of m/z 80–1500. For CID the collision energy varied between 10 and 40 eV 
with fragmentor voltage 135 V. As collision gas, high purity nitrogen was used. Product 
ion mass spectra were recorded in positive ion mode in the range of m/z 80–600. 
Fragmentor voltage was set to 80 V and the capillary voltage was 3500 V.  
The hydrolyzed sample was analyzed using the same HPLC-MS/MS apparatus equipped 
with a Zorbax NH2 normal phase column (150 x 4.6 mm i.d; 5 μm). Mobile phase 
consisted of 20 mM ammonium formate buffer (pH = 4) (A) and acetonitrile (B). Isocratic 
mode was applied with 80% B at 1 ml/min flow rate and 25°C. The injection volume was 
5 μl. Nitrogen was applied as drying gas at the temperature of 300°C at 6 l/min, the 
nebulizer pressure was 15 psi. For registering the chromatogram, SIM mode was chosen 
at m/z 130 (homoproline) and m/z 144 (homopipecolic acid). For CID the collision energy 
varied between 10 and 30 eV. As collision gas high purity nitrogen was used. The 
fragmentor voltage was set to 120 V and the capillary voltage was 4000 V. Product ion 
mass spectra were recorded in positive ion mode in the range of m/z 50-200. 
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3.IV.3. UHPLC-DAD-ESI-Orbitrap-MS/MS conditions 
For obtaining high resolution mass spectrometric data of the analytical samples a Dionex 
Ultimate 3000 UHPLC system (3000RS diode array detector, TCC-3000RS column 
thermostat, HPG-3400RS pump, SRD-3400 solvent rack degasser, WPS-3000TRS 
autosampler) was used hyphenated with an Orbitrap Q Exactive Focus Mass 
Spectrometer equipped with electrospray ionization (ESI) (Thermo Fischer Scientific, 
Waltham, MA, USA). The column and the HPLC method were the same as the ones used 
with the non-hydrolyzed analytical samples. The ESI source was operated in positive 
ionization mode and operation parameters were optimized automatically using the built-
in software. The working parameters were as follows: spray voltage, 3500 V; capillary 
temperature 256.25°C; sheath gas (N2), 47.5°C; auxillary gas (N2), 11.25 arbitrary units; 
spare gas (N2), 2.25 arbitrary units. The resolution of the full scan was of 70.000 and the 
scanning range was between 120-1000 m/z units. The most intense ions detected in full 
scan spectrum were selected for data-dependent MS/MS scan at a resolving power of 
35.000, in the range of 50-1000 m/z units. Parent ions were fragmented with normalized 
collision energy of 10, 30 and 45%. 
3.V. Polarimetry and CD conditions 
Optical rotations were determined on a Carl Zeiss Polamat A polarimeter with a 1 dm cell 
and MeOH sample solutions at 25°C. CD spectra of the aglycones (onogenin, sativanone, 
medicarpin and maackiain) were recorded on a Chirascan CD spectrometer (Applied 
Photophysics Ltd., Leatherhead, United Kingdom). Quartz cells of 10 and 0.1 mm optical 
pathlength and an instrument scanning speed of 100 nm/min with 1 s response time were 
used for measurements. The measurements are the averages of three repetitions between 
200 and 300 nm at room temperature. Spectra were baseline-corrected, and the signal 
contributions of methanol were subtracted. 
3.VI. NMR conditions 
All NMR experiments were carried out on a 600 MHz Varian DDR NMR spectrometer 
equipped with a 5 mm inverse-detection gradient (IDPFG) probehead. Standard pulse 
sequences and processing routines available in VnmrJ 3.2C/Chempack 5.1 were used for 
structure identifications. The complete resonance assignments were established from 
direct 1H–13C, long-range 1H–13C, and scalar spin–spin connectivities using 1D 1H, 13C, 
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1H–1H gCOSY, 1H–1H NOESY, 1H–1H ROESY, 1H-1H TOCSY, 1H–13C gHSQCAD (J 
= 140 Hz), 1H–13C gHMBCAD (J = 8 Hz and 12 Hz) experiments, respectively. The 
probe temperature was maintained at 298 K and standard 5 mm NMR tubes were used. 
The 1H and 13C chemical shifts were referenced to the residual solvent signals.  
 
3.VII. Method validation 
Quantification of calycosin D, calycosin, pseudobaptigenin, formononetin, onogenin, 
sativanone, maackiain and medicarpin in the O. spinosa and O. arvensis root extracts was 
performed by the external standard method using HPLC-DAD. The chromatographic 
conditions are described at section 3.IV.1. The standard substances were isolated from O. 
spinosa (see section 3.III.2) except for formononetin, which was from Sigma-Aldrich. 
The purity of the isolated compounds was evaluated by HPLC-DAD and it was min. 98% 
in all cases. Stock solution of the standards was prepared by dissolving the appropriate 
amounts in methanolic naringenin solution (0.78 µg/ml) made with the same dilution step 
as the extraction of the samples. Calibration standards were prepared by diluting the stock 
solutions with the same naringenin solution. In the calibration plots, 10 different 
concentrations (100.0, 60.0, 30.0, 10.0, 6.0, 3.0, 1.0, 0.6, 0.3 and 0.1 µg/ml) were used 
for each analyte in triplicate. Quality control (QC) samples at high, medium and low 
concentrations were prepared separately by diluting the stock solutions. All peak areas 
were standardized to the peak area of the internal standard naringenin. Calibration plot 
was constructed by plotting standardized peak areas against corresponding concentrations 
and then linearity range was determined for each calibrant. Slope, intercept and 
correlation coefficient were determined by least squares polynomial regression analysis. 
LOD and LOQ parameters were determined at 3/1 and 10/1 signal to noise ratios, 
respectively. The accuracy (deviation from nominal concentration) and precision (relative 
standard deviation) of this method was assessed by analyzing the QC samples of three 
levels (n = 3).  
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 Results 
4.I. Qualitative phytochemical results 
Based on the literature concerning the phytochemical constituents of Ononis species, the 
presence of isoflavones, isoflavanones and pterocarpans were presumed in the forms of 
glucosides, glucoside malonates and aglycones. During our work, 47 components were 
identified in the extracts of Ononis species (Table 7). The majority of these compounds 
were isoflavonoid derivatives, but beside them, phenolic lactones and a maltol glycoside 
were found in the samples. In the following, the detailed chromatographic, mass 
spectrometric and NMR results demonstrate the base of the structural identification.   
4.I.1. Chromatographic results 
During the chromatography of the analytical samples, pyrrolidine 2-acetate isoflavonoid 
glucoside esters (3, 5, 8, 9, 10, 15) eluted first, followed by the piperidine 2-acetate esters 
(12, 13, 14, 17, 20, 23). These latter molecules were not separated from glucosides, but 
the corresponding piperidine 2-acetate esters always eluted firstly. The glucosides were 
followed by minor 4”-O-malonates (24, 25, 28, 29), major 6”-O-malonates (11, 16, 33, 
35, 36, 37, 38, 39) and lastly, aglycones (30, 34, 40-47) ( Figure 22, Figure 23 and Figure 
24). Derivatives with methylenedioxy substitution always preceded the methoxy 
substituted ones. Calycosin and calycosin D derivatives (2, 4, 11, 16, 30, 34) showed 
much shorter retention times than the other isoflavones, namely formononetin and 
pseudobaptigenin. Some peaks showed duplication (for example 20 and 23). The 
sensitivity and selectivity of the UV-DAD and ESI-MS(+) detecting methods were very 
distinct. UV detection was most sensitive to isoflavones with the largest conjugated 
electron system (Figure 22), while MS detection in positive ionization mode highlighted 
the easily protonable beta amino acid derivatives (Figure 23). Although most literature 
sources mention negative ionization mode as the standard method detecting isoflavones, 
the signal/noise ratio of pterocarpans were insufficient, so positive ionization mode was 
used. In the free-range samples, glucoside malonates seemed to be the most characteristic 
derivatives, while in the in vitro samples aglycones were more abundant. The hairy root 
cultures proved to synthesize much less from the derivatives bearing methylenedioxy 
substitution, their most important isoflavonoid derivatives contained rather a methoxy 
group. 
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Table 7: The identified compounds and their high-resolution MS and MS/MS data  
No Rt [M+H]+ delta 
Protonated 
formula 
  
Aglycone MS/MS fragment ions Identification 
  min m/z ppm m/z m/z   
1 5.08 433.1338 -0.58 C18H25O12 
 145.0493, 127.0390  Licoagroside B * 
2 8.95 447.1281 -1.06 C22H23O10 285.0753 270.0521, 253.0491, 225.0542, 213.0542, 197.0594 Calycosin-D 7-O-β-D-glucoside * 
3 10.07 588.2072 -0.60 C29H34NO12 315.0857 
287.0912, 274.1284, 177.0545, 163.0383, 130.0861, 
70.0658 
Onogenin 7-O-β-D-glucoside 6"-pyrrolidine 
2-acetate  
4 10.29 447.1299 2.97 C22H23O10 285.0752 270.0517, 253.0486, 225.0538, 213.0543, 197.0593 Calycosin 7-O-β-D-glucoside 
5 10.71 574.2274 -1.55 C29H36NO11 301.1064 283.0598, 274.1280, 163.0389, 130.0862, 70.0655 
Sativanone 7-O-β-D-glucoside 6"-pyrrolidine 
2-acetate 
6 11.17 461.1435 -1.57 C23H25O10 299.0908 281.0802, 253.0854, 239.0698, 193.0493, 107.0495 Puerol A 2'-O-glucoside * 
7 11.82 475.1593 -1.21 C24H27O10 313.1069 295.0960, 267.1012, 253.0855, 207.0647, 107.0495 Clitorienolactone B 4’-O- β-D-glucoside * 
8 13.07 556.1812 -0.25 C28H30NO11 283.0789 274.1284, 70.0650 
Pseudobaptigenin 7-O-β-D-glucoside 6"-
pyrrolidine 2-acetate 
9 13.60 542.2020 0.13 C28H32NO10 269.0804 274.1282, 70.0654 
Formononetin 7-O-β-D-glucoside 6"-
pyrrolidine 2-acetate 
10 14.39 558.1968 -0.34 C28H32NO11 285.0754 274.1280, 175.0389, 151.0388, 70.0658 
Maackiain 3-O-β-D-glucoside 6"-pyrrolidine 
2-acetate 
11 14.44 533.1295 1.00 C25H25O13 285.0753 270.0518, 253.0490, 225.0542, 213.0542, 197.0597 Calycosin-D 7-O-β-D-glucoside malonate * 
12 14.50 570.1967 -0.50 C29H32NO11 283.0596 288.1434, 84.0814 
Pseudobaptigenin 7-O-β-D-glucoside 6"-
piperidine 2-acetate * 
13 14.87 556.2177 -0.04 C29H34NO10 269.0801 288.1436, 144.1017, 84.0814 
Formononetin 7-O-β-D-glucoside 6"-
piperidine 2-acetate * 
14 14.89 602.2231 -0.17 C30H36NO12 315.0855 
288.1435, 177.0543, 163.0387, 144.1017, 135.0439, 
84.0814 
Onogenin 7-O-β-D-glucoside 6"-piperidine 2-
acetate * 
15 15.27 544.2166 -2.06 C28H34NO10 271.0961 274.1281, 161.0594, 137.0595, 123.0441, 70.0646 
Medicarpin 3-O-β-D-glucoside 6"-pyrrolidine 
2-acetate 
16 15.39 533.1309 -1.40 C25H25O13 285.0753 270.0518, 253.0491, 225.0541, 213.0543, 197.0594, Calycosin 7-O-β-D-glucoside malonate 
17 15.53 588.2434 -0.91 C30H38NO11 301.1064 
288.1436, 273.1115, 163.0387, 144.1017, 135.0439, 
84.0814 
Sativanone 7-O-β-D-glucoside 6"-piperidine 
2-acetate * 
18 15.61 299.0909 -1.67 C17H15O5 
 281.0804, 253.0805, 239.0699, 193.0493, 107.0495 Puerol A * 
19 15.65 445.1124 -1.18 C22H21O10 283.0597 253.0491, 225.0543,  197.0595, 169.0647 Pseudobaptigenin 7-O-β-D-glucoside 
6
9
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20 15.95 572.2122 -0.76 C29H34NO11 285.0752 288.1436, 175.0387, 151.0388, 144.1017, 84.0814 
Maackiain 3-O-β-D-glucoside 6"-piperidine 
2-acetate * 
21 16.28 431.1345 1.95 C22H23O9 269.0805 254.0570, 237.0543, 226.0622, 213.0907, 118.0415 Formononetin 7-O-β-D-glucoside  
22 16.51 477.1382 -1.97 C23H25O11 315.0858 
297.0753, 287.0909, 257.0805, 229.0857, 178.0623, 
163.0388, 147.0439, 135.0440 
Onogenin 7-O-β-D-glucoside 
23 17.55 558.2326 -1.38 C29H36NO10 271.0959 
288.1435, 161.0594, 144.1017, 137.0595, 123.0441, 
84.0814 
Medicarpin 3-O-β-D-glucoside 6"-piperidine 
2-acetate * 
24 17.33 463.1591 -1.67 C23H27O10 301.1065 
283.1271, 273.1116, 177.1119, 164.0832, 163.0388, 
135.0440 
Sativanone 7-O-β-D-glucoside 
25 17.59 531.1125 -1.54 C25H23O13 283.0596 253.0490, 225.0542 
Pseudobaptigenin 7-O-β-D-glucoside 4"-
malonate 
26 18.14 517.1343 -0.48 C25H25O12 269.0804 253.8803 
Formononetin 7-O-β-D-glucoside 4"-
malonate 
27 18.23 447.1272 0.16 C22H23O10 285.0751 175.0388, 151.0388, 123.0442 Maackiain 3-O-β-D-glucoside 
28 18.31 563.1387 -1.48 C26H27O14 315.0858 
297.0753, 287.0909, 257.0804, 229.0857, 178.0623, 
163.0388, 147.0439, 135.0440 
Onogenin 7-O-β-D-glucoside 4"-malonate 
29 18.97 549.1600 -0.49 C26H29O13 301.1065 273.1117, 177.1119, 163.0388, 135.0440 Sativanone 7-O-β-D-glucoside 4"-malonate 
30 19.08 285.0754 1.23 C16H13O5 
 270.0519, 253.0490, 225.0540, 213.0543, 197.0596, 
137.0232 
Calycosin-D 
31 19.08 313.1066 -2.11 C18H17O5 
 295.0961, 267.1012, 253.0856, 207.0650, 107.0495 Clitorienolactone B * 
32 19.27 433.1487 -1.41 C22H25O9 271.0960 137.0596 Medicarpin 3-O-β-D-glucoside 
33 19.68 563.1382 -2.37 C26H27O14 315.0855 
297.0752, 287.0912, 257.0803, 229.0856, 178.0628, 
163.0387, 147.0438, 135.0439 
Onogenin 7-O-β-D-glucoside 6"-malonate 
34 19.90 285.0752  C16H13O5  270.0519, 253.0490, 225.0542, 213.0543, 197.0592  Calycosin # 
35 20.03 531.1132 -0.22 C25H23O13 283.0596 253.0491, 225.0543, 197.0594 
Pseudobaptigenin 7-O-β-D-glucoside 6"-
malonate 
36 20.35 549.1595 -1.40 C26H29O13 301.1066 
283.1001, 273.1110, 177.1144, 164.0832, 163.0471, 
135.0455 
Sativanone 7-O-β-D-glucoside 6"-malonate 
37 20.51 517.1353 2.42 C25H25O12 269.0803 254.0569, 237.0541, 213.0906 
Formononetin 7-O-β-D-glucoside 6"-
malonate 
38 20.98 533.1275 -2.75 C25H25O13 285.0750 175.0387, 151.0387, 123.0441 Maackiain 3-O-β-D-glucoside 6"-malonate 
39 21.77 519.1488 -1.74 C25H27O12 271.0959 161.0959, 137.0595, 123.0441 Medicarpin 3-O-β-D-glucoside 6"-malonate 
40 23.88 313.0703 -1.17 C16H13O6 
 298.0469, 283.0598, 281.0440, 268.0362, 255.0647, 
240.0413, 212.0465, 162.0310, 151.0388 
Cuneatin 
7
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41 24.72 315.0858 -1.63 C17H15O6  
297.0753, 287.0903, 257.0804, 229.0857, 178.0623, 
163.0388, 147.0435, 135.0440 
Onogenin * 
42 24.81 285.0750 0.88 C16H13O5 
 175.0388, 151.0388, 123.0442 Maackiain # 
43 24.86 299.0916 0.67 C17H15O5 
 284.0658, 267.0649, 252.0412, 243.1014, 213.0551, 
163.0387, 148.0517, 137.0596 
2'-methoxy formononetin 
44 25.22 283.0596 -1.77 C16H11O5 
 253.0491, 225.0543, 197.0595, 169, 155, 141, 115 Pseudobaptigenin  
45 25.37 301.1061 -3.16 C17H17O5 
 273.1116, 177.1272, 164.0832, 163.0388, 151.0388, 
135.0440, 107.0495 
Sativanone * 
46 25.65 269.0803 -1.99 C16H13O4  
269.0803, 253.0490, 237.0541, 226.0623, 225.0542, 
213.0906, 197.0594 
Formononetin # 
47 25.74 271.0959 1.43 C16H15O4 
 161.0595, 137.0595, 123.0441 Medicarpin # 
*The marked compounds were isolated, and their structures were examined using NMR spectroscopy. 
#The retention time and fragmentation patterns of the marked compounds were compared with standard substances. All other components were identified based on 
HR-MS data. 
7
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Figure 22: UV chromatograms registrated at 260 nm of the analytical samples made 
from O. spinosa and O. arvensis roots and their in vitro hairy root cultures 
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Figure 23: ESI-MS(+) base peak chromatograms of the analytical samples made from 
O. spinosa and O. arvensis roots and their in vitro hairy root cultures 
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Figure 24: The extracted ion chromatograms of identified compounds with various 
aglycones from O. arvensis root aqueous-methanolic extract. A: licoagroside B (1), 
puerol derivatives (6, 7, 18, 31), 2’-methoxy isoflavonoids (40, 43) B: calycosin D (2, 11, 
30) and calycosin D (4, 16, 34) derivatives C: formononetin derivatives D: 
pseudobaptigenin derivatives E: sativanone derivatives F: onogenin derivatives G: 
medicarpin derivatives H: maackiain derivatives 
 
4.I.2. Mass spectrometry results 
To obtain high resolution mass spectrometry data about all possible molecule ion or 
product ion of interest, data independent analysis was used. In addition, to link the 
fragment ions to their precursor ion, data dependent analysis was applied using ESI(+)-
MS/MS. The protonated formulas of the molecular ions and their product ions could be 
calculated based on the high-resolution mass spectrometric data (see Table 7). In the case 
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of glucosides and glucoside malonates the neutral loss of 162 and 248 Da could be 
observed, respectively, and the product ions originating from the aglycone were detected. 
On the other hand, pyrrolidine and piperidine 2-acetate esters gave rise to protonated 
product ions containing the esterified glucose moiety or the beta amino acid and the 
presence of ions originating from the aglycone moiety was much rarer. Pyrrolidine 2-
acetate (homoproline) derivatives had the ions at m/z 274, 130 and 70 in common and 
piperidine 2-acetate (homopipecolic acid) derivatives the ions at m/z 288, 144 and 84. 
Dihydroisoflavonoid derivatives showed the most abundant fragmentation profile, while 
pterocarpan derivatives had only a few characteristic product ions. Components with 
well-known MS fragmentation and previously reported in the plants (formononetin, 
pseudobaptigenin, maackiain, medicarpin and their derivatives) could be easily identified 
solely based on MS. Although, for the identification of new compounds (e.g. sativanone, 
licoagroside B) or for the differentiation of very similar structural isomers (e.g. calycosin 
vs. calycosin D, puerol B vs. clitorienolactone B) orthogonal techniques needed to be 
used.  
4.I.3. Detailed structural identification 
Structural identification of licoagroside B 
As licoagroside B (1, Figure 25) was only identified in the hairy root cultures of 
Glycyrrhiza glabra L. till date [193] and even the high-resolution mass spectrometry data 
could not prove the exact structure, 1H NMR, 1H-1H COSY, 1H-13C HSQC, 1H-13C 
HMBC and 13C NMR experiments were also executed. The 1H and 13C NMR data of 
compound 1 can be seen in Table 8. 
 
 
Figure 25: The chemical structure and numbering of licoagroside B (1) 
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Table 8: Complete 1H and 13C NMR data of licoagroside B (1) in methanol-d4 (δ in ppm, 
J in Hz) 
No. 1H 13C 
2 - 164.6 
3 - 143.3 
4 - 177.1 
5 6.45 (d, J = 5.0) 117.4 
6 8.00 (d, J = 5.0) 157.2 
7 2.41 (s) 15.8 
1’ 4.85 (d, J = 9.6) 104.9 
2’ 3.39 (d, J = 10.7) 75.3 
3’ 3.35 (d, J = 10.8) 71.2 
4’ 3.41 (d, J = 11.0) 77.8 
5’ 3.45 (m) 75.9 
6’a 4.20 (dd, J = 6.0, 6.0) 
64.3 
6’b 4.44 (d, , J = 12.0) 
1” - 172.3 
2”a 
2”b 
2.68 (d, J = 15.0) 
2.62 (d, J = 15.0) 
46.6 
3” - 70.7 
4”a 
4”b 
2.59 (d, J = 15.0) 
2.55 (d, J = 15.0) 
46.6 
5” - 176.4 (HMBC) 
6” 1.33 (s) 27.8 
 
Structural identification of but-2-enolide derivatives 
To determine the exact location of substituents on the but-2-enolide skeleton (Figure 25), 
1H NMR, 1H-1H COSY, 1H-1H NOESY, 1H-13C HSQC, 1H-13C HMBC and 13C NMR 
experiments were executed (Table 9 and Table 10). Regarding aglycones (compound 18 
and 31), R1 and R2 could be a -H or a -OCH3 group, while in the case of glucosides 
(compound 6 and 7), R1 and R2 could be a -H and a glucose moiety or a -OCH3 group and 
a glucose moiety. The position of these groups was located based on the crosspeaks 
obtained in NOE experiments (Figure 27, 28 and Figure 29).  
 R1 R2 Compound 
H H Puerol A 
H glucose Puerol A 2’-O-glucoside 
CH3 H Puerol B 
CH3 glucose Puerol B 2’-O-glucoside 
H CH3 Clitorienolactone B 
glucose CH3 Clitorienolactone B 4’-O-glucoside 
Figure 26: The chemical structure and numbering of but-2-enolide derivatives 
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Figure 27: Partial 1H-1H NOESY spectrum of clitorienolactone B (31) (600 MHz, 
methanol-d4) 
 
Table 9: 1H and 13C NMR data of puerol A (18) and clitorienolactone B (31) in methanol-
d4 (δ in ppm, J in Hz) 
 Puerol A (18) Clitorienolactone B (31) 
No. 1H 13C 1H 13C 
1 - 177.2 - 176.8 
2 6.11 (d, J = 0.8) 112.4 6.11 (d, J = 1.4) 113.66 
3 - 168.5 - 167.54 
4 5.92 m 88.8 5.90 m 85.5 
4a 2.80 (dd, J = 14.6, 6.0) 
3.25 (dd, J = 14.6, 3.5) 
39.6 
2.79 (dd, J = 14.6, 5.7) 
3.25 (dd, J = 14.6, 3.9) 
38.5 
1’ - 110.8 - 112.0 (HMBC) 
2’ - 163.2 - 163.7 
3’ 6.42 (d, J = 2.3) 104.0 6.57 (d, J = 2.2) 100.4 
4’ - 160.0 - 161.3 
5’ 6.43 (d, J = 8.9, 2.3) 109.2 6.53 (d, J = 8.5, 2.2) 109.4 
6’ 7.29 (d, J = 8.9) 132.2 7.34 (d, J = 8.5) 132.4 
OCH3 - - 3.94 (s)  55.9 
1” - 127.7 - 127.3 
2” 6.85 (d, J = 8.4) 131.8 6.79 (d, J = 8.5) 131.8 
3” 6.61 (d, J = 8.4) 115.8 6.60 (d, J = 8.5) 115.8 
4” - 157.1 -66 157.3 
5” 6.61 (d, J = 8.4) 115.8 6.60 (d, J = 8.5) 115.8 
6” 6.85 (d, J = 8.4) 131.8 6.79 (d, J = 8.5) 131.8 
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Figure 28: Partial 1H-1H NOESY spectrum of puerol A 2’-O-glucoside (6) (600 MHz, 
methanol-d4) 
 
Figure 29: Partial 1H-1H NOESY spectrum of clitorienolactone B 4’-O-glucoside 7 (600 
MHz, methanol-d4) 
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Table 10: 1H and 13C NMR data of puerol A 2’-O-glucoside (6) and clitorienolactone B 
4’-O-glucoside (7) in methanol-d4 (δ in ppm, J in Hz) 
 Puerol A 2’-O-glucoside (6) Clitorienolactone B 4’-O-glucoside (7) 
No. 1H 13C  1H 13C  
1 - 177.7 - n.d. 
2 6.12 (d, J = 0.8) 113.5 6.18 (d, J = 0.9) 115.3 
3 - 170.4 - n.d. 
4 6.12 m 86.0 5.94 m 85.4 
4a 2.78 (dd, J = 14.6, 6.7) 
3.20 (dd, J = 14.6, 3.4)  
39.1 
2.81 (dd, J = 14.6, 5.5) 
3.18 (dd, J = 14.6, 3.8) 
39.2 
1’ - 113.7 - n.d. 
2’ - 164.6 - n.d. 
3’ 6.79 (d, J = 2.3) 103.4 6.91 (d, J = 2.0) 102.0 
4’ - 159.3 - n.d. 
5’ 6.58 (d, J = 8.6, 2.2) 110.1 6.83 (d, J = 8.7, 2.1) 110.0 
6’ 7.37 (d, J = 8.6) 132.3 7.43 (d, J = 8.4) 132.0 
OCH3 - - 3.92 (s)  56.2 
1” - 129.5 - n.d. 
2” 6.92 (d, J = 8.5) 131.6 6.77 (d, J = 8.4) 131.7 
3” 6.63 (d, J = 8.5) 115.6 6.59 (d, J = 8.5) 115.7 
4” - 158.2 - n.d. 
5” 6.63 (d, J = 8.5) 115.6 6.59 (d, J = 8.5) 115.7 
6” 6.92 (d, J = 8.5) 131.6 6.77 (d, J = 8.4) 131.7 
Glu1 5.02 (d, J = 7.3) 101.71 5.02 (d, J = 7.0) 102.0 
Glu2 3.45 (m) 78.0 3.50 (m) 78.0 
Glu3 3.43 (m) 71.1 3.48 (m) 71.5 
Glu4 3.51 (m) 78.2 3.53 (m) 78.5 
Glu5 3.48 (m) 74.5 3.51 (m) 74.7 
Glu6 3.75 (m) 
62.3 
3.70 (dd, J = 12.0, 6.4) 
62.5 
Glu6 3.97 (m) 3.93 (d, J = 12.0) 
13C NMR data for compound 6 and 7 were assigned on the basis of HSQC and HMBC experiments 
Structural identification of calycosin derivatives 
Calycosin and calycosin D (3’-methoxydaidzein) derivatives did not differ in their UV 
spectra nor in their MS/MS fragmentation pattern (see Table 7) because of the high 
structural similarity (Figure 30: The structural difference of calycosin (left) and calycosin 
D (or 3'-methoxydaidzein, right)).  
Figure 30: The structural difference of calycosin (left) and calycosin D (or 3'-
methoxydaidzein, right) 
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As calycosin aglycon was available as a standard, the two aglycones could be 
differentiated based on their retention time. However, this method could not be used with 
glucosides and glucoside malonates, so that 1H NMR and 1H-1H NOESY experiments 
were used to identify the isolated compounds 2 and 11 (Figure 31 and Figure 32). Based 
on the NMR results, they were identified as the glucoside and glucoside malonate of 
calycosin D. The other two peaks (4 and 16) were deduced to be calycosin 7-O-glucoside 
and 7-O-glucoside 6”-O-malonate. 
 
Figure 31: Partial 1H-1H NOESY spectrum of calycosin D 7-O-glucoside (2) (600 MHz, 
methanol-d4) 
 
Figure 32: Partial 1H-1H NOESY spectrum of calycosin D 7-O-glucoside 6”-O-malonate 
(11) (600 MHz, methanol-d4) 
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Structural identification of dihydroisoflavonoids 
As the onogenin and sativanone derivatives had not been reported before in O. spinosa, 
the isolated compounds were investigated using 1H NMR, 1H-1H COSY, 1H-1H NOESY, 
1H-13C HSQC, 1H-13C HMBC and 13C NMR experiments (see Table 11). The chirality of 
the molecules (Figure 33) was investigated by CD spectroscopy, however, their solution 
did not display any circular dichroism signals, meaning that the two compounds were 
isolated in a racemic form.  
 
Figure 33: The structure and numbering of sativanone (left) and onogenin (right) 
 
Table 11: 1H and 13C NMR data of onogenin (41) and sativanone (45) in methanol-d4 (δ 
in ppm, J in Hz) 
No. Onogenin (41) Sativanone (45) 
 1H 13C 1H 13C 
2 4.50 – 4.55 (m, 1H) 
4.39 – 4.43 (m, 1H) 
72.0 
 
4.53 – 4.57 (m, 1H) 
4.39 – 4.43 (m, 1H) 
72.0 
3 4.18 (dd, J = 11.6, 5.5 Hz, 1H) 49.2 
 
4.16 (dd, J = 11.4, 5.4 Hz, 
1H) 
49.1 
4 - 194.1 - 194.3 
4a - 115.5 -  
5 7.76 (d, J = 8.7 Hz, 1H) 130.3 7.76 (d, J = 8.7 Hz, 1H) 130.3 
6 6.50 (dd, J = 8.7, 2.3 Hz, 1H) 112.5 6.50 (dd, J = 8.7, 2.3 Hz, 1H) 112.0 
7 -  -  
8 6.32 (d, J = 2.3 Hz, 1H) 103.7 6.32 (d, J = 2.3 Hz, 1H) 103.7 
8a  165.7  165.7 
9 5.89 (d, J = 1.4 Hz, 2H) 102.6 3.79 (s, 3H) 55.8 
10 3.72 (s, 3H) 57.1 3.76 (s, 3H) 56.0 
11 - - - - 
12 - - - - 
1’ - 117.1 -  
2’ - 154.3 - 159.8 
3’ 6.69 (s, 1H) 96.4 6.57 (d, J = 2.4 Hz, 1H) 99.9 
4’ - 142.8 - 162.2 
5’ - 149.3 6.49 (dd, J = 8.4, 2.4 Hz, 1H) 106.0 
6’ 6.61 (s, 1H) 110.9 
 
7.00 (d, J = 8.4 Hz, 1H) 131.9 
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Structural identification of pterocarpans 
Although medicarpin and maackiain were known compounds of Ononis species (see 
section 1.I.2.) their stereochemistry was not unequivocal, because plants can synthesize 
both (+) and (-) medicarpin and maackiain [95]. To determine the absolute configuration 
of the pterocarpans optical rotatory dispersion and circular dichroism were used. The 
[α]D25 value of medicarpin and maackiain was -303° and -113°, respectively, showing 
that in our sample the pterocarpans can be found in the pure form of levorotary 
(6aR,11aR)-medicarpin (47) and (6aR,11aR)-maackiain (42) (Figure 34). The minima 
and maxima of the recorded CD spectra (Figure 35) of medicarpin, λmax (Δε) 208 (-18.53 
M−1*cm−1), 236 (-9.67 M−1*cm−1), 288 (4.09 M−1*cm−1) and maackiain 212 (-4.18 
M−1*cm−1), 240 (-7.41 M−1*cm−1); 280 (0.24 M−1*cm−1), were in accordance with 
literature data [168, 199]. 
 
Figure 34: The structure and numbering of (-)-medicarpin (left) and (-)-maackiain 
(right) 
Figure 35: CD spectrum of medicarpin (47) (MeOH, pathlength: 0.1 mm c=1.3165 
mg/ml) and maackiain (42) (MeOH, pathlength: 0,01 mm c=0.071 mg/ml) 
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Structural identification of nitrogen-containing isoflavonoid derivatives 
To corroborate the mass spectrometry data of beta amino acid isoflavonoid glucoside 
esters and to assign the location of the building blocks of the molecules, homopipecolic 
acid esters were isolated and NMR studies were executed (Table 12, Table 13, Table 14). 
The most important 2D correlations of medicarpin 3-O-glucoside 6”-O-piperidine 2-
acetate (23) are shown in Figure 36.  
Figure 36: Key 2D correlations of medicarpin glucoside piperidine 2-acetate (23) 
(HMBC – red arrows, TOCSY – bold black lines, NOESY – blue arrows) 
The NMR signals showed significant splitting since isomeric pairs were isolated. The 
members of the pairs in the case of medicarpin and maackiain esters were separated and 
the first- and second-eluting isomers were subjected to 1H NMR investigation. It can be 
clearly seen on the 1H NMR spectra, that the split signals recorded in the mixture arose 
from the individual signals of the isolated isomers (Figure 37). 
 
Table 12: 1H and 13C NMR data of formononetin (13) and pseudobaptigenin (12) 
glucoside piperidine 2-acetates in DMSO-d6 (δ in ppm, J in Hz). 
 Compound 13 Compound 12 
No 1H 13C 1H 13C 
2 8.43/8.44 s 152.5 8.45/8.44 s 153.9 
3 - 123.3 - 124.8 
4 - 175.1 - 174.6 
4a - 118.9 - - 
5 8.07 d (8.8) 
8.06 d (8.9) 
127.0 
8.06 d (8.8) 
8.06 d (8.9) 
126.9 
6 7.14 dd (8.7, 2.3) 115.4 7.14 dd (8.7, 2.4) 109.3 
7 - 161.3 - 161.3 
8 7.24/7.22 d (2.3) 103.5 7.23/7.22 d (2.4) 103.3 
8a - 157.1 - 160.8 
1’ - 123.8 - 123.6 
2’/6’ 7.52/7.51 d (8.8) 130.1 7.15 d (2.4) 115.5 
3’/5’ 7.01 d (8.8) 113.5 - 152.3 
4’ - 159.1 - 147.1 
5’  113.5 7.00 d (7.7) 108.1 
6’  130.1 7.07/7.06 dd (7.7, 2.4) 122.3 
4’-OCH3 
4’-OCH2O-3’ 
3.79 s 55.1 
6.05 s 101.1 
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1” 5.20 d (5.5) 
5.19 d (5.4) 
99.4 5.20/5.19 d (5.5) 99.3 
2” 3.328 t (8.1) 73.0 3.27 t (8.1) 72.9 
3” 3.30 t (9.1) 76.1 3.30 t (9.1) 76.1 
4” 3.19/3.18 t (9.1) 69.9 3.15 t (9.1) 69.9 
5” 3.76 m  73.8 3.76 m 73.6 
6”A 4.10 dd (11.8, 7.3) 
4.07 dd (11.8, 7.1) 
63.3 
4.06/4.01 m 
63.2 6”B 4.33 dd (11.8, 2.1) 
4.32 dd (11.8, 1.9) 
4.30 m 
2”’ 2.70/2.65 m 53.1 2.71/2.66 m 53.1 
3”’ax 0.96/0.89 m 
31.8 
0.96 m 
31.8 
3”’eq 1.50/1.43 m 1.52 m 
4”’ax 1.14 m 
24.1 
1.15 m 
24.1 
4”’eq 1.60/1.52 m 1.61m 
5”’ax 1.14 m 
25.6 
1.15 m 
25.6 
5”’eq 1.36 m 1.35 m 
6”’ax 2.38/2.31 m 
46.0 
2.34 m 
46.0 
6”’eq 2.80/2.75 m 2.83/2.75 m 
7”’ 2.29/2.28 m 41.1 2.28m 41.2 
8”’ - 171.4 - 171.4 
13C NMR data for compound 12 and 13 were assigned on the basis of HSQC and HMBC experiments 
The two isomers of maackiain were investigated by HPLC-DAD after 1, 5 and 10 days 
of separation, but no interconversion of isomeric forms was observed (Figure 38). As the 
pyrrolidine 2-acetate esters were present in minute amounts, their isolation was omitted 
and thus the structural identification was carried out using indirect methods. In order to 
release the beta amino acids from their ester forms the extracts were hydrolyzed using 
ammonia and these samples were spiked with the solution of homoproline and 
homopipecolic acid standards. No difference was observed in the retention times and the 
fragmentation patterns of the standard substances and compounds present in the 
hydrolyzed plant extract (see Figure 39).  
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Table 13: 1H and 13C NMR data of sativanone (17) and onogenin (14) glucoside 
piperidine 2-acetates in DMSO-d6 (δ in ppm, J in Hz). 
 Compound 17 Compound 14 
Position 1H 13C 1H 13C 
2 4.58/4.57 m 
70.47 
4.59 m 70.36 
 4.46 m 4.45 m  
3 4.21 dd (11.4, 5.4) 46.68 4.25 m 47.23 
4 - 190.66 - 190.56 
4a - 115.88 - 115.86 
5 7.76 (8.7) 
7.76 d (8.9) 
128.53 
7.76 d (8.7) 
7.75 d (8.8) 
130.07 
6 6.72 dd (8.7, 2.3) 
6.72 dd (8.9, 2.5) 
110.81 
6.746.72 dd (8.7, 2.5) 
110.83 
7 - 162.94 - 162.99 
8 6.64 d (2.3) 
6.64 d (2.5) 
103.45 
6.64/6.63 d (2.5) 
103.45 
8a - 162.89 - 162.99 
1’ - 115.79 - 115.44 
2’ - 158.13 - 152.50 
3’ 6.59 dd (1.3) 98.87 6.82 s 95.77 
4’ - 160.09/160.07 - 140.65 
5’ 6.49/6.48 m 104.99 - 147.24 
6’ 7.01 d (8.5) 
6.99 dd (8.6, 1.3) 
130.82/130.64 
6.75/6.73 s 
109.89 
2’-OCH3  3.71 s 55.64 3.66/3.65 s 56.65 
4’-OCH3  3.75 s 55.24 - 
5.96/5.95 s 
- 
101.11 4’-OCH2O-3’ - - 
1” 5.06 d (5.0) 
5.05 d (4.9) 
99.41 
5.06/5.05 d 5.7 
99.42 
2” 3.27 dd (8.8, 7.8) 73.00 3.28 t 8.1 73.01 
3” 3.32 t (8.9) 76.14 3.31 t 9.1 76.14 
4” 3.16 t (9.2) 69.89/69.84 3.16 t 9.1 69.96 
5” 3.69 m 73.76 3.69 m 73.77 
6”A 4.07/4.04 m 
63.28 
4.07/4.03 m 
63.25 
6”B 4.35/4.32 m 4.35/4.32 m 
2’” 2.78 m 53.20/53.09 2.73 m 53.29 
3’”ax 1.02/0.97 m 
31.65 
0.96/0.92 m 
31.93 
3’”eq 1.53 m 1.55/1.48 m 
4’”ax 1.23 m 
24.04/24.01 
1.22 m 
24.21 
4’”eq 1.61 m 1.61 m 
5’”ax 1.24 m 
25.42 
1.21 m 
25.69 
5’”eq 1.44 m 1.42 m 
6’”ax 2.45 m 
45.96 
2.43 m 
46.15 
6’”eq 2.87 m 2.84 m 
7’” 2.32 m 40.98 2.30 m 41.26 
8’” - 171.26/171.23 - 171.37 
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Table 14: 1H and 13C NMR data of medicarpin (23) and maackiain (20) glucoside 
piperidine 2-acetates in DMSO-d6 (δ in ppm, J in Hz) 
No. Compound 23 Compound 20 
 1H 13C 1H 13C 
1 7.39/7.38 d (8.7) 131.92 7.37 d (8.7) 131.87 
1a - 114.19 - 114.25 
2 6.70 dd (8.7, 2.3)  110.35 6.68 dd (8.7, 2.3)  110.34 
3 - 158.23 - 158.23 
4 6.54/6.53 d (2.3) 104.02 6.54 d (2.3) 104.01 
4a - 156.18/156.16 - 156.18/156.16 
6A 4.28 m  
66.03 
4.26 m 
65.94 
6B 3.65 m  3.64 m  
6a 3.65 m  38.84 3.60 m 39.56 
7a - 119.19 - 118.24 
7 7.25d (8.5)  125.20 6.98 s 105.37 
8 6.45/6.44 d (8.5)  96.34 - 141.12 
9 - 160.53 - 147.48 
10 6.43/6.42 s   106.11 6.53 s  93.24 
10a - 160.22 - 153.64 
11a 5.59 d (7.1) 77.73 5.56 d (7.5) 77.62 
9-OCH3  3.69 s  55.29   
9-OCH2O-8 
  5.91 s 
101.05  
 
5.95 s  
 
1” 4.90/4.89 d (8.5) 
99.95 
4.89 d (7.7) 
4.89 d (7.8) 
99.97 
2” 3.22 t (8.4) 73.08 3.23 m 73.09 
3” 3.29 t (8.9) 76.20 3.29 t (8.9) 76.20 
4” 3.15 dd (9.8, 8.7) 69.90/69.85 3.15 m 69.89/69.86 
5” 3.60 m  73.65 3.60 m 73.65/73.64 
6”A 4.06/4.02 dd (12.0, 
6.8) 
63.21/63.18 
4.06/4.03 dd (12.0, 6.8) 
63.24/63.23 
6”B 4.33/4.30 dd (12.0, 
2.3) 
4.33/4.30 dd (12.0, 2.4) 
2’” 2.73 m  53.30/53.21 2.76 m  53.26/53.17 
3’”ax 0.99/0.94 m  
31.93 
1.00/0.96 m  
31.75 
3’”eq 1.53/1.49 m  1.54/1.50 m  
4’”ax 1.22 m  
24.23 
1.22 m  
24.10 
4’”eq 1.64/1.60 m  1.64/1.60 m  
5’”ax 1.20 m  
25.69 
1.21 m  
25.51 
5’”eq 1.42 m  1.42 m  
6’”ax 2.42 m  
46.15 
2.43 m  
46.05 
6’”eq 2.83 m  2.84 m  
7’” 2.28 m  41.22 2.29 m  41.05 
8’” - 171.40/171.36 - 171.32/171.29 
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Figure 37: Partial 1H NMR spectra of isolated isomers and mixture of diastereomers of 
medicarpin 7-O-glucoside 6”-O-piperidin-2-acetate (23) (600 MHz, DMSO-d6)  
 
 
 
 
1st diastereomer 
2nd diastereomer 
Mixture 
1st diastereomer 
2nd diastereomer 
Mixture 
Figure 38: Chromatograms and UV spectra of isolated peaks (A and B) and mixture (C) of 
maackiain 7-O-glucoside 6”-O-piperidin-2-acetate 20 after 10 days 
 
A B 
C 
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Figure 39: The chromatographic separation  and MS spectra of homopipecolic acid 
(12.8 min) and homoproline (17.3 min) in the hydrolyzed sample (A) and spiked with 
the authentic standards (B) 
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4.II. Quantitative phytochemical results 
4.II.1. Sample preparation 
As most literature sources recommend acidic hydrolysis in order to convert isoflavonoid 
glycosides to aglycones [10], [171], an attempt was made to optimize the hydrolysis time 
and acid concentration. After the hydrolytic process, the samples were investigated using 
HPLC-DAD-ESI-MS/MS method, and semi-quantitative results were used to compare 
the effectiveness of the various hydrolytic methods. The increase of the concentration of 
hydrochloric acid and time proved to enhance the ratio of aglycones compared to 
glycosides (see Figure 40).  
 
Figure 40: The effect of time and hydrochloric acid concentration on the ratio of 
summed peak areas of aglycones vs. glucosides 
As the 5 M hydrochloric acid resulted to be the most effective, in the following we 
investigated the amount of each aglycone during the hydrolysis process. As it can be seen 
in Figure 41, the amount of isoflavones and isoflavanones reached their maximum at 80 
min, however the amount of pterocarpans decreased constantly from the start.  
Enzymatic hydrolysis resulted to be much more convenient, as it only cleaved the 
glycosidic bond and had no effect on the aglycone skeletons. The drastic change in the 
aglycone vs. glucoside ratio can be observed on the chromatograms of Figure 42. As the 
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ratio of aglycones showed the same pattern as of the glycosides, it is presumed that no 
other enzymatic changes were made in the structures. 
 
 
Figure 41: The change in the amount of isoflavone and isoflavanone aglycones (top) 
and pterocarpans (bottom). 
 
Figure 42: UV chromatogram of the native extract made of O. spinosa root (top) and the 
chromatogram of the sample extracted after 24 h of hydrolysis (bottom). 
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4.II.2. Method validation 
Using optimized conditions, the system enabled baseline separation of 6 target isoflavone 
aglycones within 14 min. Figure 43 shows chromatograms of a standard mixture and 
typical hydrolyzed O. spinosa root extract under UV detection at wavelength of 270 nm.  
 
 
Figure 43: UV chromatograms of the standard mixture (A) and hydrolyzed O. spinosa 
extract (B) registered on 270 nm 
 
The calibration was based on the triplicate analysis of each working solution at 10 
concentration levels. The determined linearity ranges can be seen in Table 15 along with 
the regression equations and the coefficients of determination.  
 
Table 15: Calibrating curves of standard compounds 
Name of 
compound 
Linearity 
range (µg/ml)  
(number of 
points) 
Equation R2 LOD 
(µg/ml) 
LOQ 
(µg/ml) 
Pseudobaptigenin 0.3 – 30.0 (7) y = 0.1184x + 0.0268 1.000 0.1 0.3 
Formononetin 0.6 – 100.0 (8) y = 0.8967x + 0.3266 1.000 0.03 0.1 
Onogenin 0.3 – 30 (7) y = 0.3155x + 0.0219 1.000 0.03 0.1 
Sativanone 0.1 – 30.0 (8) y = 0.3328x + 0.0099 0.999 0.03 0.1 
Maackiain 0.3 – 10.0 (6) y = 0.1798x + 0.0198 0.998 0.03 0.1 
Medicarpin 0.3 – 10.0 (6) y = 0.213x + 0.0246 0.998 0.03 0.1 
 
The concentrations of the high, medium and low QC samples for each standard can be 
seen in Table 16 with the intra- and interday accuracy and precision values All results 
fulfilled the requirements of the FDA and EMEA guidelines of bioanalytical method 
DOI:10.14753/SE.2019.2295
92 
 
validation, as the accuracy and precision values did not exceed ±15%, or ±20% in the 
case of low QC samples at the limit of quantitation.  
 
Table 16: The intra-day precision and accuracy values of the six standards 
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High QC (µg/ml) 24.5  98.0  24.1  23.9 9.85 10.2 
Intra-day Accuracy (%) 0.8 0.7 0.2 0.8 0.2 0.0 
Precision (%) 2.8 2.3 0.5 0.6 0.1 0.4 
Inter-day Accuracy (%) -1.4 0.9 0.3 0.7 0.1 0.3 
Precision (%) 0.9 2.4 0.4 0.6 0.5 0.7 
Medium QC (µg/ml) 2.94 5.88 2.89 0.958 3.69 3.81 
Intra-day Accuracy (%) 10.7 1.0 9.4 -7.4 11.1 10.9 
Precision (%) 0.8 0.6 0.8 1.0 0.6 0.3 
Inter-day Accuracy (%) 11.2 1.1 9.3 -7.1 11.2 10.9 
Precision (%) 0.4 7.4 1.1 0.93 0.5 0.5 
Low QC (µg/ml) 0.294 0.588 0.289 0.0958 0.37 0.38 
Intra-day Accuracy (%) -10.3 -17.1 16.5 -6.0 1.1 3.3 
Precision (%) 3.4 0.8 4.8 7.9 5.6 4.2 
Inter-day Accuracy (%) -20.0 -16.9 11.9 1.3 0.9 0.0 
Precision (%) 5.2 0.9 9.2 15.1 11.9 7.8 
 
4.II.3. Quantitative results 
The calculated isoflavonoid concentrations in free-range samples and in vitro hairy root 
cultures of O. spinosa and O. arvensis can be seen in Table 17. Values are expressed as 
means of three parallel samples ± 95 % confidence intervals.  
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Table 17: The isoflavonoid content of O. spinosa and O. arvensis samples 
 Pseudobaptigenin 
(g/100g) 
Formononetin 
(g/100g) 
Onogenin 
(g/100g) 
Sativanone 
(g/100g) 
Maackiain 
(g/100g) 
Medicarpin 
(g/100g) 
Total 
(g/100g) 
O. spinosa     
Hűvösvölgy 0.33±0.02 0.116±0.006 0.117±0.007 0.078±0.007 0.20±0.01 0.11±0.01 0.95±0.06 
Dunaegyháza 0.31±0.04 0.18±0.03 0.13±0.02 0.11±0.01 0.25±0.06 0.24±0.01 1.22±0.18 
Commercial 1 0.41±0.04 0.15±0.02 0.25±0.01 0.132±0.007 0.31±0.04 0.21±0.01 1.47±0.14 
Commercial 2 0.08±0.04 0.031±0.002 0.091±0.004 0.0693±0.0007 0.133±0.006 0.175±0.004 0.58±0.02 
Commercial 3 0.093±0.009 0.028±0.005 0.11±0.01 0.087±0.007 0.15±0.01 0.17±0.01 0.63±0.05 
Hairy root under LOQ 0.43±0.03 0.07±0.01 2.8±0.2 under LOQ 1.37±0.06 4.7±0.3 
O. arvensis     
Kárpátalja 0.33±0.021 0.107±0.007 0.201±0.007 0.094±0.007 0.244±0-005 0.138±0.002 1.12±0.05 
Udvarhely 0.38±0.01 0.116±0.007 0.106±0.007 0.054±0.002 0.105±0.0065 0.080±0.004 0.84±0.04 
Hairy root under LOQ 0.021±0.002 under LOQ 0.46±0.03 under LOQ 0.39±0.03 0.87±0.06 
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 Discussion 
5.I. Qualitative phytochemical results 
5.I.1. Structural identification of licoagroside B 
The m/z value of the pseudo-molecular ion in positive ionization mode of compound 1 
(Figure 24) was 433.1338 and its molecular formula calculated on the basis of HR-MS 
experiments corresponds to C18H24O12 (see Table 7). Investigating the fragmentation 
pattern of this precursor ion, only two fragment ions at m/z 145.0493 (C6H9O4) and m/z 
127.0390 (C6H7O3) could be observed, contrary to the rich fragmentation profile and rDA 
cleavage of isoflavonoid derivatives [180]. Based on these results, peak 1 was tentatively 
identified as licoagroside B, the 3-hydroxy-3-methyl-glutarate ester of maltol glucoside. 
The fragment at m/z 127.0390 could result from the cleavage of the maltol ring together 
with the anomeric O atom, 
while the fragment at m/z 
145.0493 could be assigned 
to the hydroxy-methyl-
glutaric acid residue (Figure 
44). The results of the NMR 
experiments verified that 
compound 1 was 
licoagroside B (Table 8) and 
the obtained resonances 
showed perfect correlation 
with the ones reported by Li 
et al. [195].  
 
5.I.2. Structural identification of but-2-enolides 
Peak 18 showed a protonated pseudo-molecular ion at m/z 299.0908 and its fragmentation 
pattern was identical with that of peak 6 bearing precursor ion at m/z 461.1435 (Figure 
24). Based on the protonated molecular formulas (C17H15O5 and C23H25O10), these 
structures were putatively identified as puerol A and its 2’-O-glucoside (Table 1). In their 
Figure 44: Proposed fragmentation pathway of 
licoagroside B in positive ionization mode at 10 eV 
collision energy 
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MS/MS spectra two main fragmentation pathways could be observed: the cleavage of the 
whole molecule to A and B-ring and the neutral loss of small units, as CO and C2H2O.  
R1 R2 Compound 
H H Puerol A 
H glucose Puerol A 2’-O-glucoside 
CH3 H Puerol B 
CH3 glucose Puerol B 2’-O-glucoside 
H CH3 Clitorienolactone B 
glucose CH3 Clitorienolactone B 4’-O-
glucoside 
 
Applying the same fragmentation pattern described above, 7 and 31 (Figure 24) were 
assigned as the methylated derivative of puerol A and its O-glucoside, respectively. 
Between the fragment ions in the spectra of 18 and 31, a difference of 14 Da could be 
observed in all cases (Table 7), except for the ion at m/z 107.0495 (C7H7O) corresponding 
to the B-ring. These fragments indicate that a methyl substituent on the A-ring is 
responsible for the 14 Da shifts of the fragments (Figure 45).  
Kirmizgül et al. [12] isolated spinonin from O. spinosa, which is a monoglycoside and 
its structure would correspond to puerol A 2”-O-glucoside. Nevertheless, the authors 
drove to the conclusion, that spinonin contained a 2,3-dihydro-3-oxofurane ring instead 
of a 2,3-dihydro-2-oxofurane, like the puerol derivatives. Puerol A and its 4’-O-
methylated form, puerol B, along with their 2’-O-glucosides were isolated from O. 
angustissima L. by Ghribi et al [26], but another O-methylated derivative of puerol A 
(clitorienolactone B) was isolated from O. spinosa by Addotey et al. [11]. Puerol B and 
clitorienolactone differ only in the position of a methyl substitution (Figure 45). In puerol 
B the methylation occurs at the para OH group of A-ring position, whereas in 
clitorienolactone B it is in the ortho position. Since the HR-MS/MS investigations alone 
could not solve the exact location of atoms in the middle ring and the methyl group, peaks 
6, 7, 18 and 31 were isolated and subjected to NMR experiments in order to clarify the 
structures. Based on the NMR results (Table 9 and Table 10), the isolated compounds 
contained a 2,3-dihydro-2-oxofurane ring. The most decisive element was the chemical 
shift of the carbonyl atoms, as they exhibited chemical shifts at 176.8 and 177.2 ppm, 
Figure 45: The structures of but-2-enolide derivatives and the proposed fragmentation 
pathway 
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which are characteristic for unsaturated γ lactones [195], whereas 2,3-dihydro-3-
oxofurane rings possess chemical shift above 200 ppm [196]. The glucose moiety of 
compound 6 joined puerol A through the 2’-OH group, in ortho position (Figure 28). 
Based on the NOESY spectrum (Figure 28), the methyl group of compound 31 is located 
in ortho position too, so that this compound was identified as clitorienolactone B. The 
NOESY spectrum of compound 7 (Figure 29) revealed that the glucose moiety is linked 
through the 4’ OH group, in para position. To the best of our knowledge, this glucoside 
is characterized for the first time.   
 
5.I.3. Structural identification of isoflavones 
Peak 21, 26, 37 and 46 (Figure 24) provided [M+H]+ ions at m/z 431.1345 (C22H23O9), 
517.1343 (C25H25O12), 517.1353 (C25H25O12) and 269.0803 (C16H13O4), respectively, but 
they did not differ in their MS/MS spectra, meaning that they are the derivatives of the 
same aglycone. The fragmentation of these ions gave rise to m/z 254.0570 (C15H10O4) 
ion, owing to the radical cleavage of CH3
• and m/z 237.0543 (C15H9O3), deriving from 
the loss of a CH3OH unit, verifying the presence of a methoxy group. The ion at m/z 
213.0907 (C14H13O2) is a result of the loss of two CO units which is characteristic for 
isoflavonoid aglycones [184]. Fragment ion at m/z 118.0415 (C8H6O) refers to the ion 
containing the B-ring resulting from the rDA fragmentation (Figure 18). Although, the 
intact B-ring with the methoxy group at m/z 133.0648 (C9H9O) is barely detectable, the 
rDA fragment losing the CH3
• radical at m/z 118.0415 is much more intense (Table 7). 
Regarding this information the aglycone was tentatively identified as formononetin (see 
Figure 46). The neutral loss of 162.0540 (C6H10O5) Da of peak 21 corresponded to the 
loss of a hexose moiety. Taking into account, that isoflavonoids form glycosides with 
glucose in the vast majority of cases [196], the peak was assigned as formononetin 7-O-
D-glucoside or ononin (see Figure 47). Peaks 26 and 37 showed the same quasi-molecular 
ion and fragmentation spectra, and a neutral loss of 248.0550 Da (C9H12O8), therefore 
they were attributed as 7-O-D-glucoside malonates of formononetin. Based on the 
significant difference in their quantity and retention times (Figure 24), the firstly eluting 
minor derivative was tentatively identified as 4”-malonate (26) and the later eluting major 
molecule as 6”-malonate (37) (Figure 47) [197].  
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Figure 46: The structures of isoflavone aglycones 
 
 
Figure 47: The structures of 7-O-glucosides, 4”-O- and 6”-O-malonates 
 
With protonated pseudo-molecular ions at m/z 447.1281 (C22H23O10) and 447.1299 
(C22H23O10), 533.1295 (C25H25O13) and 533.1309 (C25H25O13), 285.0753 (C16H13O5) and 
285.0752 (C16H13O5), two sets of glucosides, glucoside malonates and aglycones were 
observed, all sharing identical fragmentation pattern. The same neutral losses could be 
detected as in the case of formononetin, namely the loss of a CH3• and a CH3OH, which 
are a result of a methoxy substitution. These cleavages could be combined with the loss 
of two CO moieties, resulting in ions at m/z 270.0521 (C15H10O5)[M+H-CH3•]+, 253.0491 
(C15H9O4) [M+H-CH3OH]
+, 225.0542 (C14H9O3) [M+H-CH3OH-CO]
+, 213.0542 
(C13H9O3) [M+H-CH3OH-CO]
+, 197.0594 (C13H9O2) [M+H-CH3OH-CO-CO]
+ (Table 
7). The ion at m/z 137.0232 (C7H5O3) was presumed to be the rDA fragment containing 
the A-ring, demonstrating that it could not bear any other substituents but the hydroxy 
group at C7 (Figure 18). As a result, these molecules were tentatively identified as 
structural isomers differing only in the position of the hydroxy and methoxy groups of 
the B-ring. As even the ratios of the fragment ions were not significantly different, the 
two sets were not distinguishable relying only on mass spectrometry data. Since the firstly 
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eluting peaks of the pairs were always higher in relative quantity (Figure 24), it was 
presumed that peaks 2, 11 and 30 have the same aglycone, and 4, 16 and 34 another one. 
The identity of the aglycones was investigated using calycosin as standard substance and 
its retention time and MS/MS spectrum matched with the later eluting peak (34). As 
Addotey et al. isolated calycosin D from O. spinosa, which differ only in the position of 
a methyl group (Figure 30), it was hypothesized, that the major peaks (4, 16 and 34) are 
the derivatives of this molecule [11]. To verify this hypothesis, the firstly eluting relative 
major peaks (2 and 11) were isolated and investigated by NMR. Based on the NOESY 
spectra (see Figure 31 and Figure 32), they were the 7-O-glucoside and 7-O-glucoside 
6”-O-malonate of calycosin D, so that peaks 4 and 16 were tentatively identified as the 
7-O-glucoside and 7-O-glucoside 6”-O-malonate of calycosin, respectively (Figure 46).  
Peaks 19, 25 and 35 (Figure 24) had a pseudo-molecular ion at 445.1124 (C22H21O10), 
531.1125 (C25H23O13) and 531.1132 (C25H23O13) and each provided the same fragment 
ions with peak 44 at m/z 283.0596 (C16H11O5). The fragments, which were formed by the 
loss of a CH3OH unit from the protonated calycosin ion (m/z 253.0491, 225.0543, 
197.0595) could be observed with these molecules as well. As the protonated molecular 
formula of calycosin contains two hydrogens more (C16H13O5) than the aglycone of these 
molecules (C16H11O5) (Table 7), the cause of the same fragment ions is the neutral loss 
of CH2O unit instead of a CH3OH unit. Considering these results, the peaks were 
tentatively identified as the 7-O-D-glucoside (19), 4” and 6”-malonates (25 and 35) and 
the aglycone of pseudobaptigenin (44) (Figure 46 Figure 47). 
 
5.I.4. Structural identification of isoflavanones 
Peaks 24, 29, 36 and 45 (Figure 24) had the quasi-molecular ions at m/z 463.1591 
(C23H27O10), 549.1600, 549.1595 (C26H29O13) and 301.1061 (C17H17O5) and their 
fragmentation pattern significantly differed from those of the isoflavones. Because 
tandem mass spectrometry experiments alone did not provide satisfactory evidence to 
identify the aglycone skeleton, the aglycone was isolated from the hydrolyzed plant 
extract and was unequivocally identified by NMR experiments as sativanone (see page 
81). Consequently, the peaks were identified as the 7-O-glucoside (24), the 4” and 6”-O-
glucoside malonates (29 and 36) and the aglycone (45) of sativanone (Figure 48).  
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Figure 48: The structure of sativanone (left) and onogenin (right) 
Knowing the exact structure of the aglycone, the observed product ions were assigned as 
follows. All sativanone derivatives produced fragment ions at m/z 283.0965 (C17H15O4) 
and 273.1119 (C16H17O4), corresponding to the initial ejection of a H2O or a CO unit. The 
two intense fragment ions at m/z 163.0388 (C9H7O3) and 135.0440 (C8H7O2) could be 
attributed to [M+H-B-ring]+ and [M+H-B-ring-CO]+. As isoflavanones can cleave 
alongside the bonds 1 and 3 (Figure 18), the product ion at 164.0382 (C10H12O2) could be 
assigned as 1,3B+• (Figure 49). Interestingly, the cleavage of CH3• groups was not 
characteristic.  
 
Figure 49: Proposed fragmentation pathway of isoflavanones 
The molecular formula of peaks 22, 28, 33 and 41 (Figure 24) differed from the 
corresponding ones of sativanone in that of an extra oxygen and the lack of the two 
hydrogens which could be a consequence of a methylenedioxy substitution instead of a 
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methoxy group. The loss of H2O and CO units could be observed on the MS/MS spectra 
at m/z 297.0753 (C17H13O5) and 287.0909 (C16H15O5). Proving that the substitution 
patterns of the A-ring of sativanone and the aglycone of these molecules are identical, the 
same ions at m/z 163.0388 and 135.0440 could be detected. Moreover, as an evidence of 
the methylenedioxy substituent, ions at m/z 257.0804 (C15H13O4) [M+H-CO-CH2O]
+ and 
229.0857 (C14H13O3) [M+H-2CO-CH2O]
+ could be detected (Table 7). There is 14 Da 
difference between the mass of sativanone and onogenin, which is the result of different 
B-ring. This difference is only present between product ions at m/z 178.0623 (C10H10O3) 
of onogenin and at m/z 164.0382 (C10H12O2) of sativanone, certifying that these ions 
containing the B-ring of the molecules (Figure 49). Regarding these aspects, the structures 
were identified as the 7-O-glucoside (22), 4” and 6”-O-glucoside malonates (28 and 33) 
and aglycone (41) of onogenin (Figure 48) and these results were corroborated by NMR 
experiments, too (see page 81).  
 
5.I.5. Structural identification of pterocarpans 
Peaks 32 and 39 (Figure 24) had a pseudo-molecular ion at m/z 433.1487 (C22H25O9) and 
519.1488 (C25H27O12) and showed a common aglycone fragment at m/z 271.0959 
(C16H15O4) with 47. Their MS/MS fragments could be detected at m/z 161.0595 
(C10H9O2), 137.0595 (C8H9O2) and 123.0441 (C7H7O2) (Table 7). These results were in 
concordance with the fragmentation pattern of the pterocarpan medicarpin 3-O-β-D-
glucoside (32), medicarpin 3-O-β-D-glucoside 6"-malonate (39) and medicarpin 
aglycone (47) (Figure 34). The rather poor collision induced dissociation might be 
supported by the rigid structure as well. The ion at m/z 161.0595 is corresponding to the 
loss of a C6H6O2 ([
1,4A]+) unit, which can be a consequence of the cleavage of the bonds 
1 and 4, whereas the ions at m/z 123.0441 and 137.0595 are the products of the cleavage 
of bond 2 and 4, resulting [2,4A]+ and [2,4B]+, respectively (Figure 18). Peaks 27, 38 and 
42 (Figure 24) showed similar fragmentation pattern to those of medicarpin, however a 
14 Da difference (+O-2H) could be observed in the case of the quasi-molecular ions and 
the fragment ions containing the B-ring, namely at m/z 175.0388 (C10H7O3) [M+H- 
C6H6O2]
+ and 151.0388 (C8H7O3) [
2,4B]+. Based on this fragmentation pattern and 
analogy with medicarpin, these ions could be tentatively identified as maackiain 3-O-β-
D-glucoside (27), maackiain 3-O-β-D-glucoside 6"-malonate (38) and maackiain (42) 
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(Figure 34). As the two molecules differ only in the substitution of the B-ring, the 
fragment originating from the A-ring is the same at m/z 123.0442 [2,4A]+. 
 
5.I.6. Structural identification of 2’-methoxy isoflavones 
Peak 43 showed a m/z value for the aglycone, which was not mentioned in Ononis species 
before. The formula calculated from the HR-MS data was C17H14O5 (Table 7), which 
could refer to known compounds afrormosin, cladrin or 2’-methyoxy formononetin 
(Figure 50).  
 
 
Figure 50: The structure of afrormosin (left), cladrin (middle) and 2'-methoxy 
formononetin 
As a result of collision induced dissociation, ions at m/z 284.0658 (C16H12O5), 267.0649 
(C16H11O4), 252.0412 (C15H8O4) were detected, which could refer to structures [M+H-
CH3•]
+, [M+H-CH3OH]
+ and [M+H-CH3•-CH3OH]
+, respectively. These fragments 
clearly showed that the molecule contained two methoxy groups. The product ion at m/z 
243.1014 (C15H15O3) is a result of the ejection of two CO molecules, which is diagnostic 
for isoflavonoid molecules [184]. The cleavage of the bond between the C-ring and B-
ring could provide ions at m/z 163.0387 (C9H7O3) [M+H-B-ring]
+ and 137.0596 (C8H9O2) 
[B-ring+H]+. Regarding this fragmentation pattern, the A-ring can only bear a hydroxy 
group, and the two methoxy groups are localized on the B-ring. Further evidence for the 
position of the substituents is provided by the fragment at m/z 148.0517 (C9H8O2), which 
was presumed to be the rDA product [1,3B-CH3•]
+. This fragment corresponds to the [1,3B-
CH3•]
+  ion in the MS/MS spectra of formononetin and the mass difference is caused by 
an extra methoxy substituent (see Figure 51). Since afrormosin has a methoxy and a 
hydroxy group on the A-ring and a single methoxy substituent on the B-ring, it could be 
excluded from the list of possible structures (Figure 50). Comparing the MS/MS spectra 
of cladrin [205, 206] and 2’-methoxy formononetin [200] with our data, the peaks at m/z 
163.0, 148.1 and 137.1 could be observed in all cases indicating the double methoxy 
substitution of the B-ring, however, inspecting fragments in higher m/z regions, our 
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detected peaks were clearly in agreement with the ones of the 2’-methoxy formononetin. 
2’-methoxy formononetin has been isolated from Dalbergia parviflora L. [201] and from 
Eschscholtzia californica L. (California poppy) [202], but not from Ononis species.  
 
Figure 51: The proposed fragmentation pathway of 2'-methoxy formononetin 
The protonated formula calculated based on the exact mass for peak 40 (C17H13O6) (Table 
7) suggests that this compound contains an extra oxygen atom and misses two hydrogens 
atoms compared to 2’-methoxy formononetin. The origin of this difference could be the 
methoxy – methylenedioxy substitutions of isoflavonoids, just like in the case of 
formononetin – pseudobaptigenin, sativanone – onogenin, medicarpin – maackiain pairs. 
The mass difference could be followed through the ions with smaller m/z ratio at 151.0388 
(C8H7O3) and 162.0310 (C9H6O3), which are corresponding the ones of 2’-methoxy 
formononetin at m/z 137.0596 (C8H9O2) and 148.0517 (C9H8O2) and were assigned as 
[1,3B-CH3•]
+ and [B-ring+H]+ (Figure 52). Consequently, it can be deduced, that the mass 
difference arose from the substitution pattern of the B-ring, meaning that beside a 
methoxy group, an additional methylenedioxy group is localized on it. As a proof of the 
mutual presence of OCH3 and OCH2O substituents, the loss of CH3•, CH3OH and CH2O 
units and their combination could be observed on the MS/MS spectrum at m/z 298.0469 
(C16H10O6) [M+H-CH3•]
+, 283.0598 (C16H11O5) [M+H-CH2O]
+, 281.0440 (C16H9O5) 
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[M+H-CH3OH]
+, 268.0362 (C15H8O5) [M+H-CH3•- CH2O]
+. Similarly to other 
isoflavones, the loss of CO units were also detectable at m/z 255.0647 (C15H11O4) [M+H-
CH2O-CO]
+, 240.0413 (C14H8O4) [M+H-CH3•-CH2O-CO]
+, 212.0465 (C13H8O3) [M+H-
CH3•-CH2O-2CO]
+ (Figure 50). In the literature, only cuneatin fulfills these structural 
criteria. Cuneatin was described in aerial parts of Millettia oblata ssp. teitensis [203], 
aerial parts of Retama sphaerocarpa [204], stem bark of Dalbergia frutescens [125], 
Eysenhardtia polystachya [205], aerial parts and roots of Tephrosia maxima [206] and 
most importantly, in Cicer species [207]. In his other work [21], Ingham had shown the 
chemotaxonomic similarity of genus Ononis and Cicer, and the presence of cuneatin in 
both genus corroborates this idea.  
 
Figure 52: The proposed fragmentation pathway of cuneatin 
Other confirmations of the presence of 2’-methoxy formononetin and cuneatin could be 
acquired from the biosynthesis of isoflavonoids. The final products of the isoflavonoid 
biosynthesis are medicarpin and maackiain (Figure 14). These phytoalexins with 
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pterocarpan skeleton possess a methoxy and a methylenedioxy group, respectively. 
Formononetin serves as the parent compound of medicarpin and through the calycosin-
pseudobaptigenin route it could also be considered as the precursor of maackiain. Both 
formononetin and pseudobaptigenin undergo hydroxylation, converting to 2’-hydroxy 
formononetin and 2’-hydroxy pseudobaptigenin. These molecules were not detected in 
our sample, however their 2’-O-methylated derivatives, 2’-methyoxy formononetin and 
cuneatin were confirmed. In the following step, the 2’-hydroxy isoflavones are reduced 
to the dihydro-derivatives: vestitone and sophorol [95]. Their 2’-O-methylated 
derivatives, sativanone and onogenin are representative compound in Ononis species, as 
well as pterocarpan medicarpin and maackiain [61]. 
 
5.I.7. Structural identification of nitrogen-containing derivatives 
Mass spectrometry 
The investigation of the analytical samples by LC-MS revealed characteristic nitrogen-
containing compounds (3, 5, 8, 9, 10, 15 and 12, 13, 14, 17, 20, 23) in the total ion 
chromatogram recorded in positive ionization mode (Figure 24). The even m/z ratio of 
these peaks indicates the presence of an odd number of nitrogen atoms in the structures. 
Comparing the total ion chromatogram (TIC) with the UV chromatogram, remarkable 
intensity differences were observed in the case of the corresponding peaks (see Figure 22 
Figure 23). While the peaks of the nitrogen-containing molecules were predominant in 
the TIC (due to the efficient ionization), the peaks of these compounds could hardly be 
detected in the UV chromatogram. Compounds 20 and 23 showed however significant 
splitting on the achiral C18 stationary phase, suggesting diastereomeric compounds. The 
MS/MS data and the accurate mass measurements (Figure 24) confirmed that the 
molecules of interest are isoflavonoid derivatives. As isoflavonoids possess high molar 
absorptivity, the UV chromatogram suggested that these compounds are in minute 
amount in the extract. All six isoflavonoid skeletons (formononetin, pseudobaptigenin, 
sativanone, onogenin, medicarpin and maackiain) were present in the form of glucosides 
bearing a nitrogen-containing moiety. Besides the aglycone and its corresponding 
fragments, each MS/MS spectrum showed characteristic ions at 288.1452, 144.1025 and 
84.0810 or 274.1282, 130.0862 and 70.0652 m/z values, suggesting that all the six 
compounds share a common structural motif linked to the isoflavonoid glucosides. The 
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collision induced dissociation cleaves the molecules alongside the glycosidic bond, 
resulting in the intact aglycone as Y0
+ and the cleaved fragment composed of the glucose 
and the nitrogen-containing moiety at m/z 288.1452 (C13H22NO6) or 274.1282 
(C12H20NO6). Fragmentation of the isoflavonoid glucoside moiety with a neutral loss 
results the structure at m/z 144.1025 or 130.0862 and the protonated formula of C7H13NO2 
or C6H11NO2 which were hypothesized to be the beta amino acid homopipecolic acid 
(piperidine 2-acetate) and homoproline (pyrrolidine 2-acetate). The cleavage of the 
heterocyclic ring solely could provide the ion at m/z 84.0814 (C5H10N) or at m/z 70.0650 
(C4H8N) (Figure 53). 
 
Figure 53: The proposed fragmentation pathway of homopipecolic acid (A) and 
homoproline (B) isoflavonoid glucoside esters 
 
As these beta amino acid moieties have never been described in higher plants, samples of 
different origin and vegetational period were subjected for analytical screening to detect 
the same compounds. These experiments successfully proved the presence of the 
isoflavonoid glucoside beta amino acid esters, therefore the possibility of sample 
contamination could be excluded. In order to exclude any further hypothetical structures 
and to unambiguously identify the new structures, the homopipecolic esters in relatively 
higher quantities were isolated and NMR experiments were applied (see section 5.I.7.) 
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NMR studies  
The complete structure identification of medicarpin 7-O-glucoside 6”-O-piperidin-2-
acetate (23) is described herein as an example. In the case of this compound, the MS/MS 
data suggested the presence of medicarpin aglycone (Table 7). The six aromatic protons 
at 7.39/7.38 (d J = 8.7 1H), 7.25/7.24 (d J = 8.2 Hz 1H), 6.70 (dd J = 8.7, 2.3 Hz 1H), 
6.54/6.53 (d J = 2.3 Hz), 6.45/6.44 (d J = 8.2 Hz 1H) and 6.43/6.42 (s 1H) ppm and the 
characteristic spin system (-O-CH2-CH-CH) at 4.28 (m 1H), 3.65 (m 2 H) ppm along with 
the methyl singlet of the –OCH3 group at 3.69 ppm present in the 1H NMR spectrum of 
23 corroborated by HMBC correlations and literature data [191] confirmed the 
medicarpin aglycone. The presence of a glucose moiety was also verified by NMR, key 
HMBC correlations confirmed the glycosidic linkage between the anomeric OH of the 
glucose and the C3-OH of medicarpin. The careful inspection of the 1H NMR experiment 
showed the presence of eleven 1H resonances in the aliphatic region (δH 2.83 (m 1H), 2.73 
(m 1H), 2.42 (m 1H), 2.28 (m 2H), 1.53/1.49 (m 1H), 1.61/1.58 (m 1H), 1.42 (m 1H), 
1.22 (m 1H), 1.20 (m 1H), 0.99/0.94 (m 1H)). The COSY, TOCSY and especially the 
HMBC spectra with J = 12 Hz heteronuclear coupling constant helped to construct the 
missing building block forming a piperidine ring substituted at C2”’. In the HMBC 
experiment two crucial correlations were observed for a carbonyl resonance at 
171.40/171.36 ppm: intense crosspeaks were detected between the C=O and protons (2.28 
ppm) of the side chain and similarly between the C=O and the H6” (4.06/4.03 ppm) 
resonance of the glucose moiety (Figure 36). These correlations clearly indicate that the 
piperidine 2-acetic acid linked to the glucose moiety with an ester bond at the C6” 
position. The complete NMR characterization of compound 23 can be found in the Table 
14. As the cyclic beta amino acid residue introduces a new stereogenic center, some of 
the NMR resonances show diastereomeric splitting. The MS/MS fragmentation can also 
be corroborated by the piperidine 2-acetate moiety. In the case of compound 20, the NMR 
data revealed a methylenedioxy group and the lack of the methoxy function in the 
aglycone skeleton compared to 23. All 1H and 13C NMR resonances were in agreement 
with the maackiain aglycone as proposed by the MS experiments (Table 7) thus; 
compound 20 was identified as maackiain 3-O-β-D-glucoside 6”-O-piperidine 2-acetate. 
The NMR resonances of the glucose and the piperidine 2-acetate moieties were found to 
be almost identical for all compounds (12, 13, 14, 17, 20, 23) confirming the same 
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structural motif but various aglycones (Table 12Table 13 Table 14). For compound 13 
two sets of aromatic protons and a singlet at 8.44/8.43 ppm indicated isoflavonoid 
aglycone skeletons. The HMBC spectrum indicated a key correlation between an O-
methyl resonance (3.79 ppm) and C4’ (159.06 ppm) therefore the aglycone was identified 
as formononetin (Table 12). Compound 12 showed HMBC correlation between the 
methylenedioxy group (6.05 ppm) and C3’ (152.26 ppm) and C4’ (147.09 ppm) 
confirming the isoflavonoid skeleton pseudobaptigenin (Table 12). The NMR 
characteristics of compound 17 and 14 were similar to 13 and 12 with a subtle difference 
of an additional methoxy group at C2’ and the lack of an aromatic singlet (Table 1). The 
aglycones of 13 and 12 were identified as sativanone and onogenin, respectively.  
Indirect structural analysis 
Although, these nitrogen-containing esters ionize extremely well in positive ionization 
mode, their actual quantity compared to other isoflavonoid derivatives is quite low. The 
homoproline derivatives are orders of magnitude lower compared to the homopipecolic 
esters therefore their isolation for NMR experiments was not feasible. In order to verify 
that the compounds 3, 5, 8, 9, 10 and 15 are homoproline derivatives, the sample was 
subjected to hydrolysis to free beta amino acids. This hydrolyzed sample was then spiked 
with the a standard solution of homopipecolic acid and homoproline in aqueous medium, 
as they tend to form esters with methanol [208]. The original and the spiked samples were 
investigated by HPLC-MS/MS. As no differences were observed in retention time and in 
fragmentation pattern (Figure 39), it could be concluded that the samples factually contain 
the esters of homopipecolic acid and homoproline.  
Stereochemistry 
Regarding the aglycones, the two isoflavones, formononetin and pseudobaptigenin 
contain no chiral atoms. However, the two dihydroisoflavonoids onogenin and sativanone 
are chiral compounds. Based on the information that the isolated aglycones have no 
detectable CD spectrum we assumed that our sample contains the derivatives of (3R,S)-
onogenin and sativanone, in concordance with literature [190]. Pterocarpans contain two 
chiral centers, however, from the four possible isomers only two, with cis-fused 
benzofuranyl-benzopyran rings can be found in nature [209]. To determine the absolute 
configuration of the pterocarpans optical rotatory dispersion and circular dichroism were 
used (see section 1005.I.5.), which proved that they can be found in the form of the 
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levorotatory enantiomer. Even in the screening chromatographic runs the peaks of 
medicarpin and maackiain 7-O-glucoside 6”-O-piperidin-2-acetate (20 and 23) showed 
significant peak splitting on achiral stationary phase. This effect could be observed on all 
derivatives in the preparative LC chromatogram and was further investigated on various 
analytical stationary phases (C18, C8, C18 core shell and phenyl-hexyl). The complete 
separation of the two diastereomers of formononetin, pseudobaptigenin, medicarpin and 
maackiain derivatives could be achieved on all four columns. However, the four isomers 
of the racemic onogenin and sativanone could not be baseline separated. Beside the two 
baseline resolved peaks (originating hypothetically from the diastereomeric splitting due 
to the racemic nature of the amino acid), a third peak (as a shoulder) can be observed 
using the core shell C18 column. To investigate the stability of the isomers, the peaks of 
compound 20 were isolated separately. The isolated compounds were then reinjected after 
1, 5 and 10 days. The transformation of the isomers into each other resulting in peak 
duplication could not been observed (Figure 38). As the NMR signals of all six 
compounds showed signal duplication, but the stereochemistry of the aglycones are so 
different, we hypothesized that the source of the phenomenon originated from the 
common structural motifs. The 1H NMR spectra of the isolated diastereomers of 
compound 23 were recorded and it clearly indicates that the duplication of the NMR 
signals arose from the overlap of the 1H resonances of the two diastereomers (Figure 37). 
Examining the chemical shifts and coupling constants of the sugar moiety, the presence 
of β-D-glucopyranose could be proved in all six molecules. Consequently, the 
hypothesized source of the diastereomerism is the stereogenic center of the beta amino 
acid.  
5.II. Quantitative phytochemical results 
5.II.1. Sample preparation 
Because isoflavonoids can be found in Ononis species as a very heterogenous mixture – 
glucosides, glucoside malonates, beta amino acid derivatives and aglycones – the 
quantification of all compounds in their native form could not be executed. Moreover, 
glucoside malonates are very labile derivatives and tend to hydrolyze to glucosides. In 
order to decrease the complexity of the sample, the hydrolysis of all glucosides to 
aglycones was aimed. In other sources, acidic hydrolyses with hydrochloric acid was 
carried out [9], [10], [171], so that we aimed the optimization of a similar method 
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finetuning the acid concentration and hydrolysis time. Because the acidic hydrolysis 
digested not only the glycosidic bonds, but the pterocarpan skeletons as well, it was no 
further used. Based on the work of Boldizsár et al. [210], the endogenous glucosidase 
enzymes of the root was activated with pure distilled water in the dried samples. After 24 
hours of enzymatic fermentation, the amount of glucosides and glucoside malonates 
decreased quantitatively (Figure 42). The samples were extracted after enzymatic 
hydrolysis using 70% aqueous methanol, three times. In order to correct any possible 
imperfections and loss during sample extraction, filtration and dilution, naringenin was 
added at the start of the sample treatment and all results were standardized to the peak of 
it.  
 
 
Figure 54: Total isoflavonoid content of O. spinosa and O. arvensis samples 
 
5.II.2. Quantitative results 
Regarding the sum of different isoflavonoid aglycones, the overall content ranged from 
0.6 to 4.7 g/100 g with a mean of 0.97 g/100 g (Figure 54) in the free-range samples. 
Comparing the free-range samples, no significant difference could be observed between 
the two species (p0.05 = 0.905). On the other hand, O. spinosa hairy root sample showed a 
significantly higher total isoflavonoid content, than the other samples (one-way ANOVA, 
Bonferroni post-hoc test). Interestingly, the O. arvensis hairy root cultures were not so 
outstandingly rich in isoflavonoids. As the free-range samples had no significant 
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difference in their total isoflavonoid content, the origin of this phenomenon could not be 
originated from the genetical variance between the species. One of the possible 
explanations, is that the Ri plasmid randomly builds into the genetical matter of the plants 
and in O. spinosa it induces the isoflavonoid biosynthesis directly. The other possibility 
is that the cultures of O. spinosa and O. arvensis are not equally adapted to the in vitro 
circumstances. The culture of O. arvensis is weaker, grows slower and demands higher 
saccharose concentration in the culture medium (see page 59). The suboptimal 
circumstances could result in lower isoflavonoid production.  
 
Figure 55: Relative amount of isoflavonoid aglycones in O. spinosa and O. arvensis 
samples 
 
Figure 55 shows the relative amount of the different type of aglycones. Whereas earlier 
formononetin and its derivatives were thought to be the most characteristic compounds 
of Ononis species, it resulted to be only in lower relative quantities in free-range samples. 
Pseudobaptigenin was present in much higher levels. On the other hand, the detector 
sensitivity was much lower for pseudobaptigenin, which could mislead the estimation of 
the quantitative relations of formononetin and pseudobaptigenin. The isoflavanones and 
pterocarpans could be found in the free-range samples in a commeasurable ratio. 
Comparing the two species no drastic difference can be observed between the species or 
places of origin between free-range samples. However, between the free-range samples 
and in vitro cultures, there is an extreme change in the relative isoflavonoid content. The 
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hairy root cultures produce mainly formononetin, sativanone and medicarpin and the 
other three derivatives – pseudobaptigenin, onogenin and maackiain – are present only in 
trace quantities. The common feature of the synthesized molecules in the hairy root 
cultures that they are all methoxylated, while the missing compounds possess a 
methylenedioxy ring. Regarding the biosynthesis of the later molecules (see Figure 14), 
it can be hypothesized, that the function of I3’H or the CYP P450 enzyme closing the 
methylenedioxy ring is damaged. However, the function of these enzymes is not 
completely missing, as the molecules of interest can be found, but only in trace quantities.  
 
Figure 56: Absolute quantity of isoflavonoid aglycones in O. spinosa and O. arvensis 
cultures 
 
One reason of the change in isoflavonoid profile can be genetic transformation which can 
upregulate the production of methoxylated derivative and suppress the synthesis of the 
ones with methylenedioxy ring. Another cause can lay in the in vitro circumstances. 
Isoflavonoids are phytoalexins which protects the plant from abiotic and biotic stress. As 
these stressors (for example UV radiation, heat and drought) do not threat the cultures, 
they might change their isoflavonoid profile. Moreover, isoflavonoids can be signaling 
molecules between symbiont Rhizobium species [211], and in the lack of these bacteria 
the plant modifies its set of isoflavonoids.  
Investigating the absolute quantity of the aglycones (Figure 56), it can be concluded that 
the collected samples of O. spinosa (from Hűvösvölgy and Dunaegyháza) and the 
commercial sample (from Bioberta Ltd.) show very similar isoflavonoid content. 
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Furthermore, the commercial samples from Rózsahegyi Ltd. and from Rome possessed 
comparable isoflavonoid pattern. The average formononetin content in the free-range 
samples is 0.10 g/100 g, which shows very good correlation with other values in the 
literature (Table 6). The O. spinosa hairy root contains sativanone and medicarpin in huge 
quantities compared to the other samples, which makes this in vitro culture a promising 
source of biologically valuable isoflavonoids. Plotting the samples after Principal 
Component Analysis (Figure 57), the same similarities can be observed. The commercial 
samples of O. spinosa from Rózsahegyi Ltd. and from Rome seem to form a group, but 
the other free-range O. spinosa and O. arvensis samples are not distinguishable. Although 
the two hairy root samples were similar regarding the lack of isoflavonoids with 
methylenedioxy ring, the huge difference in the absolute quantities of isoflavonoids 
causes a large distance between the two spots. Because of the low number of the samples, 
these results are not significant.  
 
Figure 57: The results of the Principal Component Analysis 
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 Conclusions 
During the qualitative phytochemical analysis of the root extract made from O. spinosa 
and arvensis 47 compounds were identified. These are mostly the glucosides, glucoside 
malonates and aglycones of isoflavonoids, but some special phenolic lactones – puerol A 
and clitorienolactone B – and a maltol derivative were described, too. The presence of 
calycosin, sativanone, onogenin and their derivatives were firstly proved in O. spinosa, 
while in O. arvensis pseudobaptigenin, calycosin and sativanone had not been mentioned 
before.  The calycosin content could be established by the biosynthetic pathway of 
isoflavonoids, as calycosin serves as an intermediate between formononetin and 
pseudobaptigenin. The presence of 2’-methoxy isoflavones and isoflavanones is 
justifiable by the biosynthesis, too. Genistein, biochanin A and daidzein had been 
previously reported in O. spinosa root, however, we could not confirm these results. 
Furthermore, the biosynthetic origin of formononetin is liquiritigenin, while genistein and 
biochanin A are synthesized from naringenin.  
As new isoflavonoid derivatives, beta amino acid esters were characterized for the first 
time, as well. Homopipecolic acid was described before in Lycopodium species as an 
intermediate of the synthesis of Lycopodium alkaloids [216, 217], while homoproline was 
isolated from Asteraceae species, as a precursor of pyrrolizidines [208], but their co-
occurrence has never been reported in plants and their biosynthetic origin is not known. 
Their function might be a nitrogen reservoir, or they can protect the plants from insects 
as toxic amino acid analogues.  
The total isoflavonoid content of soy products based on the USDA database is 
approximately 0.1 - 0.2 g/100 g [214] and the total content of Trifolium species varies 
between 0.6 mg - 1.7 g/100 g [215]. Since free-range and commercially available Ononis 
samples contain an average of 0.97 g/100 g isoflavonoids, their total isoflavonoid content 
could be considered very high. On the other hand, the isoflavonoid profile of soy and 
Ononis species is very distinct, so deductions about the phytoestrogenic effect of the 
plants are hard to make. Beside isoflavones, Ononis species proved to contain a 
remarkable amount of isoflavanones and pterocarpans, which possess convincing 
biological and pharmacological effects. Moreover, the hairy root cultures of O. spinosa 
could be promising tool to produce methoxylated isoflavones, isoflavanones and 
pterocarpans.   
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 Summary  
The root of O. spinosa and O. arvensis have been used in ethnomedicine since hundreds 
of years and the root of O. spinosa is official in the European and Hungarian 
Pharmacopoeia, too. The main use of the herbal remedy is to treat infections and 
inflammations of the urinary tract and the diuretic effect of Ononidis radix is proved in 
vivo, but the responsible phytochemical constituents are poorly defined.  
Based on the literature concerning the phytochemical content of O. spinosa and O. 
arvensis it can be concluded that they are not characterized in detail. The available 
literature about other Ononis species focused mainly on other phytochemical groups such 
as essential oil or aromatic alkyl derivatives. Beside the proved diuretic effect, O. spinosa 
extract possesses anti-inflammatory, wound-healing and analgesic effects, based on in 
vivo tests, but the majority of pharmacological information about other Ononis species is 
limited to in vitro tests.  
During our experimental work, we identified 47 compounds of both O. spinosa and O. 
arvensis root extracts, the derivatives of 8 isoflavonoid aglycones, 2 special phenolic 
lactones and a maltol derivative. In addition, we firstly characterized homopipecolic acid 
and homoproline esters as special forms of isoflavonoid glucosides. Based on the 
endogenous glucosidase enzymes of the plant the simplification of the heterogenous 
glycosidic derivatives was managed. Using the developed and validated quantitative 
method, the amount of 6 isoflavonoids was determined in the form of aglycones in 
collected, commercial and in vitro cultured samples of O. spinosa and O. arvensis. Our 
results confirmed, that these herbal drugs contain significant amount of biologically 
active isoflavonoid components and in vitro cultures can serve as a rich source for their 
isolation.  
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 Összefoglalás 
A népgyógyászatban évszázadok óta alkalmazzák a tövises és mezei iglice gyökerét, és a 
tövises iglice a jelenleg érvényben lévő Európai és Magyar Gyógyszerkönyvekben is 
hivatalos Ononidis radix néven. Az iglicegyökér elsősorban húgyúti fertőzések és 
gyulladások kezelésében nyer felhasználást, és vizelethajtó hatását állatkísérletekben is 
igazolták, azonban a hatásért felelős vegyületek nem ismertek. Mivel az Ononis fajok 
legjellemzőbb vegyületei az izoflavonoid származékok, ezért munkánk elsődleges 
céljaként segítséget szerettünk volna nyújtani a hazai Ononis fajok megalapozott 
fitoterápiás alkalmazásához izoflavonoid profiljuk minőségi és mennyiségi ismeretében.  
Az O. spinosa és O. arvensis tartalmi anyagaival foglalkozó irodalmi források igen 
töredékesnek bizonyultak, és más Ononis fajok esetében is sokszor eltérő fitokémiai 
csoportokra (pl. illóolaj, aromás alkil származékok) helyeződött a hangsúly. A biológiai 
vizsgálatok során a vizelethajtó hatás mellett sikerült a tövises iglice gyökér 
gyulladáscsökkentő, fájdalomcsillapító és sebgyógyulást elősegítő hatásait is igazolni 
állatkísérletekben, azonban a többi Ononis fajjal főleg csak in vitro vizsgálatokat 
végeztek.  
Kísérletes munkánk során 47 vegyületet azonosítottunk a tövises és mezei iglice 
gyökeréből készült kivonatban, amelyek 8 izoflavonoid aglikon és 2 speciális lakton 
származékai, illetve egy maltol származék jelenlétét is igazoltuk. Továbbá elsőként írtuk 
le a növényekben homopipekolinsav és homoprolin jelenlétét, izoflavonoid glükozid 
észter formában. A növény saját glikozidáz enzimaktivitását kihasználva a 
mintaelőkészítés során megvalósítottuk a növényben található változatos glükozid-
származékok hidrolízisét aglikonokká. Az általunk fejlesztett validált kvantitatív módszer 
segítségével 6 izoflavonoid mennyiségét tudtuk jellemezni aglikonok formájában, a 
szabadban gyűjtött, kereskedelmi és in vitro kultúrákban.  Eredményeink alapján az 
iglicegyökér jelentős mennyiséget tartalmaz biológiailag igen értékes izoflavonoidokból, 
és az in vitro kultúrák ígéretes forrást nyújtanak ezen vegyületek kinyeréséhez, akár 
léptéknövelést is alkalmazva.  
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a  b  s  t  r  a  c  t
Restharrow  root  has  been  used  in traditional  medicine  for  thousands  of years;  however,  the  active  ingre-
dients  responsible  for  the  diuretic  effect  are  still  unknown.  Previous  studies  have  proved  that  the root
extract  contains  isoﬂavonoids,  however  only  few  derivatives  were  identiﬁed,  mostly  relying  on retention
times  or UV data.  The  aim  of  our work  was  to perform  a  detailed  structural  characterization  of  the  com-
plete  isoﬂavonoid  proﬁle  in  the aqueous-methanolic  extract  of Ononis  spinosa  root  by  high-performance
liquid chromatography  coupled  with  electrospray  ionization  accurate-mass  quadrupole  time-of-ﬂight
and  tandem  mass  spectrometry  in  positive  ionization  mode  (HPLC-ESI-QTOF-MS,  HPLC-ESI–MS/MS)  and
nuclear magnetic  resonance  spectroscopy  (NMR).  On  the  basis  of  the  accurate  masses  and  fragmentation
patterns  isoﬂavones  (formononetin,  calycosin  and  pseudobaptigenin)  and  pterocarpans  (maackiain  and
medicarpin)  were  identiﬁed.  Two further  dihydroisoﬂavone  aglycones,  namely  onogenin  and sativanone
and  a  unique  glucoside  were  isolated  and their structures  were  elucidated  by  NMR  experiments.  Caly-
cosin, onogenin  and  sativanone  were  detected  in  this  plant  for the  ﬁrst  time.  In  contrast  to  previous
works,  the  presence  of  biochanin  A  could  not  be conﬁrmed,  however  its  regioisomer  calycosin  and  its
derivatives  were  identiﬁed.  Similarly,  neither  tectorigenin  derivatives  could  be  detected,  however  the
isobar compound  sativanone  and  its  various  glucosides  were  elucidated.  The  presence  of  genistein  and
daidzein  could  not  be conﬁrmed  in the  extract.  Fragmentation  pathways  for onogenin  and  sativanone  are
presented.  In the  aqueous-methanolic  extract  9  glucosides,  6 minor  and  8  major  glucoside  malonates,  4
glucoside  acetates  and  7  aglycones  were  found.  In total,  34 compounds  were  successfully  identiﬁed.
©  2016  Elsevier  B.V.  All  rights  reserved.
1. Introduction
Ononis spinosa L. is a member of the Fabaceae family, and widely
spread in Europe and in the Mediterranean region [1]. It is known
for thousands of years that spiny restharrow root possesses diuretic
effect and the drug is ofﬁcial in many pharmacopoeias. Nowadays
several spiny restharrow root products are on the market: it is avail-
able in the form of single herbal substance products, in herbal teas
or liquid extracts combined with other diuretic herbs. Preparations
from spiny restharrow root are conventionally used as infusions
for the stimulation of diuresis, to treat inﬂammatory conditions
of the lower urinary tract and as a remedy for kidney disorders
such as gravels and small stones [2]. These indications were con-
∗ Corresponding authors.
E-mail addresses: beni.szabolcs@pharma.semmelweis-univ.hu (S. Béni),
kursinszki.laszlo@pharma.semmelweis-univ.hu (L. Kursinszki).
ﬁrmed by animal studies but no clinical trials have been done yet.
Although the herb is used since ancient times, there is no evidence
for the active compound of the root responsible for the diuretic
effect. Recent in vivo experiments certiﬁed that the root extract
not only increases the excreted urinary volume but holds antioxi-
dant, analgesic, antimicrobial and anti-inﬂammatory features [3].
That could serve as an explanation why Ononis species are used for
gout, rheumatic complaints and externally for skin disorders and
wound healing as folk remedies in Turkey [4].
Phytosterols, phenolic acids, essential oil and a speciﬁc triter-
pene, -onocerin, beside isoﬂavonoids and their glucosides are the
major constituents in restharrow root [2] (Fig. 1). Isoﬂavonoids
are phytoestrogens due to their structural similarity to estra-
diol and possess antioxidant activity. Moreover, isoﬂavonoids
can play an important role in the prevention and treatment
of hormone-dependent cancers, osteoporosis, cardiovascular dis-
eases and diseases of civilization like metabolic syndrome or
http://dx.doi.org/10.1016/j.jpba.2016.01.058
0731-7085/© 2016 Elsevier B.V. All rights reserved.
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Fig. 1. The structures of the known isoﬂavonoids along with spinonin in the extract of restharrow root.
polycystic ovary syndrome [5]. As a consequence, plants with high
isoﬂavonoid content (such as soy or red clover) are under thorough
investigations. Interestingly, during the traditional use of O. spinosa
none of the above mentioned effects was observed, therefore we
aimed at analyzing the isoﬂavonoids in restharrow root.
To date, the following isoﬂavonoids were described in
restharrow root: formononetin, ononin (formononetin 7-O-
glucoside), pseudobaptigenin glucoside, genistein, biochanin A
7-O-glucoside 6”-O-malonate, formononetin 7-O-glucoside 6”-
O-malonate, 2,3-dihydro-ononin, tectoridin (tectorigenin 7-O-
glucoside), trifolirhizin (maackiain 7-O-glucoside) and medicarpin
7-O-glucoside [2] (see Fig. 1).
High performance liquid chromatography is the fundamental
technique for separating ﬂavonoids and isoﬂavonoids. Because iso-
cratic elution is usually insufﬁcient to separate compounds with
subtle differences, an optimized gradient elution is preferred for
the separation [6].
From an analytical point of view, one of the most powerful tools
is mass spectrometry since it provides high sensitivity, opportuni-
ties of coupling with liquid chromatography and the possibility of
tandem mass spectrometry. Single stage MS  joined with UV detec-
tor is seldom employed for full structural characterization, but if
standards or reference data are available it is efﬁcient for conﬁrm-
ing or identifying target isoﬂavonoids. Tandem mass spectrometry
grants various utilization modes which can be remarkably helpful
in the investigation of ﬂavonoid derivatives. The highest sensitivity
can be reached by negative ionization mode, on the other hand, pos-
itive ionization mode yields a more complete fragmentation proﬁle
of the structurally similar aglycones [7]. With the application of Q-
TOF hybrid instruments an accurate mass determination can be
performed. As a result, the molecular formula of the investigated
substance can be calculated and isobar molecules and molecule
fragments can be differentiated.
In the structural elucidation of unknown molecules the appli-
cation of various NMR  techniques is inevitable. This technique
is essential to distinguish positional isomers of ﬂavonoids and
isoﬂavonoids with a complete assignment of the aglycone skele-
ton. On the other hand, NMR  requires considerably large amounts
of substances, therefore preparative sample isolation has to be per-
formed.
Previous studies on the isoﬂavonoids in the spiny restharrow
root conﬁrmed the presence of the major representatives, however
their structural identiﬁcation strongly relied on UV data [8–13].
In addition, high temperature was  applied during the extraction
precluding the analysis of the glucosides and glucoside malonates
[11,13]. Until now, no efforts have been made to systematically
identify the isoﬂavonoid proﬁle of O. spinosa. Therefore, the aim
of this study is to provide detailed structural information on the
isoﬂavonoid proﬁle of the aqueous-methanolic extract of O. spinosa
root by HPLC-ESI–MS/MS, HPLC-ESI-QTOF-MS in positive ioniza-
tion mode and NMR.
2. Experimental
Formononetin and calycosin were purchased from Sigma-
Aldrich (Steinheim, Germany). Ononin was  kindly provided by
Professor S. Antus (University of Debrecen, Hungary), medicarpin
and maackiain by Professor J. Hohmann (University of Szeged,
Hungary). Standard solutions of ononin, formononetin and caly-
cosin were prepared at 1 mg/mL  concentration in 70% v/v methanol.
Standard solutions of medicarpin and maackiain were prepared
at 300 g/mL concentration in a mixture of methanol and DMSO
(9:1, v/v). HPLC-grade methanol and DMSO were obtained from
Sigma Aldrich (Steinheim, Germany). CD3OD (99.8 atom% D) for
NMR were purchased from Sigma–Aldrich (Steinheim, Germany).
Puriﬁed water prepared by Millipore Milli-Q equipment (Billerica,
MA,  USA) was used throughout the study. All other chemicals were
of analytical reagent grade.
2.1. Sample preparation
2.1.1. Analytical sample
O. spinosa L. (Fabaceae) root was obtained from Biohorticul-
ture Bio-Berta (Kisko˝rös, Hungary) and was  received in a dried
and chopped form according to the 8th European Pharmacopoeia.
Voucher specimens were deposited in the Department of Pharma-
DOI:10.14753/SE.2019.2295
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cognosy, Semmelweis University, Budapest with voucher number
141016-On06.
From the dried and powdered sample 0.5 g was extracted with
2 × 30 mL  of aqueous methanol (3:7, v/v) by sonication for 2 × 6 min
(Braun Labsonic U, Melsungen, Germany). After ﬁltration the sol-
vent was evaporated to dryness under reduced pressure (Büchi
Rotavapor R-200, Flawil, Switzerland). The residue was  redissolved
in 2.5 mL  of 70% v/v methanol and passed through Supelclean SPE
LC-18 column (500 mg,  3 mL;  Supelco, Bellefonte, PA, USA). SPE
micro columns were activated with 2.5 mL  methanol and water
before 2.5 mL  stock solution was loaded. After air drying the car-
tridge 1.5 mL  methanol was applied to achieve complete elution of
isoﬂavonoids. Prior to HPLC analysis the eluted extract was evapo-
rated to dryness again and redissolved in 2.0 mL  70% v/v methanol
and ﬁltered through Minisart RC 15 0.2 m membrane (Sartorius
AG, Goettingen, Germany).
2.1.2. Extraction and isolation of aglycones
The same plant material was used for preparative samples.
10.0 g dried and powdered plant material was hydrolized and
extracted with the mixture of 400 mL  aceton and 40 mL  of 25%
v/v hydrochloric acid for 60 min  on its boiling point with reﬂux.
After ﬁltration, the extract was diluted with 800 mL  puriﬁed water
and was partitioned with petroleum ether and ethyl-acetate. The
ethyl-acetate phase was evaporated to dryness under reduced
pressure and the residue was dissolved in methanol and ﬁltered,
since the extract contains considerable amount of saccharide. The
methanolic phase was evaporated again in order to concentrate
the extract and the residue was redissolved in 5.0 mL  methanol
and ﬁltered through Minisart RC 15 0.2 m membrane (Sarto-
rius AG, Göttingen, Germany). The solution was fractioned by a
Waters 2690 HPLC system with a Waters 996 diode array detec-
tor (Waters Corporation, Milford, MA,  USA) equipped with a Luna
C18(2) 100 A (5 m)  reversed phase column (150 × 10.00 mm i.d;
Phenomenex, Inc; USA). Eluents consisted of 0.3% v/v acetic acid (A)
and methanol (B). The following gradient program was  applied:
0.0 min, 10% B; 30.0 min, 100% B; 34 min, 100% B. Solvent ﬂow
rate was 4.0 mL/min and the column temperature was  set to 30 ◦C,
100 L extract was subjected on the column. The fraction con-
taining the aglycones of interest was collected and evaporated to
dryness, ﬁnally redissolved in methanol. This solution was  injected
again to the same column using isocratic elution. The mobile phase
consisted of 27% acetonitrile and 73% of the aqueous solvent. Alto-
gether seven fractions were collected of which Fr2 was determined
as formononetin (2.11 mg), Fr4 as onogenin (2.08 mg)  and Fr6 as
sativanone (2.54 mg).
2.1.3. Extraction and isolation of glucosides
20.0 g dried and powdered plant material was  extracted with
2 × 200 mL  of 70% methanol in ultrasonic bath for 2 × 25 min. The
extract was ﬁltered and evaporated to 100 mL.  Four SPE micro
columns (500 mg,  3 mL;  Supelco, Bellefonte, PA, USA) were acti-
vated with 2 × 2.5 mL  methanol and 2 × 2.5 mL  water. 3 × 2.5 mL
of the extract were applied on each cartridge, then washed with
2.5 mL  water and the glucosides were eluted with 2.5 mL  of 50% v/v
methanol. These fractions were pooled and evaporated to dryness,
redissolved in 1.5 mL  of 50% v/v methanol and ﬁltered before par-
titioned by HPLC. The same equipment was used for separation as
mentioned in 2.1.2. and 100 L was injected. Mobile phases con-
sisted of methanol (B) and 0.3% v/v acetic acid (A). Linear gradient
elution was applied from 30% B up to 38% B from start to 12.0 min,
70% B from 12.1 min  to 22.0 min. Flow rate was 4.0 mL/min, column
temperature was 30 ◦C. Fr3 was determined as spinonin (11.80 mg).
2.2. HPLC-DAD-ESI–MS/MS conditions
For chromatographic separation and mass spectral analysis
an Agilent 1100 HPLC system (degasser, binary gradient pump,
autosampler, column thermostat and diode array detector) was
used hyphenated with an Agilent 6410 Triple Quad LC/MS system
equipped with ESI ion source (Agilent Technologies, Santa Clara,
CA, USA).
HPLC separation was attained on a Zorbax SB-C18 Solvent Saver
Plus (3.5 m) reversed phase column (150 × 3.0 mm  i.d; Agilent
Technologies, Santa Clara, CA, USA). Mobile phase consisted of 0.3%
v/v formic acid (A) and methanol (B). The following gradient pro-
gram was applied: 0.0 min, 29% B; 32.0 min, 80% B; 34 min, 100% B;
37 min, 100% B; 42.0 min, 29% B. Solvent ﬂow rate was  0.4 mL/min
and the column temperature was  set to 25 ◦C. The injection volume
was 2 L. Nitrogen was applied as drying gas at the temperature of
350 ◦C at 9 L/min, the nebulizer pressure was  45 psi. Full scan mass
spectra were recorded in positive ion mode in the range of m/z
80–1500.
For collision induced dissociation (CID) the collision energy var-
ied between 10 and 60 eV. As collision gas high purity nitrogen was
used. The fragmentor voltage was set to 80 V and the capillary volt-
age was  3500 V. Product ion mass spectra were recorded in positive
ion mode in the range of m/z 80–600.
2.3. HPLC-DAD-ESI-QTOF conditions
For exact mass determination an Agilent 1200 Series HPLC sys-
tem was  used hyphenated with an UV–vis diode array detector
(DAD) and with an Agilent 6520 Time of Flight Mass spectrome-
ter (Agilent Technologies, Santa Clara, CA, USA) equipped with an
ESI ion source (dual electro-spray) operated in positive ionization
mode. HPLC separation was  attained on a Zorbax SB-C18 Solvent
Saver Plus (3.5 m)  reversed phase column (150 × 3.0 mm  i.d; Agi-
lent Technologies, Santa Clara, CA, USA). Mobile phase consisted
of 0.3% v/v formic acid (A) and methanol (B). The following gradi-
ent program was applied: 0.0 min, 29% B; 32.0 min, 80% B; 34 min,
100% B; 37 min, 100% B; 42.0 min, 29% B. Solvent ﬂow rate was
0.4 mL/min and the column temperature was set to 25 ◦C. The injec-
tion volume was 2 L and 30% of the eluent was  allowed to ﬂow into
the mass spectrometer by solvent splitting. Nitrogen was applied
as drying gas at the temperature of 325 ◦C at 5 L/min, the nebu-
lizer pressure was  30 psi. Full scan mass spectra were recorded in
positive ion mode in the range of m/z 80–1200.
For collision induced dissociation (CID) the collision energy var-
ied between 10 and 60 eV. As collision gas high purity nitrogen was
used. The fragmentor voltage was set to 175 V and the capillary volt-
age was  3500 V. Product ion mass spectra were recorded in positive
ion mode in the range of m/z 25–700.
2.4. NMR  conditions
All NMR  experiments were carried out on a 600 MHz Varian
DDR NMR  spectrometer equipped with a 5 mm inverse-detection
gradient (IDPFG) probehead. Standard pulse sequences and pro-
cessing routines available in VnmrJ  3.2C/Chempack 5.1 were used
for structure identiﬁcations. The complete resonance assignments
were established from direct 1H–13C, long-range 1H–13C, and scalar
spin–spin connectivities using 1D 1H, 13C, 1H–1H gCOSY, 1H–1H
NOESY, 1H–13C gHSQCAD (J = 140 Hz), 1H–13C gHMBCAD (J = 8 Hz)
experiments, respectively. The probe temperature was maintained
at 298 K and standard 5 mm NMR  tubes were used. The 1H chem-
ical shifts were referenced to the applied NMR  solvent CD3OD (ı
(CD2HOD) = 3.310 ppm) and 13C chemical shifts were referenced to
49.00 ppm.
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3. Result and discussion
Considering the literature data a liquid chromatographic
method was developed to separate the isoﬂavonoids in the extract
of restharrow root. The obtained chromatogram can be seen in
Fig. 2. According to their hydrophobicity, ﬁrstly glucosides, fol-
lowed by the glucoside malonates and glucoside acetates eluted,
ﬁnally the aglycones reached the detector. In contrary to previ-
ous works, in the methanolic-aqueous extract of O. spinosa two
sets of glucoside malonates could be detected. According to the
experiments of de Rijke et al. the major and later eluting ones
were identiﬁed as 7-O--d-glucoside 6”-O-malonates while the
minor ones eluting earlier as 7-O--d-glucoside 4”-O-malonates,
respectively [14]. The elution order of glucosides and their 4′′-
O-malonate derivatives follows the same pattern, ie: calycosin,
pseudobaptigenin, formononetin, onogenin and sativanone. The
major glucoside malonates and aglycones showed a different
order which could be originated from the gradient elution. To
screen for isoﬂavonoid derivatives in O. spinosa root extract, sam-
ple was investigated in full scan mode. For the identiﬁcation of
isoﬂavonoids, the total ion chromatogram was compared to the one
registered by UV as the former was rather complex solely. Under
the employed conditions protonated molecular ions, monomer and
dimer sodium adducts were observable. Ion source fragmentation
occured frequently; therefore information on the aglycones could
be gained as well. Altogether 34 compounds (labeled as peak 1,
2 etc. according to elution order) were identiﬁed as isoﬂavonoid
derivatives (see Table 1). For complete structure identiﬁcations
MS/MS  scan mode was chosen. In the characterization of aglycone
isomers and the elucidation of fragmentation pathways product ion
analysis provided invaluable help.
3.1. Isoﬂavones
In the case of isoﬂavone aglycones two characteristic fragmen-
tation pathways can be distinguished: the retrocyclization of the
C-ring, or the gradual degradation of the molecule. The most com-
mon  retrocyclization is the retro Diels-Alder (rDA) reaction in
which the molecule cleaves alongside the bonds 1 and 3 creating
two product ions containing intact A and B-rings. Both fragments
can be protonated, but the 1,3A+ fragment could be observed more
frequently. Fragmentation nomenclature according to Ma  et al. [15]
can be seen in Fig. 3. The other fragmentation pathway, the gradual
degradation of the molecule occurs by the loss of CO, CH3 and CH4O.
The loss of two CO moieties with the expansion of the C-ring is diag-
nostic for isoﬂavonoids [16]. Only methoxylated molecules can lose
a CH3 radical, which leads to a product ion with even electrons. In
the extract, three isoﬂavones and their derivatives were found. The
fragmentation properties of formononetin standard were studied
ﬁrst in positive ESI–MS and ESI–MS/MS experiments, to provide
entry points in structure elucidation of isoﬂavonoids. MS  data
obtained was in accordance with other literature sources [16,17].
Formononetin provided protonated molecular ion [M+H]+ at m/z
269 and yielded main fragments at m/z  254, 237, 226, 213, 136,
118, respectively. The fragmentation pathway, in which the gradual
degradation of the molecule occurs by the loss of CO, CH3 and CH4O
units can be seen in the product ion spectrum of formononetin: m/z
254 [M+H-CH3]+, m/z 237 [M+H-CH4O]+, m/z 226 [M+H-CH3-CO]+,
m/z 213 [M+H-CO-CO]+. Regarding retro Diels Alder reaction m/z
137 [1,3A]+ and m/z 118 [1,3B-CH3] + could be easily assigned to
the appropriate fragments, however beside m/z  137 (13.15%), m/z
136 (15.18%) can be observed at 43 eV collision energy. In the case
of an odd m/z  value for the pseudo molecular ion, the loss of the
CH3 radical yields product ion with even m/z  value. However, the
origin of the m/z 136 fragment can not be explained as A-ring of for-
mononetin is not methylated. Maul et al. [17] experienced the same
phenomenon, namely a fragment, 1 Da less than the expected rDA
fragment, was  additionally observed and explained this with the
formation of charged but not protonated rDA A-ring. It is found,
that this mechanism occurs only in the case of isoﬂavonoids O-
methylated on the B-ring, such as formononetin or biochanin A.
In the extract of O. spinosa root we managed to determine ﬁve
formononetin derivatives. They differed in the mass of pseudo
molecular ion but possessed identical collision-induced disso-
ciation patterns. Peak 9 provided [M+H]+ ion at m/z 431 and
was identiﬁed as ononin also conﬁrmed by authentic standard.
Peak 13 and 21 both were tentatively identiﬁed as formononetin
O-glycoside malonates since they showed identical product ion
spectrum and [M+H]+ at m/z 517, although there was a more than
2 min  difference in their retention time. Peak 25 was  identiﬁed as
formononetin O-glycoside-acetate as it exhibited an [M+H]+ ion at
m/z 473 and CID resulted in [M+H-204]+ at m/z 269 related to the
neutral loss of an acetyl-glycoside residue. The retention time is
also in accordance with the structure as glucoside acetate elutes
between glucoside malonates and the aglycone. Peak 33 possessed
the same spectrum as the standard so it was conﬁrmed to be for-
mononetin aglycone.
Compound 1, 2, 4 and 7 were derivatives with [M+H]+ at m/z
285 in full scan mode. Among the known compounds of O. spinosa
reported in the literature, biochanin A and maackiain both pos-
sess 284 Da molecular weights (Fig. 1). However, these aglycones
could be excluded. Maackiain has a rigid, apolar pterocarpan core
structure which contradicts early elution and the product ion spec-
trum of its authentic standard differed from the observed ones.
Biochanin A possesses a hydroxyl group in C5 position, capable
of hydrogen bonding with the oxo group, resulting in a signiﬁ-
cant increase in its retention time [18]. Moreover, since biochanin
A is dihydroxylated on A-ring, it gives a 1,3A+ rDA  fragment at
m/z 153 which could not been observed. On the other hand, a
fragment ion at m/z 137 appears indicating an aglycone with
a single OH group on A-ring (Fig. 4). Based on these informa-
tion, the presence of calycosin is much more corroborated by
experimental facts, therefore the presence of biochanin A can be
excluded. Supporting that the investigated molecules are the glu-
cosidic derivatives of calycosin, their spectra were compared with
that of the authentic standard and literature data as well, and
they were in good agreement. In addition, calycosin is the link
between formononetin and pseudobaptigenin in the biosynthe-
sis of isoﬂavonoids [19]. Peaks 1, 2, 4 and 7 exhibited product
ions m/z 285 [Y0+H]+, 270 [Y0+H-CH3]+, 253 [Y0+H-CH4O]+, 225
[Y0+H-CH4O-CO]+, 214 [Y0+H-CH3-2CO]+, 197 [Y0+H-CH4O-2CO]+
and 137 [1,3A]+ (Table 1). Peaks 1 and 2 were identiﬁed as calycosin
glycosides as calycosin 7-O-glucoside is more polar than 3′-O-
glucoside [20]. Most isoﬂavonoid glucosides bear a sugar moiety
at the C-7 position, however, as calycosin has two hydroxyl groups
it is possible that in a less signiﬁcant amount of C-3′ glucosides are
also biosynthesized. Peaks 4 and 7 were determined as calycosin
glucoside malonate isomers. Calycosin and its derivatives have not
been found in O. spinosa till date. Peak 8, 12, 19, 24 and 31 showed
aglycone fragment at m/z 283 and possessed similar fragmentation
pattern as calycosin (Table 1). Based on the 2 Da difference and the
similarity of fragmentation patterns these compounds were iden-
tiﬁed as pseudobaptigenin glucoside, pseudobaptigenin glucoside
malonate isomers, pseudobaptigenin glucoside acetate and pseu-
dobaptigenin aglycone, respectively (Fig. 1). The fragmentation
pathway of pseudobaptigenin has not been described yet. How-
ever, comparing the structures of calycosin and pseudobaptigenin
high similarity can be seen since calycosin is the precursor of the
latter. While on the B-ring of calycosin a methoxy and a hydroxyl
group are located, pseudobaptigenin possesses a methylenedioxy
group at the same position (see Figs. 1 and 4). Following the cleav-
age of a CH4O and a CH2O unit for calycosin and pseudobaptigenin,
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Fig. 2. UV-DAD chromatogram of the aqueous-methanolic extract of spiny restharrow root on a Zorbax SB-C18 Solvent Saver Plus column.
Table 1
The observed and calculated exact masses along with the characteristic product ions of the identiﬁed compounds.
No. Rt [M+H]+ Mt observed Mt calculated Error Aglycon Fragments Name
m/z  Da Da ppm m/z
1 8.93 447 446.1224 446.1213 2.47 285 270, 253, 225, 214, 197,
137
Calycosin 7-O--d-glucoside
2  10.18 447 446.1210 446.1213 −0.67 285 Calycosin 3’-O--d-glucoside
4 11.64 533 532.1221 532.1217 0.75 285 Calycosin 7-O--d-glucoside 4”-O-malonate
7  14.53 533 532.1228 532.1217 2.07 285 Calycosin 7-O--d-glucoside 6”-O-malonate
3  11.18 461 460.1370 460.1369 0.22 299 281, 253, 239, 193, 107 Spinonin
5  12.69 547 546.1373 546.1373 0.00 299 Spinonin 4′′-O-malonate
6  14.09 547 546.1375 546.1373 0.37 299 Spinonin 6′′-O-malonate
29  24.86 299 298.0842 298.0841 0.34 299 Spinonin aglycone
8  15.65 445 444.1068 444.1056 2.70 283 253, 225, 197, 183, 169,
141, 115
Pseudobaptigenin 7-O--d-glucoside
12 17.62 531 530.1062 530.1060 0.38 283 Pseudobaptigenin 7-O--d-glucoside 4”-O-malonate
19  20.09 531 530.1063 530.1060 0.57 283 Pseudobaptigenin 7-O--d-glucoside 6”-O-malonate
24  22.22 487 486.1166 486.1162 0.82 283 Pseudobaptigenin 7-O--d-glucoside 6”-O-acetate
31  25.27 283 282.0530 282.0528 0.71 283 Pseudobaptigenin
9  16.26 431 430.1264 430.1264 0.00 269 254, 237, 226, 213, 197,
136, 118
Formononetin 7-O--d-glucoside
13 18.14 517 516.1269 516.1268 0.19 269 Formononetin 7-O--d-glucoside 4”-O-malonate
21  20.55 517 516.1280 516.1268 2.33 269 Formononetin 7-O--d-glucoside 6”-O-malonate
25  22.69 473 472.1368 472.1369 −0.21 269 Formononetin 7-O--d-glucoside 6”-O-acetate
33  25.78 269 268.0737 268.0736 0.37 269 Formononetin
10  16.54 477 476.1325 476.1332 −1.47 315 297, 287, 257, 229, 177,
163, 147, 135
Onogenin 7-O--d-glucoside
15 18.34 563 562.1324 562.1323 0.18 315 Onogenin 7-O--d-glucoside 4′′-O-malonate
18  19.69 563 562.1328 562.1323 0.89 315 Onogenin 7-O--d-glucoside 6′′-O-malonate
28  24.60 315 314.0794 314.0790 1.27 315 Onogenin
11  17.35 463 462.1533 462.1526 1.51 301 283, 273, 213, 163, 151,
135, 121, 107
Sativanone 7-O--d-glucoside
16 18.98 549 548.1532 548.1530 0.36 301 Sativanone 7-O--d-glucoside 4′′-O-malonate
20  20.26 549 548.1538 548.1530 1.46 301 Sativanone 7-O--d-glucoside 6′′-O-malonate
26  22.84 505 504.1630 504.1632 −0.40 301 Sativanone 7-O--d-glucoside 6′′-O-acetate
32  25.37 301 300.1002 300.0998 1.33 301 Sativanone
14  18.25 447 446.1215 446.1213 0.45 285 175, 165, 151, 147, 135,
123
Maackiain 3-O--d-glucoside
22 21.00 533 532.1219 532.1217 0.38 285 Maackiain 3-O--D-glucoside 6”-O-malonate
30  24.93 285 284.0686 284.0685 0.35 285 Maackiain
17  19.25 433 432.1423 432.1420 0.69 271 161, 147, 137, 123, 109 Medicarpin 3-O--d-glucoside
23  21.81 519 518.1425 518.1424 0.19 271 Medicarpin 3-O--d-glucoside 6”-O-malonate
27  24.46 475 474.1524 474.1526 −0.42 271 Medicarpin 3-O--d-glucoside 6”-O-acetate
34  25.84 271 270.0895 270.0892 1.11 271 Medicarpin
Fig. 3. Proposed fragmentation pathways of isoﬂavones and pterocarpans.
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Fig. 4. ESI–MS/MS spectra of compound 1 and the rDA fragmentation of biochanin A and calycosin.
Fig. 5. The proposed fragmentation pathways of sativanone and onogenin.
respectively, the degradation pathways of the two  molecules show
considerable similarity. The lack of the m/z 270 product ion in the
MS/MS  spectrum of pseudobaptigenin is also diagnostic since no
methyl loss can occur in the case of pseudobaptigenin (see Table 1).
Other characteristic fragments detected for pseudobaptigenin are
m/z 183, m/z 169 and m/z 141.
3.2. Pterocarpans
Peak 14, 22 and with the same m/z  285 were determined as
monoglucoside and glucoside malonate of maackiain; while peak
30 was identiﬁed as the free aglycone (Fig. 1). Observed fragments
can be assigned based on the pathway suggested by Zhang et al. [21]
as m/z  285 [M+H]+, m/z 175 [M+H-C6H6O2]+, m/z 151 [2,4B]+, m/z
123 [2,4B-CO]+ (Fig. 3). These results were conﬁrmed with authentic
standard as well.
In the determination of peaks 17, 23, 27 and 34 the same analogy
could be used. According to the retention times and the molecular
mass of the aglycone these compounds were identiﬁed as medi-
carpin glucoside, medicarpin glucoside malonate and medicarpin
(Fig. 1). The fragmentation pattern of medicarpin was deduced from
that of maackiain due to high structural similarity. Both medicarpin
glucoside and the aglycone followed directly the corresponding
peaks of maackiain glycoside and maackiain. Maackiain and medi-
carpin are both pterocarpan derivatives differing in the substitution
of B-ring. Maackiain possesses a methylendioxy substituent while
medicarpin has a single methoxy group. This 14 Da mass differ-
ence between the two compounds can be observed by pairing their
product ions as well. In the spectrum of medicarpin derivatives
product ions could be determined as follows: m/z 271 [Y0+H]+, m/z
161 [Y0+H-C6H6O2]+, m/z 137 [2,4B]+, m/z 109 [2,4B-CO]+ while frag-
ment ion of m/z 123 could be found in the case of both maackiain
and medicarpin, so that it was  identiﬁed as [2,4A]+ (Table 1). The
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Table  2
1H- and 13C NMR  data of onogenin, sativanone and spinonin.
No. Onogenin Sativanone Spinonin
1H 13C 1H 13C 1H 13C
2 4.50–4.55 (m,  1H)
4.39–4.43 (m,  1H)
72.0 4.53–4.57 (m,  1H)
4.39–4.43 (m,  1H)
72.0 6.11–6.09 (m,  1H) 86.3
3  4.18 (dd, J = 11.6, 5.5 Hz, 1H) 49.2 4.16 (dd, J = 11.4, 5.4 Hz, 1H) 49.1 – 176.5
4  – 194.1 – 194.3 6.11 (d, J = 1.5 Hz, 1H) 113.7
4a  – 115.5 – – –
5  7.76 (d, J = 8.7 Hz, 1H) 130.3 7.76 (d, J = 8.7 Hz, 1H) 130.3 – 169.0
6  6.50 (dd, J = 8.7, 2.3 Hz, 1H) 112.5 6.50 (dd, J = 8.7, 2.3 Hz, 1H) 112.0 – 112.8
7  – – – 158.3
8  6.32 (d, J = 2.3 Hz, 1H) 103.7 6.32 (d, J = 2.3 Hz, 1H) 103.7 6.80 (d, J = 2.3 Hz, 1H) 103.7
8a  – 165.7 – 165.7 – –
9  5.89 (d, J = 1.4 Hz, 2H) 102.6 3.79 (s, 3H) 55.8 – 163.5
10  3.72 (s, 3H) 57.1 3.76 (s, 3H) 56.0 6.58 (dd, J = 8.6, 2.3 Hz, 1H) 111.4
11  – – – – 7.37 (d, J = 8.6 Hz, 1H) 132.6
12  – – – – 3.20 (dd, J = 14.8, 3.6 Hz, 1H)
2.78 (dd, J = 14.7, 6.6 Hz, 1H)
39.4
1′ – 117.1 – – 128.0
2′ – 154.3 – 159.8 6.92 (d, J = 8.4 Hz, 2H) 131.9
3′ 6.69 (s, 1H) 96.4 6.57 (d, J = 2.4 Hz, 1H) 99.9 6.63 (d, J = 8.4 Hz, 2H) 115.8
4′ – 142.8 – 162.2 – 157.3
5′ – 149.3 6.49 (dd, J = 8.4, 2.4 Hz, 1H) 106.0 – –
6′ 6.61 (s, 1H) 110.9 7.00 (d, J = 8.4 Hz, 1H) 131.9 – –
1′′ – – – – 5.02 (d, J = 7.3 Hz, 1H) 102.0
2′′ – – – – 3.47–3.5 (m,  1H) 74.7
3′′ – – – – 3.44–3.47 (m, 1H) 78.3
4′′ – – – – 3.42–3.45 (m, 1H) 71.3
5′′ – – – – 3.49–3.52 (m, 1H) 78.5
6′′ – – – – 3.97 (dd, J = 12.1, 2.3 Hz, 1H)
3.73-3.77 (m, 1H)
62.6
same product ions could be observed in the spectrum of medicarpin
standard.
3.3. Dihydroisoﬂavones
In the plant extract two aglycones were observed with exact
molecular masses and predicted formulas which had not been
mentioned in the literature of O. spinosa before. Since their CID
spectra differed signiﬁcantly from that of isoﬂavones and ptero-
carpans, tandem mass spectrometry experiments alone did not
provide satisfactory evidence to identify the aglycon skeleton. From
the hydrolyzed plant extract the aglycones were isolated and were
unequivocally identiﬁed by NMR  experiments as sativanone and
onogenin (Fig. 5). The complete resonance assignments can be seen
in Table 2.
Investigating the tandem mass spectra of isoﬂavones some com-
mon  features can be observed. Both molecules tend to lose one CO
moiety and H2O. However, sativanone and onogenin are methoxy-
lated derivatives, the cleavage of a CH3 radical or CH4O moiety can
not be seen. Opposed to isoﬂavones, these dihydroisoﬂavans do not
yield rDA fragments from the intact molecule. Sativanone and ono-
genin are identical considering the A and C-ring and differ only in
the substitution of the B-ring alike medicarpin and maackiain. The
fragments with m/z 163, 135, 107 are present in the spectra of both
dihydroisoﬂavones so it was concluded that these fragments origi-
nated from corresponding parts of the aglycons. Regarding this, the
product ions were assigned as [M+H-B-ring]+, [M+H-B-ring-CO]+,
[M+H-B-ring-2CO]+, respectively (Fig. 5). There is 14 Da difference
between the mass of the two molecules, which is the result of differ-
ent B-ring. This difference is present between product ion m/z 177
of onogenin and m/z 163 of sativanone, too. Consequently, these
fragments were assigned as [1,3B-2H]+ (Fig. 5). There could be per-
ceived some differences between the fragmentation pathways of
the two dihydroisoﬂavones. Firstly, product ions m/z 257 [M+H-
CH2O-CO]+ and m/z 229 [M+H-CH2O-2CO]+ were only present in
the MS/MS  spectrum of onogenin, while these could not be found
Fig. 6. The proposed fragmentation of spinonin aglycone.
in the product ion spectrum of sativanone (Table 1). On the other
hand, only sativanone yields product ions m/z 151 [2,3B]+ and m/z
121 [2,3B-CH2O]+ (Fig. 5). Based on these facts, peaks 11, 16, 20, 26
and 32 were identiﬁed as the glucoside, glucoside malonates, glu-
coside acetate and the aglycone of sativanone, respectively. Peaks
10, 15, 18 and 28 showed [M+H]+ ions at m/z 477, 563, 563 and
315, so they were identiﬁed as the glucoside, two glucoside mal-
onates and aglycone of onogenin. None of these derivatives were
mentioned before in this plant.
3.4. Spinonin
This molecule with a unique aglycone skeleton was  ﬁrstly men-
tioned by Kirmizigül et al. [22] (Fig. 1). As its fragmentation pattern
was not available in literature and its molecular formula can refer
to several isoﬂavonoids, NMR  experiments had to be performed to
characterize it unambiguously (Table 2). The following product ions
with the characteristic losses were proposed: m/z 299 [M+H]+, m/z
281 [M+H-H2O]+, m/z 253 [M+H-H2O-CO]+, m/z  239 [M+H-H2O-
C2H2O]+ (Table 1). In addition, the aglycone can cleave between C2
and C12 to yield product ions m/z 193 and m/z 107 (Fig. 6). In the
extract of O. spinosa beside the glucoside two  glucoside malonates
and the aglycone were present.
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4. Conclusions
HPLC-ESI–MS/MS and HPLC-ESI-QTOF-MS analysis in positive
ionization mode is a very promising tool for aglycone analysis of
isoﬂavonoids. The MS  fragmentations described in this study was
successfully applied for the differentiation of structural isomers
as biochanin A, calycosin and maackiain; and verify the presence
of homologous derivatives as calycosin and pseudobaptigenin or
medicarpin and maackiain. On the other hand, in the investigation
of new compounds with unknown fragmentation routes and in the
exact characterization of aglycon structures NMR  must be used.
The presence of formononetin, pseudobaptigenin, medicarpin
and maackiain derivatives was conﬁrmed. However, biochanin A,
genistein and daidzein, mentioned in earlier works, were not found
in the extract. Calycosin, sativanone and onogenin was  described
for the ﬁrst time in this plant. Moreover, 4”-O glucoside malonates
of pseudobaptigenin, formononetin, calycosin and spinonin beside
6”-O ones were characterized. Fragmentation patterns of medi-
carpin, pseudobaptigenin, onogenin and sativanone were proposed
for the ﬁrst time.
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A B S T R A C T
Spiny restharrow root (Ononis spinosa L.) and its preparations are mainly used for the treatment of urinary
infections or bladder stones in numerous countries. Spiny restharrow root is rich in isoﬂavonoids (formononetin,
calycosin and pseudobaptigenin), pterocarpans (medicarpin and maackiain) and dihydroisoﬂavonoids (onogenin
and sativanone), which metabolites are present as glucosides, glucoside malonates, glucoside acetates and free
aglycones in the root. The in-depth analysis of tandem mass spectrometric (MS) and high-resolution MS (HR-MS)
data revealed the presence of nitrogen-containing compounds in the root extracts. An ion-exchange-based
puriﬁcation and a preparative-scale reversed phase chromatographic isolation procedure was developed for the
characterization of these new natural products. For the unambiguous identiﬁcation of the isolated compounds
NMR experiments were carried out. The thorough characterization conﬁrmed the presence of six piperidin-2-yl-
acetic acid (homopipecolic acid) esters of isoﬂavonoid glucosides. This is the ﬁrst report of homopipecolic acid
esters isolated from higher plants.
1. Introduction
The Ononis genus includes 75 species, out of which Ononis spinosa L.
(Fabaceae) is native to the semi-arid grasslands and pastures of Europe,
Western Asia and Northern Africa. Spiny restharrow is a perennial
subshrub with pink papilionaceous ﬂowers and straight thorns [1]. The
dried root of the plant can be found in the 9th European Pharmacopoeia
as Ononidis radix. The drug and its preparations are used mainly for the
treatment of urinary infections or bladder stones [2]. Its diuretic and
ﬂushing-out eﬀect were established by in vivo studies [3]. However,
clinical studies have not been done to conﬁrm the eﬀectiveness in hu-
mans.
Several studies aimed to elucidate the chemical composition of
Spiny restharrow root. Firstly, Háznagy et al. investigated the essential
oil components of the root, and Daruházi et al. described its phytosterol
proﬁle [4,5]. In our view, the most promising bioactive secondary
metabolites in Ononidis radix are the isoﬂavonoids. Attempts were
made to characterize the isoﬂavonoid content of the plant material
[6–8], however the used methods relied mainly on their chromato-
graphic behavior and UV spectra. In our previous work, we have pro-
vided the most complete isoﬂavonoid proﬁle of the aqueous-methanolic
extract of the root supported by detailed structural studies. As a result,
isoﬂavonoids (formononetin, calycosin and pseudobaptigenin), pter-
ocarpans (medicarpin and maackiain) and dihydroisoﬂavonoids
(onogenin and sativanone) were found in the forms of glucosides,
glucoside malonates, glucoside acetates and aglycones [9]. The thor-
ough mass spectrometric investigation of the extract in positive ioni-
zation mode revealed nitrogen-containing derivatives of the iso-
ﬂavonoids mentioned above. Previous studies conﬁrmed the presence
of anthranilic acid derivatives in the aerial parts of Ononis species [10],
however the high-resolution mass spectrometry experiments and pro-
duct ion spectra excluded these structures. Although nitrogen-con-
taining pterocarpan derivatives were reported before [11], the spec-
troscopic data of these structures were not in agreement with our
results, so the isolated compounds must have a diﬀerent structure. In
order to identify the structures of these derivatives, the combination of
mass spectrometric and NMR data of the isolated compounds were
used. Herein we report the unambiguous identiﬁcation of six previously
undescribed isoﬂavonoid derivatives from the aqueous-methanolic ex-
tract of spiny restharrow root.
2. Material and methods
2.1. General and plant material
HPLC-grade methanol and acetonitrile were obtained from Fisher
Scientiﬁc (Loughborough, UK). DMSO‑d6, for NMR measurements was
purchased from Sigma-Aldrich (Steinheim, Germany). Puriﬁed water
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prepared by Millipore Milli-Q equipment (Billerica, MA, USA) was used
throughout the study. All other chemicals were of analytical grade.
Ononis spinosa L. (Leguminosae) root was obtained from Rózsahegyi
Ltd. (Erdőkertes, Hungary) and was received in a dried and chopped
form according to the 8th European Pharmacopoeia. Other root samples
were collected from Dunaegyháza (Hungary, 46°50′56.88″ N,
18°56′35.57″ E) and Hűvösvölgy (Hungary, 47°33′22.88″ N,
18°58′33.89″ E) and were identiﬁed by Dr. Imre Boldizsár from the
Department of Plant Anatomy, Eötvös Loránd University. Voucher
specimens were deposited in the Department of Pharmacognosy,
Semmelweis University, Budapest with voucher number 141016-On06,
160725-On01 and 150710-On03, respectively.
2.2. Sample preparation of analytical samples
From the dried and powdered sample of all three plant material
extracts were made using the same method as described in our previous
work [9].
2.3. Extraction and isolation of the isoﬂavonoid derivatives
300.0 g dried and powdered plant material from Rózsahegyi Ltd.
was extracted with 2×3000mL of 70% methanol in ultrasonic bath for
2× 25min. The extract was ﬁltered and evaporated to dryness to ob-
tain a dark brown gum. The residue was redissolved in 200mL water
and divided into 5mL fractions. Each fraction was mixed with 5mL of
methanol and acetone to precipitate the majority of the saccharides.
The supernatant was ﬁltered and the organic solvents were evaporated
at 45 °C. 10mL portions of the residual dark solution were passed
through a weak cation exchanger cartridge (Strata WCX Giga Tube,
Phenomenex Inc.; Torrance, CA, USA) in order to enrich the nitrogen-
containing compounds. The SPE cartridges were ﬁrst conditioned by
washing with 20mL methanol and equilibrated with 20mL water. The
loaded cartridges were washed with 40mL water and 40mL methanol
then eluted with 5% formic acid in methanol. After evaporation to
dryness the sample was fractionated by a Hanbon Newstyle NP7000
HPLC system with a Hanbon Newstyle NP3000 UV detector (Hanbon
Sci. & Tech. CO. Jiangsu, China) equipped with a Gemini C18 reversed
phase column (150×21.2 mm i.d; 5 μm, Phenomenex Inc.; Torrance,
CA, USA). Eluents consisted of 0.3% v/v acetic acid (A) and acetonitrile
(B). Gradient elution was used with 10mL/min ﬂow rate and solvent
system with 20% B at 0min to 30% B in 20min. Eight fractions were
obtained with this method, out of which Fr 1–2 contained degradation
products and minor contaminants. From Fr 3 compound 2 (0.6 mg) was
obtained as a mixture with another isoﬂavonoid glucoside derivative.
From Fr 4 compound 1 (1.3 mg) was isolated. Compound 4 (1.6 mg)
was puriﬁed from Fr 5. Fr 6 provided compound 3 (1.5 mg) in high
purity. Fr 7 and Fr 8 contained solely the diastereomers of compound 6
(4.5 mg) and compound 5 (3.7 mg), respectively. For investigation of
diastereomers, the two isomers of compound 5 and 6 was further
puriﬁed with the same HPLC equipment. Gradient elution was used
with 10mL/min ﬂow rate and solvent system with 15% B at 0min to
20% B at 15min and 20% B at 25min. The isolated isomers of com-
pound 5 were investigated by NMR experiments and diastereomers of
compound 6 were kept at 35 °C and their stability were examined after
1 day, 5 days and 10 days of isolation.
2.4. HPLC-DAD conditions
The isolated isomers of compound 6 and their mixture were ex-
amined on a Waters 2690 HPLC system with a Waters 996 diode array
detector (Waters Corporation, Milford, MA, USA) equipped with a
Xselect reversed phase C18 column (150×4.60mm i.d; 5 μm, Waters
Corporation, Milford, MA, USA). Eluents consisted of 0.3% v/v acetic
acid (A) and acetonitrile (B). The following gradient program was ap-
plied: 0.0min, 15% B; 20.0min, 20% B; 30min, 20% B. Solvent ﬂow
rate was 1.0mL/min and the column temperature was set to 25 °C.
2.5. HPLC-DAD-ESI–MS/MS conditions
For chromatographic separation and mass spectrometric analysis an
Agilent 1100 HPLC system (degasser, binary gradient pump, auto-
sampler, column thermostat and diode array detector) was used hy-
phenated with an Agilent 6410 Triple Quad LC/MS system equipped
with ESI ion source (Agilent Technologies, Santa Clara, CA, USA). For
the screening of Ononis extracts HPLC separation was attained on a
Zorbax SB-C18 Solvent Saver Plus (3.5 μm) reversed phase column
(150× 3.0mm i.d; Agilent Technologies, Santa Clara, CA, USA).
Mobile phase consisted of 0.3% v/v formic acid (A) and methanol (B).
The following gradient program was applied: 0.0min, 29% B; 32.0min,
80% B; 34min, 100% B; 37min, 100% B; 42.0min, 29% B. Solvent ﬂow
rate was 0.4 mL/min and the column temperature was set to 25 °C. The
injection volume was 2 μL. For the separation of diastereomers of ni-
trogen-containing isoﬂavonoid glucoside esters the same column was
tested beside a Phenomenex Luna C-8 column (300×4.6mm i.d;
5 μm), a Kinetex C-18 core shell column (100×2.1mm i.d; 2.6 μm;
both Phenomenex Inc.; Torrance, CA, USA) and a Waters XSelect CSH
Phenyl-Hexyl column (100×2.1mm i.d; 2.5 μm; Waters Corporation,
Milford, MA, USA). The eluents were 0.1% TFA in water (A) and
acetonitrile (B). The injection volume was 1 μL from the eluted fraction
gained from the WCX cartridges and the temperature was set to 25 °C.
Applying the Zorbax C-18 column, isocratic 25% B was used with
0.4 mL/min ﬂow rate. On the XSelect Phenyl-Hexyl column isocratic
20% B was used with 0.1mL/min ﬂow rate, while isocratic 25% B was
used with 1mL/min ﬂow rate on the C-8 column. The separation using
the Kinetex column required an isocratic method using 20% B with a
0.2 mL/min ﬂow rate. Nitrogen was applied as drying gas at the tem-
perature of 350 °C at 9 L/min, the nebulizer pressure was 45 psi. The
fragmentor voltage was set between 100 and 135 V and the capillary
voltage was 3500 V. Full scan mass spectra were recorded in positive
ion mode in the range of m/z 80–1500. For collision induced dis-
sociation (CID) the collision energy varied between 10 and 40 eV with
fragmentor voltage 135 V. As collision gas, high purity nitrogen was
used. Product ion mass spectra were recorded in positive ion mode in
the range of m/z 80–600.
2.6. HPLC-DAD-ESI-QTOF conditions
For exact mass determination, an Agilent 1200 Series HPLC system
was used hyphenated with an UV–vis diode array detector and with an
Agilent 6520 Time of Flight Mass spectrometer (Agilent Technologies,
Santa Clara, CA, USA) equipped with an ESI ion source (dual electro-
spray) operated in positive ionization mode. HPLC separation was at-
tained on a Zorbax SB-C18 Solvent Saver Plus (3.5 μm) reversed phase
column. The same eluents and gradient program were used as on the
Agilent 1100 HPLC system. Solvent ﬂow rate was 0.4mL/min and the
column temperature was set to 25 °C. The injection volume was 2 μL
and 30% of the eluent was allowed to ﬂow into the mass spectrometer
by solvent splitting. Nitrogen was applied as drying gas at the tem-
perature of 325 °C at 5 L/min, the nebulizer pressure was 30 psi. Full
scan mass spectra were recorded in positive ion mode in the range of m/
z 80–1200. For collision induced dissociation (CID), the collision energy
varied between 20 and 40 eV. As collision gas, high purity nitrogen was
used. The fragmentor voltage was set to 175 V and the capillary voltage
was 3500 V. Product ion mass spectra were recorded in positive ion
mode in the range of m/z 25–700.
2.7. NMR conditions
All NMR experiments were carried out on a 600MHz Varian DDR
NMR spectrometer equipped with a 5mm inverse-detection gradient
(IDPFG) probehead. Standard pulse sequences and processing routines
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available in VnmrJ 3.2C/Chempack 5.1 were used for structure iden-
tiﬁcations. The complete resonance assignments were established from
direct 1He13C, long-range 1He13C, and scalar spin–spin connectivities
using 1D 1H, 13C, 1He1H gCOSY, 1He1H NOESY, 1He1H ROESY
(mixing time 300ms), 1He1H TOCSY (mixing time 150ms), 1He13C
gHSQCAD (J=140 Hz), 1He13C gHMBCAD (J=8Hz and 12 Hz) ex-
periments, respectively. The probe temperature was maintained at
298 K and standard 5mm NMR tubes were used. The 1H and 13C che-
mical shifts were referenced to the residual solvent signal
δH=2.500 ppm and δC= 39.52 ppm, respectively.
2.8. Investigation of optical rotation power and circular dichroism
To isolate isoﬂavonoid aglycones, 50.0 g dried and powdered plant
material from Rózsahegyi Ltd. was mixed with 500mL of water to ac-
tivate the indigenous glycosidase enzymes of the plant for 24 h. After
ﬁltration, the extract was evaporated to dryness. 150mL acetone was
added to the dark brown gum to redissolve the isoﬂavonoid aglycones
and to leave behind the saccharides. The extract was ﬁltered and dried
to gain 2 g residual. This was redissolved in HPLC methanol to obtain a
solution of 100mg/mL concentration. For the separation of iso-
ﬂavonoid aglycones the same preparative HPLC system was used.
Eluents consisted of 0.3% v/v acetic acid (A) and acetonitrile (B).
Gradient elution was used with 10mL/min ﬂow rate and solvent system
with 40% B at 0min to 43% B in 18min. Six fractions were obtained
with this method, which contained pseudobaptigenin (1.22 mg), for-
mononetin (3.15mg), onongenin (2.87 mg), sativanone (2.45mg),
maackiain (5.19mg) and medicarpin (5.26 mg), respectively. The
aglycones were redissolved in HPLC methanol to further experiments.
Optical rotations were determined on a Carl Zeiss Polamat A polari-
meter with a 1 dm cell and MeOH sample solutions at 25 °C. CD spectra
of the aglycones were recorded on a Chirascan CD spectrometer
(Applied Photophysics Ltd., Leatherhead, United Kingdom). Quartz
cells of 10 and 0.1mm optical path length and an instrument scanning
speed of 100 nm/min with 1 s response time were used for measure-
ments. The measurements are the averages of three repetitions between
200 and 300 nm at room temperature. Spectra were baseline-corrected
and the signal contributions of methanol were subtracted.
3. Results and discussion
3.1. LC-MS/MS analysis
The investigation of the analytical samples by LC-MS revealed
characteristic nitrogen-containing compounds (1–6) in the total ion
chromatogram recorded in positive ionization mode (Fig. 1). The even
m/z ratio of these peaks indicates the presence of an odd number of
nitrogen atoms in the structures. Comparing the total ion chromato-
gram (TIC) with the UV chromatogram, remarkable intensity diﬀer-
ences were observed in the case of the corresponding peaks (Fig. 1).
While the peaks of the nitrogen-containing molecules were pre-
dominant in the TIC (due to the eﬃcient ionization), these compounds
could hardly be detected in the UV chromatogram. Compounds 5 and 6
showed however signiﬁcant splitting on the achiral C18 stationary
phase, suggesting diastereomeric compounds. The tandem mass spec-
trometric (MS/MS) data and the accurate mass measurements (Table 1)
compared with our previous study conﬁrmed that the molecules of
interest are isoﬂavonoid derivatives [9]. As isoﬂavonoids possess high
molar absorptivity, the UV chromatogram suggested that these com-
pounds are in minute amount in the extract. All six isoﬂavonoid ske-
leton (formononetin, pseudobaptigenin, sativanone, onogenin, medi-
carpin and maackiain) were present in the form of glucosides bearing a
nitrogen-containing moiety. Besides the aglycone and its corresponding
fragments, each MS/MS spectrum showed characteristic ions at
288.1452, 144.1025 and 84.0810m/z values, respectively (Fig. 2),
suggesting that all the six compounds share a common structural motif
linked to the isoﬂavonoid glucosides. The collision induced dissociation
cleaves the molecules alongside the glycosidic bond, resulting in the
Fig. 1. The extract ion chromatograms of the compounds of interest (EIC, bottom), total ion chromatogram (TIC, middle) along with the UV chromatogram detected
at 260 nm (top).
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intact aglycone as Y0+ and the cleaved fragment composed of the
glucose and the nitrogen-containing moiety at m/z 288.1452 (Fig. 3).
Fragmentation of the isoﬂavonoid glucoside moiety with a neutral loss
results the unknown structure at 144.1025m/z and the protonated
formula of C7H13NO2. This formula may correspond to the common
natural compound stachydrine (also known as proline betaine). As this
compound can be found in various plants exposed to drought-stress
[12], it would be a plausible explanation for its presence in spiny
restharrow root, as well. Moreover, the co-localization of isoﬂavonoid
glucosides and stachydrine in plant tissues has already been proven by
Ye et al. (2013) [13]. The tandem mass spectrometric results could also
support the presence of stachydrine, as the characteristic base peak at
84m/z in the QQQ-MS/MS spectrum (Fig. 2) may also originate from
this moiety [14]. Wood et al. described the MS/MS behavior of sta-
chydrine and showed that a rearrangement fragmentation process re-
sulting in the loss of C3H6 followed by loss of water provides the
characteristic fragment at 84m/z with a protonated molecular ion
formula of C4H6NO [15]. Based on the HRMS experiments the proto-
nated fragment ion at 84.0810m/z value in our samples possesses a
formula of C5H10N, which could exclude the possibility of stachydrine,
but could arise from monosubstituted piperidine derivatives (e.g.
homopipecolic acid) [16,17], however the occurrence of these deriva-
tives in the plant kingdom is rather rare. As the piperidin-2-ylacetate
moiety has never been described in higher plants, samples of diﬀerent
origin and vegetational period were subjected for analytical screening
to detect the same compounds. These experiments successfully proved
the presence of the isoﬂavonoid homopipecolinic glucosides, therefore
the possibility of sample contamination could be excluded. In order to
exclude any further hypothetical structures and to unambiguously
identify the unknown structure, NMR experiments were applied.
3.2. NMR experiments
All the six compounds were isolated and subjected to NMR experi-
ments. The complete structure identiﬁcation of compound 5 is de-
scribed herein as an example. In the case of compound 5 the MS/MS
data suggested the presence of medicarpin aglycone (see Table 2). TheTa
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Fig. 2. Partial product ion spectrum of medicarpin 7-O-β-D-glucoside (bottom)
and that of medicarpin 7-O-β-D-glucoside-derivative, labeled as compound 5
(top). The m/z values in bold face correspond to the nitrogen-containing frag-
ments.
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six aromatic protons at 7.39/7.38 (d J=8.7 1H), 7.25 (d J=8.5 Hz
1H), 6.69 (dd J=8.7, 2.3 Hz 1H), 6.54/6.53 (d J=2.3 Hz), 6.45 (d
J=8.5 Hz 1H) and 6.42 (dd J=8.5, 2.3 Hz 1H) ppm and the char-
acteristic spin system (-O-CH2-CH-CH) at 4.28 (m 1H), 3.65 (m 2H)
ppm along with the methyl singlet of the –OCH3 group at 3.69 ppm
present in the 1H NMR spectrum of 5 corroborated by HMBC correla-
tions and literature data [18] conﬁrmed the medicarpin aglycone. The
presence of a glucose moiety was also veriﬁed by NMR, key HMBC
correlations conﬁrmed the glycosidic linkage between the anomeric OH
of the glucose and the C3-OH of medicarpin. The careful inspection of
the 1H NMR experiment showed the presence of eleven 1H resonances
in the aliphatic region (δH 2.83 (m 1H), 2.73 (m 1H), 2.42 (m 1H), 2.28
(m 2H), 1.53/1.49 (m 1H), 1.64/1.60 (m 1H), 1.42 (m 1H), 1.22 (m
1H), 1.20 (m 1H), 0.99/0.94 (m 1H)). The COSY, TOCSY and especially
the HMBC spectra with J=12Hz heteronuclear coupling constant
helped to construct the missing building block forming a piperidine ring
substituted at C2”’. In the HMBC experiment two crucial correlations
were observed for a carbonyl resonance at 171.40/171.36 ppm: intense
crosspeaks were detected between the C]O and protons (2.28 ppm) of
the side chain and similarly between the C]O and the H6” (4.06/
4.03 ppm) resonance of the glucose moiety (Fig. 4). These correlations
clearly indicate that the piperidin-2-yl-acetic acid linked to the glucose
moiety with an ester bond at the C6” position. The complete NMR
characterization of compound 5 can be found in Table 2. As the cyclic
beta amino acid residue introduces a new stereogenic center, some of
the NMR resonances show diastereomeric splitting. The MS/MS frag-
mentation can also be corroborated by the piperidin-2-ylacetate moiety.
As indicated in Fig. 3., the loss of the entire beta amino acid residue
refers to the fragment 144m/z, while the cleavage of the acetic acid
side chain provides the protonated fragments 1,2,3,4-tetra-
hydropyridine at 84m/z. In the case of compound 6 the NMR data
revealed a methylenedioxy group and the lack of the methoxy function
in the aglycone skeleton compared to 5. All 1H and 13C NMR resonances
were in agreement with the maackiain aglycone as proposed by the MS
experiments (Fig. 5) thus; compound 6 was identiﬁed as maackiain 3-O-
β-D-glucoside-6”-O-piperidin-2-ylacetate. The NMR resonances of the
glucose and the piperidin-2-ylacetate moieties were found to be almost
identical for all compounds (1–6) conﬁrming the same structural motif
but various aglycones (Tables 2–4). For compound 1 two sets of aro-
matic protons and a singlet at 8.44/8.43 ppm indicated isoﬂavonoid
aglycone skeletons. The HMBC spectrum indicated a key correlation
between an O-methyl resonance (3.79 ppm) and C4’ (159.06 ppm)
therefore the aglycone was identiﬁed as formononetin (Table 3).
Compound 2 showed HMBC correlation between the methylenedioxy
group (6.05 ppm) and C3’ (152.26 ppm) and C4’ (147.09 ppm) con-
ﬁrming the isoﬂavonoid skeleton pseudobaptigenin (Fig. 5). The com-
plete NMR resonance assignment can be found in Table 3. The NMR
characteristics of compound 3 and 4 were similar to 1 and 2 with a
subtle diﬀerence of an additional methoxy group at C2’ and the lack of
Fig. 3. The fragmentation pattern of the piperidin-2-ylacetate esters illustrated on the example of compound 5.
Table 2
1H and 13C NMR data of medicarpin (5) and maackiain (6) glucoside piperidin-
2-ylacetates in DMSO‑d6 (δ in ppm, J in Hz).
No. Compound 5 Compound 6
1H 13C 1H 13C
1 7.39/7.38 d
(8.7)
131.92 7.37 d (8.7) 131.87
1a – 114.19 – 114.25
2 6.69 dd (8.7,
2.3)
110.35 6.68 dd (8.7,
2.3)
110.34
3 – 158.23 – 158.23
4 6.54/6.53 d
(2.3)
104.02 6.53 d (2.3) 104.01
4a – 156.18/
156.16
– 156.18/
156.16
6A 4.28m 66.03 4.27m 65.94
6B 3.65m 3.66m
6a 3.65m 38.84 3.61m 39.56
7a – 119.19 – 118.24
7 7.25 d (8.5) 125.20 6.98 s 105.37
8 6.45 d (8.5) 96.34 – 141.12
9 – 160.53 – 147.48
10 6.42 dd (8.5,
2.3)
106.11 6.52 s 93.24
10a – 160.22 – 153.64
11a 5.59 d (7.1) 77.73 5.56 d (7.5) 77.62
9-OCH3 3.69 s 55.29
9-OCH2O-8 5.90 s 101.05
5.94 s
1” 4.90/4.89 d
(8.5)
99.95 4.89 d (7.7) 99.97
4.89 d (7.8)
2” 3.22 t (8.4) 73.08 3.23m 73.09
3” 3.29 t (8.9) 76.20 3.29 t (8.9) 76.20
4” 3.15 dd (9.8,
8.7)
69.90/69.85 3.15m 69.89/69.86
5” 3.60m 73.65 3.60m 73.65/73.64
6”A 4.06/4.02 dd
(12.0, 6.8)
63.21/63.18 4.07/4.04 dd
(12.0, 6.8)
63.24/63.23
6”B 4.33/4.30 dd
(12.0, 2.3)
4.33/4.30 dd
(12.0, 2.4)
2’” 2.73m 53.30/53.21 2.78m 53.26/53.17
3’”ax 0.99/0.94m 31.93 1.00/0.96m 31.75
3’”eq 1.53/1.49m 1.56/1.52m
4’”ax 1.22m 24.23 1.22m 24.10
4’”eq 1.64/1.60m 1.64/1.60m
5’”ax 1.20m 25.69 1.21m 25.51
5’”eq 1.42m 1.44m
6’”ax 2.42m 46.15 2.46m 46.05
6’”eq 2.83m 2.87m
7’” 2.28m 41.22 2.29m 41.05
8’” – 171.40/
171.36
– 171.32/
171.29
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an aromatic singlet (Table 4). The aglycones of 3 and 4 were identiﬁed
as sativanone and onogenin, respectively (Fig. 5).
3.3. Stereochemistry
Regarding the aglycones, the two isoﬂavones, formononetin and
pseudobaptigenin contain no chiral atoms. However, the two dihy-
droisoﬂavonoids onogenin and sativanone are chiral compounds. Based
on the information that the isolated aglycones have no detectable CD
spectrum we assumed that our sample contains the derivatives of
(3R,S)-onogenin and sativanone, in concordance with literature [19].
Pterocarpans contain two chiral centers, however, from the four
possible isomers only two, with cis-fused benzofuranyl-benzopyran
rings can be found in nature (Tőkés et al., 1999) [20]. In the ROESY
experiment of compound 6 intense crosspeaks were detected between
the H6a (3.60 ppm) and H11a (5.56 ppm) verifying the cis conﬁgura-
tion of the aglycone maackiain. To determine the absolute conﬁgura-
tion of the pterocarpans optical rotatory dispersion and circular di-
chroism were used. The [α]D25 value of medicarpin and maackiain was
−303° and− 113°, respectively, showing that in our sample the pter-
ocarpans can be found in the pure form of (6aR,11aR)-medicarpin and
(6aR,11aR)-maackiain. The minima and maxima of the recorded CD
spectra (medicarpin, λmax (Δε) 208 (−18.53M−1*cm−1), 236
(−9.67M−1*cm−1), 288 (4.09M−1*cm−1); maackiain 212
Fig. 4. Key HMBC (curved arrows), COSY (bold lines) and ROESY (straight arrows) correlations for compound 5.
Fig. 5. The structures and numbering of isoﬂavonoid glucoside 6”-O-piperidin-2-ylacetates 1–6.
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(−4.18M−1*cm−1), 240 (−7.41M−1*cm−1); 280 (0.24M−1*cm−1))
were in accordance with literature data [21,22] (Figs. S58 and S59).
Even in the screening chromatographic runs the peaks of compound 5
and 6 showed signiﬁcant peak splitting on achiral stationary phase.
This eﬀect could be observed on all derivatives in the preparative LC
chromatogram and was further investigated on various analytical sta-
tionary phases (C-18, C-8, C-18 core shell and phenyl-hexyl). The
complete separation of the two diastereomers of formononetin, pseu-
dobaptigenin, medicarpin and maackiain derivatives could be achieved
on all four columns (Figs. S60–S67). However, the four isomers of the
racemic onogenin and sativanone could not be baseline separated. Be-
side the two baseline resolved peaks (originating hypothetically from
the diastereomeric splitting due to the racemic nature of the amino
acid), a third peak (as a shoulder) can be observed using the core shell
C18 column (Fig. S67). To investigate the stability of the isomers, the
peaks of compound 6 were isolated separately. The isolated compounds
were then reinjected after 1, 5 and 10 days. The transformation of the
isomers into each other resulting in peak duplication could not been
observed (Figs. S56 and S57). As the NMR signals of all six compounds
showed signal duplication, but the stereochemistry of the aglycones are
so diﬀerent, we hypothesized that the source of the phenomenon ori-
ginated from the common structural motifs. The 1H NMR spectra of the
isolated diastereomers of compound 5 were recorded and it clearly
indicates that the duplication of the NMR signals arose from the overlap
of the 1H resonances of the two diastereomers (Figs. S33–S37). Ex-
amining the chemical shifts and coupling constants of the sugar moiety,
the presence of β-D-glucopyranose could be proved in all six molecules.
Consequently, the hypothesized source of the diastereomerism is the
stereogenic center of the beta amino acid.
4. Conclusions
A preparative method was developed and applied to separate, iso-
late and characterize six unknown isoﬂavonoid glucoside homo-
pipecolic esters using the combination of ion exchange puriﬁcation and
preparative reversed phase chromatographic isolation. The unexpected
structures were characterized by the means of HR-MS/MS, NMR and CD
spectroscopy. The presence of the beta amino acid homopipecolic acid
is ﬁrstly published in higher plants. Although the botanical function of
these compounds is unclear, their presence of homopipecolic acid in the
form of isoﬂavonoid esters can serve as chemotaxonomic marker in the
Fabaceae family.
Table 3
1H and 13C NMR data of formononetin (1) and pseudobaptigenin (2) glucoside
piperidin-2-ylacetates in DMSO‑d6 (δ in ppm, J in Hz).
Position Compound 1 Compound 2
1H 13C 1H 13C
2 8.43/8.44 s 152.5 8.45/8.44 s 153.9
3 – 123.3 – 124.8
4 – 175.1 – 174.6
4a – 118.9 – –
5 8.07 d (8.8) 127.0 8.06 d (8.8) 126.9
8.06 d (8.9) 8.06 d (8.9)
6 7.14 dd (8.8, 2.3) 115.4 7.14 dd (8.8, 2.4) 109.3
7 – 161.3 – 161.3
8 7.24/7.22 d (2.3) 103.5 7.23/7.22 d (2.4) 103.3
8a – 157.1 – 160.8
1’ – 123.8 – 123.6
2’/6’ 7.52/7.51 d (8.8) 130.1 7.15 d (2.4) 115.5
3’/5’ 7.01 d (8.8) 113.5 – 152.3
4’ – 159.1 – 147.1
5’ 113.5 7.00 d (7.7) 108.1
6’ 130.1 7.07/7.06 dd (7.7, 2.4) 122.3
4’-OCH3 3.79 s 55.1 6.06 s 101.1
4’-OCH2O-3’
1” 5.20 d (7.5) 99.4 5.21/5.20 d (5.5) 99.3
5.19 d (7.4)
2” 3.28 t (8.1) 73.0 3.23 t (8.1) 72.9
3” 3.30 t (9.1) 76.1 3.30 t (9.1) 76.1
4” 3.19/3.18 t (9.1) 69.9 3.15 t (9.1) 69.9
5” 3.76m 73.8 3.76m 73.6
6”A 4.10 dd (11.8, 7.3) 63.3 4.06/4.01m 63.2
4.07 dd (11.8, 7.1)
6”B 4.33 dd (11.8, 2.1) 4.30m
4.32 dd (11.8, 1.9)
2”’ 2.70/2.65m 53.1 2.70/2.66m 53.1
3”’ax 0.96/0.89m 31.8 0.96m 31.8
3”’eq 1.50/1.43m 1.52m
4”’ax 1.14m 24.1 1.15m 24.1
4”’eq 1.60/1.52m 1.61m
5”’ax 1.14m 25.6 1.15m 25.6
5”’eq 1.36m 1.35m
6”’ax 2.38/2.31m 46.0 2.34m 46.0
6”’eq 2.80/2.75m 2.83/2.75m
7”’ 2.29/2.28m 41.1 2.28m 41.2
8”’ – 171.4 – 171.4
13C NMR data for Compound 1 and 2 were assigned on the basis of HSQC and
HMBC experiments.
Table 4
1H and 13C NMR data of sativanone (3) and onogenin (4) glucoside piperidin-2-
ylacetates in DMSO‑d6 (δ in ppm, J in Hz).
Position Compound 3 Compound 4
1H 13C 1H 13C
2 4.59/4.57m 70.47 4.59m 70.36
4.46m 4.45m
3 4.21 dd (11.4,
5.4)
46.68 4.25m 47.23
4 – 190.66 – 190.56
4a – 115.88 – 115.86
5 7.76 d (8.8) 128.53 7.76 d (8.7) 130.07
7.75 d (8.8) 7.75 d (8.7)
6 6.72 dd (8.8, 2.4) 110.81 6.73/6.72 dd (8.7,
2.5)
110.83
7 – 162.94 – 162.99
8 6.64 d (2.4) 103.45 6.64/6.63 d (2.5) 103.45
8a – 162.89 – 162.99
1’ – 115.79 – 115.44
2’ – 158.13 – 152.50
3’ 6.58 d (1.3) 98.87 6.82 s 95.77
4’ – 160.09/
160.07
– 140.65
5’ 6.49/6.48m 104.99 – 147.24
6’ 7.01/6.99 d (8.6) 130.82/
130.64
6.74/6.72 s 109.89
2’-OCH3 3.71/3.70 s 55.64 3.66/3.65 s 56.65
4’-OCH3 3.75 s 55.24 – –
4’-OCH2O-3’ 5.96/5.95 s 101.11
1” 5.06 d (7.5) 99.41 5.06 d (7.0) 99.42
5.05 d (6.5) 5.05 d (6.7)
2” 3.27 t (8.8) 73.00 3.28 t (8.1) 73.01
3” 3.32 t (8.9) 76.14 3.31 t (9.1) 76.14
4” 3.16 t (9.2) 69.89/69.84 3.16 t (9.1) 69.96
5” 3.69m 73.76 3.69m 73.77
6”A 4.07/4.04m 63.28 4.07/4.03m 63.25
6”B 4.35/4.32m 4.35/4.32m
2′” 2.78m 53.20/53.09 2.73m 53.29
3′”ax 1.02/0.97m 31.65 0.96/0.92m 31.93
3′”eq 1.53m 1.55/1.48m
4′”ax 1.23m 24.04/24.01 1.22m 24.21
4′”eq 1.61m 1.61m
5′”ax 1.24m 25.42 1.21m 25.69
5′”eq 1.44m 1.42m
6′”ax 2.45m 45.96 2.43m 46.15
6′”eq 2.87m 2.84m
7′” 2.32m 40.98 2.30m 41.26
8′” – 171.26/
171.23
– 171.37
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Abstract
Ononis arvensis L. can be found overall in Europe and is used to treat infections of the
urinary tract and skin diseases in ethnopharmacology. Flavonoids, hydroxycinnamic
acids, oxycoumarin, scopoletin and scopolin, phytosterols, lectins, and some selected
isoflavonoids were identified in O. arvensis till date; however, there is a lack of the
detailed investigation of the isoflavonoid profile of the plant. With the application
of high‐resolution tandem mass spectrometry, the fragmentation patterns of
isoflavonoid derivatives found in O. arvensis roots and aerial parts were investigated
and discussed. Isoflavonoid glucosides, glucoside malonates, aglycones, and beta
amino acid derivatives were characterized, among which homoproline isoflavonoid
glucoside esters were described for the first time. Besides the known isoflavonoid
aglycones described earlier in other Ononis species, two 2′‐methoxy isoflavonoid
derivatives were detected. The presence of licoagroside B was verified, and its struc-
ture was also corroborated by NMR experiments. Altogether, the high‐resolution frag-
mentation pattern of 47 isoflavonoids and glycosides is presented, and their relative
quantity in the roots and the aerial parts can be evaluated. Based on this information,
the chemotaxonomic relation of Ononis species and the biosynthesis of their com-
pounds could be comprehended to a greater depth.
KEYWORDS
fragmentation, HPLC‐ESI‐MS/MS, isoflavonoid, Ononis, UHPLC‐ESI‐Orbitrap‐MS/MS
1 | INTRODUCTION
The members of the Ononis genus, which belongs to the family
Leguminosae, are natively distributed in Europe, Central Asia, and
North Africa. Ononis arvensis L. is a perennial shrub preferring humid
fields and meadows overall in Europe. The 50 to 100 cm‐high erect
stem is covered by trichomes. It has elliptical leaves and pink flowers.1
The synonym names are Ononis hircina Jacq. and Ononis spinosa subsp.
hircina (Jacq.) Gams. In the Renaissance, it was used in the treatment
of epilepsy,2 but its most widespread use is to treat infections of the
urinary tract and for skin diseases.3 In ethnomedicinal reports, the
decoction of the aerial part has been applied to liver and stomach dis-
orders in the human and veterinary medicine, as well.4,5
In the aerial parts, flavonoids and hydroxycinnamic acids were
characterized and determined quantitatively using UHPLC‐ESI‐Q‐
TOF‐MS.5 Sichinava et al. isolated oxycoumarins, scopoletin and
scopolin from the plant.6 The distribution of phytosterols and
triterpene onocerin was investigated in the aerial parts and the
roots of O. arvensis by GLC‐MS.7 Only a limited number of papers
can be found dealing with the chemical composition of the roots.
Horoejsi et al. isolated and characterized the lectins of O. arvensis
root.8 The isoflavonoid glucoside ononin and the dihydroi-
soflavonoid onogenin were isolated from the roots, and the struc-
ture of onogenin was elucidated by NMR spectroscopy9; however,
there is a lack of the detailed investigation of the isoflavonoid pro-
file of the plant.
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For screening numerous isoflavonoid derivatives, liquid chroma-
tography coupled with tandem mass spectrometry is the most power-
ful tool regarding its selectivity and sensitivity. With the application of
tandem mass spectrometry, the fragmentation patterns of
isoflavonoid derivatives can be examined and compared. As
isoflavonoids can be found in the form of glucosides, glucoside
malonates, aglycones10 and beta amino acid glucoside esters,11 the
similarity of their product ion spectra can be used to classify the deriv-
atives with the same aglycone. In some cases, mass spectrometry on
its own is not sufficient for the complete structural elucidation, so
the application of NMR techniques is inevitable. To obtain the neces-
sary amount of pure compound for NMR experiments, the most
repeatable and reliable way is to use preparative HPLC.
Previous studies on the composition of O. arvensis aerial parts and
root dealt in depth only with selected compounds, and the structural
analysis and characterization of other derivatives were missed. There-
fore, the aim of this study is to systematically identify the isoflavonoid
profile of the aqueous‐methanolic extract of O. arvensis aerial parts
and root by HPLC‐ESI‐MS/MS, UHPLC‐ESI‐FTMS/MS in positive ion-
ization mode in conjunction with NMR.
2 | EXPERIMENTAL
2.1 | General and plant material
HPLC‐grade methanol was obtained from Fisher Scientific (Loughbor-
ough, UK). Methanol‐d4, for NMR measurements, was purchased from
Sigma‐Aldrich (Steinheim, Germany). Purified water prepared by
Millipore Milli‐Q equipment (Billerica, MA, USA) was used throughout
the study. Calycosin, homoproline, and homopipecolic acid were pur-
chased from Sigma‐Aldrich (Steinheim, Germany). All other chemicals
were of analytical grade. O. arvensis was collected near Beregújfalu
(location: N 48°17′21.1″, E 22°48′08.7″—Beregszászi járás, Ukraine,
July 2017). Voucher specimens were deposited in the Department of
Pharmacognosy, Semmelweis University, Budapest with voucher num-
ber 170727‐OnArv02. The roots and the aerial parts of the plant were
separated. The roots were washed to remove soil, and the dried roots
were ground. The aerial parts were ground without further separation
of leaves and stems.
2.2 | Preparation of analytical sample
From the ground plant material, 0.500 g was mixed with 30 mL of 70%
aqueous methanol and extracted in ultrasonic bath for 10 minutes on
25°C. After filtration, the sample was dried under vacuum with rotary
evaporator (60°C, Heidolph Instruments, Laborata 4000, Schwabach,
Germany). The resulting residue was redissolved in 2 mL of 70% aque-
ous methanol and filtered through 0.22 μm PTFE filter (Nantong
FilterBio Membrane Co., Ltd; Nantong City, Jiangsu P. R China). For
the hydrolyzed sample, 1 mL of the analytical sample was mixed with
1 mL of concentrated ammonia and evaporated to dryness with rotary
evaporator set to 60°C. The residue was mixed with 2 mL of purified
water, and the liquid was passed through the same PTFE filter.
2.3 | HPLC‐ESI‐MS/MS conditions
For chromatographic separation and mass spectral analysis, an Agilent
1100 HPLC system (degasser, binary gradient pump, autosampler, col-
umn thermostat, and diode array detector) was used hyphenated with
an Agilent 6410 Triple Quad LC/MS system equipped with ESI ion
source (Agilent Technologies, Santa Clara, CA, USA). The HPLC sepa-
ration of the root and aerial part extracts was attained on a Zorbax
SB‐C18 Solvent Saver Plus (3.5 μm) reversed phase column
(150 × 3.0 mm i.d; Agilent Technologies, Santa Clara, CA, USA). Mobile
phase consisted of 0.3% v/v formic acid (A) and methanol (B). The fol-
lowing gradient program was applied: 0.0 minutes, 29% B;
32.0 minutes, 80% B; 34 minutes, 100% B; 37 minutes, 100% B;
42.0 minutes, 29% B. Solvent flow rate was 0.4 mL/min, and the col-
umn temperature was set to 25°C. The injection volume was 2 μL.
Nitrogen was applied as drying gas at the temperature of 350°C at
9 L/min; the nebulizer pressure was 45 psi. Full scan mass spectra
were recorded in positive ionization mode in the range of m/z 80 to
1500. For collision induced dissociation (CID), the collision energy var-
ied between 10 and 40 eV. As collision gas, high purity nitrogen was
used. The fragmentor voltage was set to 80 V, and the capillary volt-
age was 3500 V. Product ion mass spectra were recorded in positive
ionization mode in the range of m/z 50 to 600.
The hydrolyzed sample was analyzed using the same HPLC‐MS/
MS apparatus equipped with a Zorbax NH2 normal phase column
(150 × 4.6 mm i.d; 5 μm). Mobile phase consisted of 20 mM ammonium
formate buffer (pH = 4) (A) and acetonitrile (B). Isocratic mode was
applied with 80% B at 1 mL/min flow rate and at 25°C. The injection
volume was 5 μL. Nitrogen was applied as drying gas at the tempera-
ture of 300°C at 6 L/min; the nebulizer pressure was 15 psi. For regis-
tering the chromatogram, selective ion monitoring mode was chosen at
m/z 130 (homoproline) and m/z 144 (homopipecolic acid). For CID, the
collision energy varied between 10 and 30 eV. As collision gas high
purity nitrogen was used. The fragmentor voltage was set to 120 V,
and the capillary voltage was 4000 V. Product ion mass spectra were
recorded in positive ion mode in the range of m/z 50 to 200.
2.4 | UPLC‐ESI‐Orbitrap‐MS/MS conditions
For obtaining high resolution mass spectrometric data of the root and
aerial part extracts, a Dionex Ultimate 3000 UHPLC system (3000RS
diode array detector, TCC‐3000RS column thermostat, HPG‐3400RS
pump, SRD‐3400 solvent rack degasser, WPS‐3000TRS autosampler)
was used hyphenated with a Orbitrap Q Exactive Focus Mass Spec-
trometer equipped with electrospray ionization (Thermo Fischer Sci-
entific, Waltham, MA, USA). The column and the HPLC method
were the same as the ones used with the non‐hydrolyzed analytical
samples. The electrospray ionization source was operated in positive
ionization mode, and operation parameters were optimized automati-
cally using the built‐in software. The working parameters were as fol-
lows: spray voltage, 3500 V; capillary temperature 256.25°C; sheath
gas (N2), 47.5°C; auxillary gas (N2), 11.25 arbitrary units; spare gas
(N2), and 2.25 arbitrary units. The resolution of the full scan was of
70 000, and the scanning range was between 120 and 1000 m/z units.
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The most intense ions detected in full scan spectrum were selected for
data‐dependent MS/MS scan at a resolving power of 35 000, in the
range of 50 to 1000 m/z units. Parent ions were fragmented with nor-
malized collision energy of 10%, 30%, and 45%.
2.5 | NMR conditions
All NMR experiments were carried out on a 600 MHz Varian DDR
NMR spectrometer equipped with a 5 mm inverse‐detection gradient
(IDPFG) probehead. Standard pulse sequences and processing rou-
tines available in VnmrJ 3.2C/Chempack 5.1 were used for structure
identifications. The complete resonance assignments were established
from direct 1H‐13C, long‐range 1H‐13C, and scalar spin‐spin connectiv-
ities using 1D 1H, 13C, 1H‐1H gCOSY, 1H‐1H NOESY, 1H‐1H ROESY,
1H‐1H TOCSY, 1H‐13C gHSQCAD (J = 140 Hz), and 1H‐13C
gHMBCAD (J = 8 Hz and 12 Hz) experiments, respectively. The probe
temperature was maintained at 298 K, and standard 5 mm NMR tubes
were used. The 1H and 13C chemical shifts were referenced to the
residual solvent signal δH = 3.310 ppm and δC = 49.00 ppm,
respectively.
2.6 | Isolation of licoagroside B
Using ultrasonic bath on room temperature, 20.0 g ground root was
extracted with 200 mL of 70% methanol twice. After filtration, the
extract was dried under reduced pressure. The residue was
redissolved in water, and 10 mL of acetone was added to remove sac-
charides. The precipitate was filtered, and the liquid phase was dried.
The residue was redissolved in 10 mL of water and passed through
Supelclean SPE LC‐18 columns (500 mg, 3 mL; Supelco, Bellefonte,
PA, USA). After air drying the cartridges, 3 mL of 50% methanol was
used to elute glycosides, then 6 mL pure methanol was applied to
achieve complete elution of isoflavonoids. The weights of the first
and second eluates were 274 and 171 mg, respectively. The 50%
methanol fraction was redissolved in 2 mL of water and filtered
through 0.22 μm PTFE filter before subjected to preparative HPLC.
For fractionation, a Hanbon Newstyle NP7000 HPLC system with a
Hanbon Newstyle NP3000 UV detector (Hanbon Sci. & Tech. CO.
Jiangsu, China) equipped with a Gemini C18 reversed phase column
(150 × 21.2 mm i.d; 5 μm, Phenomenex Inc; Torrance, CA, USA) was
used. Eluents consisted of 0.3% v/v acetic acid (A) and methanol (B).
Gradient elution was used with a 10 mL/min flow rate and a solvent
system using 10% B at 0 minutes, 40% B in 10 minutes, 100% B in
15 minutes, and 10% B in 25 minutes. This method has not been opti-
mized in terms of performance parameters as it only served for isola-
tion purposes. Licoagroside B eluted at 11.41 minutes, the obtained
fraction was reinjected for further purification. Finally, 8.9‐mg
licoagroside B was yielded in high purity
2.7 | Isolation of but‐2‐enolide aglycones
From the same plant material, 30.0 g was mixed with 200 of mL water
for 48 hours to activate the plant's indigenous glucosidase enzymes.
After filtration, the drug was extracted twice with 200 mL of 70%
methanol using ultrasonic bath at room temperature. The extract
was dried under reduced pressure and redissolved in water. The sac-
charides were precipitated with the same method as mentioned
above. The total weight of the extract was 835 mg and was
redissolved in 10 mL of water and filtered through 0.22 μm PTFE filter
before subjected to the same preparative HPLC system. The chosen
chromatographic conditions fulfilled the criteria of isolation but were
not optimized in terms of performance parameters. Eluents consisted
of 0.3% v/v acetic acid (A) and methanol (B). Gradient elution was
used with a 10 mL/min flow rate and solvent system with 50% B at
0 minutes, 50% B in 10 minutes, 100% B in 15 minutes, and 50% B
in 20 minutes. Puerol A eluted at 8.40 minutes, while clitorienolactone
B eluted at 12.25 minutes. Clitorienolactone B was reinjected for fur-
ther purification with isocratic 25% acetonitrile as solvent B. The
yields were 4.8 mg for puerol A and 3.1 mg for clitorienolactone B,
respectively.
2.8 | Isolation of but‐2‐enolide glycosides and
calycosin D glycosides
100 gram powdered drug was extracted by 400 mL of 70% aqueous
methanol twice. After filtration, the liquid phase was dried under
reduced pressure at 60°C. The residue was dissolved in water to gain
a viscous solution of 500 mg/mL concentration. This sample was puri-
fied using a CombiFlash NextGen 300+ (Teledyne ISCO, Lincoln, USA)
equipped with a RediSep Rf Gold C18 column (150 g). As eluents,
methanol (solvent B) and 0.3% acetic acid (solvent A) were used with
the following gradient program: 0 minutes 30% B, 20 minutes 50% B,
25 minutes 100% B, and 30 minutes 100% B. The flow was set to
60 mL/min and 16 mL fractions were collected. Fractions 23 to 27,
38 to 41, and 49 to 53 were unified and further purified by the same
preparative HPLC system using isocratic 25% acetonitrile as eluent
with 10 mL/min flow. Fractions 23 to 27 yielded 15.4 mg calycosin
D glucoside. From fractions 38 to 41, puerol A 2′‐O‐glucoside was
isolated (eluted at 7.2 minutes, 63.2 mg) along with clitorienolactone
B 4′‐O‐glucoside (eluted at 8.6 minutes). Clitorienolactone B
4′‐O‐glucoside was further purified on a Luna C18(2) 100 A (5 μm)
reversed phase column (150 × 10.00 mm i.d; Phenomenex, Inc; USA)
using isocratic 25% acetonitrile and 2 mL/min flow, yielding 2.3 mg.
Calycosin D 6″‐O‐glucoside malonate was isolated from fractions 49
to 53 eluting at 11.3 min (1.1 mg).
3 | RESULTS AND DISCUSSION
In the aqueous‐methanolic extract of O. arvensis aerial parts and roots
altogether, 47 compounds were described (Figure 1). Isoflavonoids,
dihydroisoflavonoids, and pterocarpans were characterized in the
form of glucosides, glucoside malonates, aglycones, and esters of
homopipecolic acid besides several new compounds. Moreover, the
glucosides of some special phenolic compounds with their aglycones
(puerol A and clitorienolactone B) and a maltol glucoside derivative
(licoagroside B) were also identified in the samples (see Table 1). In
the case of nitrogen containing compounds, diastereomeric splitting
could be observed depending on the type of the aglycone and the
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retention time (Figure 1). Comparing the metabolic profile of the aerial
parts and the roots, a significant difference emerges between the
amounts of dihydroisoflavonoid compounds (onogenin and
sativanone). These derivatives could be found in the aerial parts only
in trace quantities, while they were quite abundant in the root
extracts, indicating a divergence in biosynthesis (Table 1).
3.1 | Identification of licoagroside B
The m/z value of the pseudo‐molecular ion in positive ionization mode
of compound 1 (Figure 1A) was 433.1338, and its molecular formula
calculated on the basis of HR‐MS experiments corresponds to
C18H24O12 (see Table 1). Investigating the fragmentation pattern of
this precursor ion, only two fragment ions at m/z 145.0493
(C6H9O4) and m/z 127.0390 (C6H7O3) could be observed, contrary
to the rich fragmentation profile and retro Diels‐Alder (rDA) cleavage
of isoflavonoid derivatives.12 Based on these results, peak 1 was ten-
tatively identified as licoagroside B, the 3‐hydroxy‐3‐methyl‐glutarate
ester of maltol glucoside. The fragment at m/z 127.0390 could result
from the cleavage of the maltol ring together with the anomeric O
atom, while the fragment at m/z 145.0493 could be assigned to the
hydroxy‐methyl‐glutaric acid residue (Figure 2). The results of the
NMR experiments verified that compound 1 was licoagroside B (Table
S1), and the obtained resonances showed perfect correlation with the
ones reported by Li et al.13 Licoagroside B was only identified in the
hairy root cultures of Glycyrrhiza glabra L. till date. However,
licoagroside B is present in high quantity in O. arvensis, showing that
this compound is a characteristic metabolite of Ononis species.
FIGURE 1 The extracted ion chromatograms of the described compounds with various aglycones from O. arvensis root aqueous‐methanolic
extract. A, Licoagroside B (1—433.1338), puerol derivatives (6—461.1435, 7—475.1593, 18—299.0909, 31—313.1066), 2′‐methoxy
isoflavonoids (39—313.0703, 42—299.0916); B, Calycosin D derivatives (2—447.1281, 11—533.1295, 30—285.0754) and calycosin derivatives (4
—447.1299, 16—533.1309, 34—285.0752); C, Formononetin derivatives (9—542.2020, 13—556.2177, 21—431.1345, 26—517.1343, 36—
517.1353, 45—269.0803); D, Pseudobaptigenin derivatives (8—556.1812, 12—570.1967, 19—445.1124, 25—531.1125, 35—531.1132, 44—
283.0596); E, Sativanone derivatives (5—574.2274, 17—588.2234, 24—463.1591, 29—549.1600, 36—549.1595, 45—301.1061); F, Onogenin
derivatives (3—588.2072, 14—602.2231, 22—477.1382, 28—563.1387, 33—563.1382, 41—315.0858); G, Medicarpin derivatives (15—544.2166,
23—558.2326, 32—433.1487, 39—519.1488, 47—271.0989); H, Maackiain derivatives (10—558.1968, 20—572.2122, 27—447.1272, 38—
533.1275, 42—285.0750)
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3.2 | Identification of but‐2‐enolides
Peak 18 showed a protonated pseudo‐molecular ion at m/z 299.0908,
and its fragmentation pattern was identical with that of peak 6 bearing
precursor ion at m/z 461.1435 (Figure 1A). Based on the protonated
molecular formulas (C17H15O5 and C23H25O10), these structures were
putatively identified as puerol A and its 2′‐O‐glucoside (Table 1). In
their MS/MS spectra, two main fragmentation pathways could be
observed: the cleavage of the whole molecule to A and B‐ring and
the neutral loss of small units, as CO and C2H2O.
Applying the same fragmentation pattern described above, 7 and
31 (Figure 1A) were assigned as the methylated derivative of puerol
A and its O‐glucoside, respectively. Between the fragment ions in
the spectra of 18 and 31, a difference of 14 Da could be observed
in all cases (Table 1), except for the ion at m/z 107.0495 (C7H7O) cor-
responding to the B‐ring (Figure 3). These fragments indicate that a
methyl substituent on the A‐ring is responsible for the 14 Da shifts
of the fragments (Figure 3).
The nomenclature and structural identification of puerol deriva-
tives are rather tangled in previous interpretations; naming and struc-
tures are briefly discussed below and summarized in Figure S8. Firstly,
Kinjo et al. isolated pueroside A and B in 1985 and identified them as
diglycosides of a ζ‐lactone.14 Shirataki et al. isolated sophoraside A
(monoglycoside) and two aglycones, puerol A, and its 4′‐O‐methylated
form, puerol B, possessing the same ζ‐lactone structure,15 and Barrero
et al. identified specionin and its glucoside speciozide A with ζ‐lactone
structure in O. speciosa.16 In their later work, Nohara et al.17 described
that pueroside A and B and sophoraside A were actually γ‐lactones, in
contrary to previous works. Kirmizgül et al.18 isolated spinonin from O.
spinosa, which is a monoglycoside and its structure would correspond
to puerol A 2′‐O‐glucoside. Nevertheless, the authors drove to the
conclusion that spinonin contained a 2,3‐dihydro‐3‐oxofurane ring
instead of a 2,3‐dihydro‐2‐oxofurane, like the puerol derivatives.
Puerol A and its 4′‐O‐methylated form, puerol B, along with their
2′‐O‐glucosides were isolated from O. angustissima L. by Ghribi
et al.19 but another O‐methylated derivative of puerol A
(clitorienolactone B) was isolated from O. spinosa by Addotey et al.20
(See Figure S8). Puerol B and clitorienolactone differ only in the posi-
tion of a methyl substitution. In puerol B, the methylation occurs atTA
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FIGURE 2 Proposed fragmentation profile of licoagroside B in
positive ionization mode at 10 eV collision energy
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the para OH group of A‐ring position, whereas in clitorienolactone B it
is in the ortho position. Since the HR‐MS/MS investigations alone
could not solve the exact location of atoms in the middle ring and
the methyl group, peaks 6, 7, 18, and 31 were isolated and subjected
to NMR experiments in order to clarify the structures. Based on the
NMR results, the isolated compounds contained a 2,3‐dihydro‐2‐
oxofurane ring. The most decisive element was the chemical shift of
the carbonyl atoms, as they exhibited chemical shifts at 176.8 and
177.2 ppm which are characteristic for unsaturated γ‐lactones,21
whereas 2,3‐dihydro‐3‐oxofurane rings possess chemical shift above
200 ppm.22 The glucose moiety of compound 6 joined puerol A
through the 2′‐OH group, in ortho position. Based on the NOESY
spectrum, the methyl group of compound 31 is located in ortho posi-
tion, too, so that this compound was identified as clitorienolactone
B. The NOESY spectrum of compound 7 revealed that the glucose
moiety is linked through the 4′ OH group, in para position. To the best
of our knowledge, this glucoside is characterized for the first time.
3.3 | Identification of isoflavonoids
Peak 21, 26, 37, and 46 (Figure 1C) provided [M + H]+ ions at m/z
431.1345 (C22H23O9), 517.1343 (C25H25O12), 517.1353 (C25H25O12),
and 269.0803 (C16H13O4), respectively, but they did not differ in their
MS/MS spectra, meaning that they are the derivatives of the same agly-
cone. The fragmentation of these ions gave rise to m/z 254.0570
(C15H10O4) ion, owing to the radical cleavage of CH3
• and m/z
237.0543 (C15H9O3), deriving from the loss of a CH3OH unit, verifying
the presence of a methoxy group. The ion atm/z 213.0907 (C14H13O2)
is a result of the loss of two CO units which is characteristic for
isoflavonoid aglycones.23 Fragment ion at m/z 118.0415 (C8H6O)
refers to the ion containing the B‐ring resulting from the rDA fragmen-
tation (Figure 4A). Although, the intact B‐ring with the methoxy group
atm/z 133.0648 (C9H9O) is barely detectable, the rDA fragment losing
the CH3
• radical at m/z 118.0415 is much more intense (Table 1).
Regarding this information, the aglycone was tentatively identified as
formononetin. The neutral loss of 162.0540 (C6H10O5) Da of peak 21
corresponded to the loss of a hexose moiety. Taking into account, that
isoflavonoids form glycosides with glucose in the vast majority of
cases,24 the peak was assigned as formononetin 7‐O‐β‐D‐glucoside or
ononin. Peaks 26 and 37 showed the same quasi‐molecular ion and
fragmentation spectra, and a neutral loss of 248.0550 Da (C9H12O8);
therefore, they were attributed as 7‐O‐β‐D‐glucoside malonates of
formononetin. Based on the significant difference in their quantity
and retention times (Figure 1C), the firstly eluting minor derivative
was tentatively identified as 4″‐malonate (26) and the later eluting
major molecule as 6″‐malonate (37).25
With protonated pseudo‐molecular ions at m/z 447.1281
(C22H23O10) and 447.1299 (C22H23O10), 533.1295 (C25H25O13) and
533.1309 (C25H25O13), 285.0753 (C16H13O5) and 285.0752
(C16H13O5), two sets of glucosides, glucoside malonates and agly-
cones were observed, all sharing identical fragmentation pattern.
The same neutral losses could be detected as in the case of
formononetin, namely the loss of a CH3
• and a CH3OH, which are a
result of a methoxy substitution. These cleavages could be combined
with the loss of two CO moieties, resulting in ions at m/z 270.0521
(C15H10O5) [M + H‐CH3
•]+, 253.0491 (C15H9O4) [M + H‐CH3OH]
+,
225.0542 (C14H9O3) [M + H‐CH3OH‐CO]
+, 213.0542 (C13H9O3)
[M + H‐CH4OH‐CO‐CO]
+, 197.0594 (C13H9O2) [M + H‐CH3OH‐
CO‐CO]+ (Table 1). The ion at m/z 137.0232 (C7H5O3) was presumed
to be the rDA fragment containing the A‐ring, demonstrating that it
could not bear any other substituents but the hydroxy group at C7
(Figure 4A). As a result, these molecules were tentatively identified
as structural isomers differing only in the position of the hydroxy
and methoxy groups of the B‐ring. As even the ratios of the fragment
ions were not significantly different, the two sets were not distin-
guishable relying only on mass spectrometry data. Since the firstly
eluting peaks of the pairs were always higher in relative quantity (see
Figure 1), it was presumed that peaks 2, 11, and 30 have the same
aglycone, and 4, 16, and 34 another one. The identity of the agly-
cones was investigated using calycosin as standard substance and
its retention time and MS/MS spectrum matched with the later elut-
ing peak (34). As Addotey et al. isolated calycosin D from O. spinosa,20
which differ only in the position of a methyl group (see Figure 7), it
FIGURE 3
The structure of puerol derivatives
FIGURE 4 Schematic structures and main
proposed fragmentation patterns of Ononis
isoflavonoids (A), pterocarpans (B),
dihydroisoflavonoids (C) and their glycosides (D)
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was hypothesized that the major peaks (4, 16, and 34) are the deriv-
atives of this molecule. To verify this hypothesis, the firstly eluting
relative larger peaks (2 and 11) were isolated and investigated by
NMR. Based on the NOESY spectra, they were the 7‐O‐glucoside
and 7‐O‐glucoside 6″‐O‐malonate of calycosin D, so that peaks 4
and16were tentatively identified as the 7‐O‐glucoside and 7‐O‐glucoside
6″‐O‐malonate of calycosin, respectively. Peaks 19, 25, and 35
(Figure 1D) had a pseudo‐molecular ion at 445.1124 (C22H21O10),
531.1125 (C25H23O13) and 531.1132 (C25H23O13) and each provided
the same fragment ions with peak 44 at m/z 283.0596 (C16H11O5).
The fragments, which were formed by the loss of a CH3OH unit from
the protonated calycosin ion (m/z 253.0491, 225.0543, 197.0595),
could be observed with these molecules as well. As the protonated
molecular formula of calycosin contains two hydrogens more
(C16H13O5) than the aglycone of these molecules (C16H11O5)
(Table 1), the cause of the same fragment ions is the neutral loss of
CH2O unit instead of a CH3OH unit. Considering these results, the
peaks were tentatively identified as the 7‐O‐β‐D‐glucoside (19), 4″
and 6″‐malonates (25 and 35), and the aglycone of pseudobaptigenin
(44) (Figure 7).
3.4 | Identification of pterocarpans
Peaks 32 and 39 (Figure 1G) had a pseudo‐molecular ion at m/z
433.1487 (C22H25O9) and 519.1488 (C25H27O12) and showed a com-
mon aglycone fragment at m/z 271.0959 (C16H15O4) with 47. Their
MS/MS fragments could be detected at m/z 161.0595 (C10H9O2),
137.0595 (C8H9O2), and 123.0441 (C7H7O2) (Table 1). These results
were in concordance with the fragmentation pattern of the
pterocarpan medicarpin 3‐O‐β‐D‐glucoside (32), medicarpin 3‐O‐β‐D‐
glucoside 6″‐malonate (39), and medicarpin aglycone (47) (Figure 7).
The ion at m/z 161.0595 is corresponding to the loss of a C6H6O2
([1,4A]+) unit, which can be a consequence of the cleavage of the bonds
1 and 4, whereas the ions atm/z 123.0441 and 137.0595 are the prod-
ucts of the cleavage of bond 2 and 4, resulting [2,4A]+ and [2,4B]+,
respectively (Figure 4C). Peaks 27, 38, and 42 (Figure 1H) showed sim-
ilar fragmentation pattern to those of medicarpin; however, a 14‐Da
difference (+O‐2H) could be observed in the case of the quasi‐
molecular ions and the fragment ions containing the B‐ring, namely at
m/z 175.0388 (C10H7O3) [M + H‐ C6H6O2]
+ and 151.0388 (C8H7O3)
[2,4B]+. Based on this fragmentation pattern and analogy with
medicarpin, these ions could be tentatively identified as maackiain
3‐O‐β‐D‐glucoside (27), maackiain 3‐O‐β‐D‐glucoside 6″‐malonate
(38), and maackiain (42) (Figure 7). As the two molecules differ only in
the substitution of the B‐ring, the fragment originating from the A‐ring
is the same at m/z 123.0442 [2,4A]+.
3.5 | Identification of dihydroisoflavonoids
Peak 24, 29, 36, and 45 (Figure 1E) had the quasi‐molecular ions atm/z
463.1591 (C23H27O10), 549.1600, 549.1595 (C26H29O13), and
301.1061 (C17H17O5), and their fragmentation pattern significantly
differed from those of the isoflavones. The MS/MS of these ions
produced m/z 283.0965 (C17H15O4) and 273.1119 (C16H17O4) ions,
corresponding to the initial ejection of a H2O or a CO unit
(Table 1). The two intense fragment ions at m/z 163.0388 (C9H7O3)
and 135.0440 (C8H7O2) could be attributed to [M + H‐B‐ring]
+ and
[M + H‐B‐ring‐CO]+ (Figure 4B). This typical fragmentation pattern
was in agreement with our previous results10; consequently, the
peaks were tentatively identified as the 7‐O‐glucoside (24), the 4″
and 6″‐O‐glucoside malonates (29 and 36), and the aglycone (45) of
sativanone (Figure 7). The molecular formula of peaks 22, 28, 33,
and 41 (Figure 1F) differed from the corresponding ones of
sativanone in that of an extra oxygen and the lack of the two hydro-
gens which could be a consequence of a methylenedioxy substitution
instead of a methoxy group. The loss of H2O and CO units could be
observed on the MS/MS spectra at m/z 297.0753 (C17H13O5) and
287.0909 (C16H15O5). Proving that the substitution patterns of the
A‐ring of sativanone and the aglycone of these molecules are identi-
cal, the same ions at m/z 163.0388 and 135.0440 could be detected.
Moreover, as an evidence of the methylenedioxy substituent, ions at
m/z 257.0804 (C15H13O4) [M + H‐CO‐CH2O]
+ and 229.0857
(C14H13O3) [M + H‐2CO‐CH2O]
+ could be detected (Table 1).
Regarding these aspects, the structures were putatively identified as
the 7‐O‐glucoside (22), 4″ and 6″‐O‐glucoside malonates (28 and 33),
and aglycone (41) of onogenin (Figure 7).
3.6 | Identification of the rare 2′‐methoxy
isoflavonoids
All the former discussed isoflavonoids, dihydroisoflavonoids, and
pterocarpans were already known for O. spinosa10; however, peak
43 showed a m/z value for the aglycone which was not mentioned
in Ononis species before. The formula calculated from the HR‐MS data
was C17H14O5 (Table 1), which could refer to known compounds
afrormosin, cladrin, or 2′‐methoxy formononetin. As a result of CID,
ions at m/z 284.0658 (C16H12O5), 267.0649 (C16H11O4), and
252.0412 (C15H8O4) were detected, which could refer to structures
[M + H‐CH3
•]+, [M + H‐CH3OH]
+, and [M + H‐CH3
•‐CH3OH]
+,
respectively. These fragments clearly showed that the molecule
contained two methoxy groups. The product ion at m/z 243.1014
(C15H15O3) is a result of the ejection of two CO molecules, which is
diagnostic to isoflavonoid molecules.12 The cleavage of the bond
between the C‐ring and B‐ring could provide ions at m/z 163.0387
(C9H7O3) [M + H‐B‐ring]
+ and 137.0596 (C8H9O2) [B‐ring+H]
+.
Regarding this fragmentation pattern, the A‐ring can only bear a
hydroxy group, and the two methoxy groups are localized on the B‐
ring. Further evidence for the position of the substituents is provided
by the fragment at m/z 148.0517 (C9H8O2), which was presumed to
be the rDA product [1,3B‐CH3
•]+. This fragment corresponds to the
[1,3B‐CH3
•]+ ion in the MS/MS spectra of formononetin, and the mass
difference is caused by an extra methoxy substituent. Since
afrormosin has a methoxy and a hydroxy group on the A‐ring and a
single methoxy substituent on the B‐ring, it could be excluded from
the list of possible structures (Figure 5). Comparing the MS/MS spec-
tra of cladrin26,27 and 2′‐methoxy formononetin28 with our data, the
peaks at m/z 163.0, 148.1, and 137.1 could be observed in all cases
indicating the double methoxy substitution of the B‐ring; however,
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inspecting fragments in higher m/z regions, our detected peaks were
clearly in agreement with the ones of the 2′‐methoxy formononetin.
2′‐Methoxy formononetin has been isolated from Dalbergia parviflora
L.29 and from Eschscholtzia californica L. (California poppy),30 but not
from Ononis species. The protonated formula calculated based on
the exact mass for peak 40 (C17H13O6) (Table 1) suggests that this
compound contains an extra oxygen atom and misses two hydrogens
atoms compared with 2′‐methoxy formononetin. The origin of this dif-
ference could be the methoxy‐methylenedioxy substitutions of
isoflavonoids, just like in the case of formononetin‐pseudobaptigenin,
sativanone‐onogenin, and medicarpin‐maackiain pairs. The mass dif-
ference could be followed through the ions with smaller m/z ratio at
151.0388 (C8H7O3) and 162.0310 (C9H6O3), which are corresponding
to the ones of 2′‐methoxy formononetin at m/z 137.0596 (C8H9O2)
and 148.0517 (C9H8O2) and were assigned as [
1,3B‐CH3
•]+ and [B‐
ring+H]+ (Figure 6). Consequently, it can be deduced that the mass dif-
ference arose from the substitution pattern of the B‐ring, meaning
that beside a methoxy group an additional methylenedioxy group is
localized on it. As a proof of the mutual presence of OCH3 and
OCH2O substituents, the loss of CH3
•, CH3OH, and CH2O units and
their combination could be observed on the MS/MS spectrum at m/
z 298.0469 (C16H10O6) [M + H‐CH3
•]+, 283.0598 (C16H11O5)
[M + H‐CH2O]
+, 281.0440 (C16H9O5) [M + H‐CH3OH]
+, and
268.0362 (C15H8O5) [M + H‐CH3
•‐CH2O]
+. Similarly to other
isoflavones, the loss of CO units was also detectable at m/z
255.0647 (C15H11O4) [M + H‐CH2O‐CO]
+, 240.0413 (C14H8O4)
[M + H‐CH3
•‐CH2O‐CO]
+, and 212.0465 (C13H8O3) [M + H‐CH3
•‐
CH2O‐2CO]
+ (Table 1). In the literature, only cuneatin fulfills these
structural criteria. Cuneatin was described in aerial parts of Millettia
oblata ssp. teitensis,31 aerial parts of Retama sphaerocarpa,32 stem bark
of Dalbergia frutescens,33 Eysenhardtia polystachya,34 aerial parts and
roots of Tephrosia maxima35 and most importantly, in Cicer species.36
In his other work,37 Ingham had shown the chemotaxonomic similarity
of genus Ononis and Cicer, and the presence of cuneatin in both genus
corroborates this idea.
Other confirmations of the presence of 2′‐methoxy formononetin
and cuneatin could be acquired from the biosynthesis of isoflavonoids.
The final products of the isoflavonoid biosynthesis are medicarpin and
maackiain (Figure 7). These phytoalexins with pterocarpan skeleton
possess a methoxy and a methylenedioxy group, respectively.
Formononetin serves as the parent compound of medicarpin, and
through the calycosin‐pseudobaptigenin route it could also be consid-
ered as the precursor of maackiain. Both formononetin and
pseudobaptigenin undergo hydroxylation, converting to 2′‐hydroxy
formononetin and 2′‐hydroxy pseudobaptigenin. These molecules
were not detected in our sample; however, their 2′‐O‐methylated
derivatives, 2′‐methoxy formononetin, and cuneatin were confirmed.
In the following step, the 2′‐hydroxy isoflavones are reduced to the
dihydro‐derivatives: vestitone and sophorol.38 Their 2′‐O‐methylated
derivatives, sativanone and onogenin, are representative compound
in Ononis species, as well as the pterocarpan medicarpin and
maackiain.39
3.7 | Identification of beta amino acid derivatives
The most intense peaks in the chromatogram in positive ionization
mode were 12, 13, 14, 17, 20, and 23 (Figure 1). Based on our previ-
ous work,11 these compounds were identified as homopipecolic acid
esters of isoflavonoid glucosides. These molecules are analogous
structures to glucoside malonates, but instead of a malonic acid, the
beta amino acid homopipecolic acid is involved in the esterification.
However, their fragmentation differs rather from the glucoside
malonates, where solely the 0Y+ ion and its fragments emerge and
the glucose moiety along with the malonic acid cleave as a neutral
fragment (Figure 4D). In the case of homopipecolic esters, the beta
amino acid protonates relatively easily due to the secondary amine
function enabling the detection of the fragments containing the glyco-
sidic part as well (Table 1). These nitrogen‐containing product ions
were common for all six isoflavonoid derivatives, whereas the exact
mass of the 0Y+ ion and its smaller fractions promoted the identifica-
tion of the aglycone. The whole homopipecolic acid isoflavonoid
FIGURE 5 Proposed fragmentation pathway of 2′‐methoxy
formononetin
FIGURE 6 Proposed fragmentation pathway of cuneatin
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glucoside ester could cleave alongside the glycosidic bond, resulting in
the intact protonated aglycone or the homopipecolic glucoside ester
with a truncated glucose moiety at m/z 288.1435 (C13H22NO6). As a
protonated fragment at m/z 144.1017 (C7H14NO2), the beta amino
acid unit dissociates from the molecule. The cleavage of the heterocy-
clic ring solely could provide the ion at m/z 84.0814 (C5H10N)
(Figure 8A). Interestingly, an analogous fragmentation pattern could
be observed for compounds 3, 5, 8, 9, 10, and 15. The HR‐MS/MS
data suggested that these compounds contained the same
isoflavonoid aglycones mentioned before; however, the complete for-
mula is short of a CH2 unit (Table 1). Investigating the MS/MS spectra,
fragment ions at m/z 274.1284 (C12H20NO6), 130.0862 (C6H12NO2),
and 70.0658 (C4H8N) were detected, indicating that the CH2 differ-
ence arose from the heterocyclic ring (Figure 8B). As a homologue of
homopipecolic acid, the pyrrolidine ring containing beta amino acid
homoproline was presumed.
Although, these nitrogen‐containing esters ionize extremely well
in positive mode, their actual quantity compared with other
isoflavonoid derivatives is quite low. The homoproline derivatives
are orders of magnitude lower compared with the homopipecolic
esters; therefore, their isolation for NMR experiments was not feasi-
ble. In order to verify that the compounds 3, 5, 8, 9, 10, and 15 are
homoproline derivatives, the sample was subjected to hydrolysis to
free beta amino acids. This hydrolyzed sample was then spiked with
the a standard solution of homopipecolic acid and homoproline in
aqueous medium, as they tend to form esters with methanol.40 The
original and the spiked samples were investigated by HPLC‐MS/MS.
As no differences were observed in retention time and in fragmenta-
tion pattern (Figure 9), it could be concluded that the samples actually
contained the esters of homopipecolic acid and homoproline.
Homopipecolic acid was described before in Lycopodium species as
an intermediate of the synthesis of Lycopodium alkaloids,41,42 while
homoproline was isolated from Asteraceae species, as a precursor of
pyrrolizidines,40 but their co‐occurrence has never been reported in
plants and their biosynthetic origin is not known.
FIGURE 8 The proposed fragmentation pathways of homopipecolic
acid (A) and homoproline esters (B)
FIGURE 7 Biosynthesis of isoflavonoid and pterocarpans (based on the work of Davies and Schwinn, 2006). Grey: Compounds not detected.
Dashed arrows: Unknown enzymatic steps
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